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Existing limitations of conventional Nucleic Acid (NA) detection prompted us to conduct a 
Proof-of-Concept of a novel NA sensing platform called environment-Sensing Response 
System (e-SRS), which could deliver a physical response upon sensing its NA Target 
Sequence (NTS). e-SRS is a NA sensing and response system with two components: 1) An 
RNA based sensor that changes conformation and activates upon binding specific NTS; 2) A 
Response System that is triggered by the activated sensor to initiate some physical response, 
such as emitting a fluorescent signal to indicate presence of the NTS, or other biomolecular 
actions like induction of gene expression. Its modular nature, whereby the sensor is separate 
from the Response System, allows e-SRS flexibility in adapting to different formats and 
applications. 
The ability to activate Response System after sensing enables the e-SRS sensor to serve as a 
signal transducer, which passes a signal of one form from the environment (e.g. presence of 
specific NA), to that of another form as produced by the Response System (e.g. activation of 
inducible expression system). A biomolecular signal transducer could function in more diverse 
ways than a biomolecular probe, and could be a powerful tool in research, diagnostics and 
therapy. 
After initial tests, an early design known as e-SIGE was unworkable, likely because the 
sensor’s RNA folding was designed without computational secondary structure prediction. 
The RNA folding likely did not occur as intended. 
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We redesigned the physical implementation to create the current e-SRS, adapting an existing 
allosteric ribozyme, the Maxizyme, as e-SRS sensor, employing computational secondary 
structure prediction. We were able to successfully test e-SRS in the test tube environment via 
Ribozyme Trans-cleavage Assays (RTA). Unsatisfied with RNA cleavage assays via 
Denaturing Polyacrylamide Gel Electrophoresis, we developed the Reporter Substrate (RS), 
which provided real time fluorescence reporting of e-SRS sensor activity, and served as a gene 
detection Response System. Our attempts to activate an inducible gene system as the 
Response System within cell lines were unsuccessful, likely due to interfering RNA secondary 
structure in the cellular environment. 
e-SRS sensor with RS for fluorescence based real-time test tube detection and resolution of 
closely related RNA sequences was tested on 7 NTS from 2 categories: 1) 3 strains of Malaria 
parasites (Plasmodium falciparum), denoted as Mfs, Mfr1, and Mfr2; 2) 4 common serotypes 
of Dengue viruses, denoted as D1, D2, D3, and D4. We developed a computational algorithm 
in Perl that greatly automated the design and assessment of e-SRS Mz-based sensors. 
Our seven e-SRS sensors were optimised to specifically detect their sNTS (19 to 24 nt 
synthesised RNA). Addition of a 24 nt “competitor nucleotide” (sNTS-Mfr2) allowed Mfr1 
e-SRS sensor to distinguish a single nucleotide difference out of 24 nt between Mfs and Mfr1. 
For Malaria, we created long NTS (120 nt) from genomic sequences using NASBA 
(isothermal RNA amplification). Addition of antisense oligonucleotides allowed the detection 
of otherwise undetectable long NTS. Mfs and Mfr2 long NTS were specifically detected, 
while the same for Mfr1 required further work to establish.
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AS Antisense oligonucleotides. Added to long NTS to improve access to the NTS by 
binding to sequences close to and flanking the NTS. 
e-SRS environment-Sensing Response System. A system that senses the environment (e.g. a 
specific mRNA or metabolite) and couples this sensing to the regulation of RS or 
PLG(s) expression(s). 
iECFP pcDNA4/TO/ECFP/myc-His A plasmid with the ECFP sequence cloned into the 
provided MCS. The starting “i” stands for “inducible”. 
iEGFP pcDNA4/TO/EGFP/myc-His A plasmid with the EGFP sequence cloned into the 
provided MCS. The starting “i” stands for “inducible”. 
iEYFP pcDNA4/TO/EYFP/myc-His A plasmid with the EYFP sequence cloned into the 
provided MCS. The starting “i” stands for “inducible”. 
NASBA Nucleic Acid Sequence-Based Amplification. An isothermal amplification 
technique that amplifies DNA or RNA into RNA. 
NNS Nucleic acid Non-targeted Sequence. Typically an RNA sequence that is close to the 
NTS, and needs to be distinguished from the NTS by e-SRS. 
NTS Nucleic acid Target Sequence. An nucleic acid sequence that is to be targeted or 
identified by e-SRS. 
NTS’ Reverse complement of NTS. 
PCR Polymerase Chain Reaction. 
PLG Payload gene. A “gene” (could be a protein coding gene, or a non-coding “gene”, such 
as siRNA, antisense, Rz, or miRNA) whose expression that is regulated by e-SRS. 
pTR pcDNA6/TR plasmid that expresses the repressor protein, R1. 
pPLG pcDNA4/TO/myc-His plasmid with a PLG cloned into the provided MCS. 
RCA Ribozyme Cis-cleavage Assays. 
RCAA Ribozyme Cis-cleavage Allosteric Assay. RCA with an allosteric RNA trigger. 
RS Reporter Substrate. 
RTA Ribozyme Trans-cleavage Assays. 
SB Stability Buffer. Used in the stability analysis of RNA combinations of 
Mz+NTS+STS, Mz+NNS+STS and Mz+STS structures. This indicated how much 
“buffer” the most stable structure had for it to stay in its conformation, and thus how 
stable that particular structure was likely to be. 
SB% 
SB calculated as a percentage of the free energy value of the most stable structure. 
structure) stable(most Energy 
SB 100%  SB%   
SAS Sensor Arm Split. The MzL segment of the sensor arm is separated from the MzR 
segment at the SAS. The SAS is defined numerically as the number of sensor arm 
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Term Explanation 
nucleotides that exist on the MzR. 
SAS’ SAS’ is the corresponding point of the SAS on the NTS that separates the segment that 
binds to MzL and the segment that binds to MzR. 
sNTS Short NTS. 
STS Substrate Target Sequence. An RNA sequence that is cleaved by the activated e-SRS 
sensor (typically existing on the RS, or the mRNA sequence of a repressor involved in 
repressing the PLG). 
STS’ Reverse complement of STS. 
tRES tRNA expression system. This is an RNA expression plasmid where the RNA to be 
expressed is placed under a pol III promoter. The version used here is that of a 
modified human tRNA for Valine (tRNAVal) with the last seven bases removed and 
replaced with a short linker to prevent 3’ end processing.  
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CHAPTER 1 INTRODUCTION 
1.1 Conventional methods of Nucleic Acid sequences 
detection 
Conventional methods of detecting Nucleic Acid sequences (NA) are based on hybridisation 
of complementary fluorescent or radioactive oligonucleotides to target NA, such as 
fluorescence in situ hybridization (FISH). Various implementations of FISH includes probes 
consisting of DNA, RNA, 2’-O-methyl RNA, and protein nucleic acids [Dirks et al, 2003]. 
However, such methods utilising hybridisation alone have two intrinsic weaknesses: 1) They 
are often limited in their ability to detect small differences in sequence, especially single 
nucleotide differences (SND), and 2) They usually have poor Signal to Noise Ratio (SNR) as 
typically each hybridisation of probe and target results in only 1 signal generation event, 
meaning that each target transcript can at most give rise to a single weak signal. In addition, 
the more probes added, the more unhybridised probes exist, which contribute to a significant 
background. 
The lack of signal amplification of conventional hybridisation probes often result in the need 
for a prior NA amplification step, such as Polymerase Chain Reaction (PCR), before they can 
be applied to gene detection. Many conventional methods of gene detection simply rely on 
amplification of targeted DNA using gene specific primers, followed by gel electrophoresis 
and staining with NA binding dyes such as ethidium bromide. Such methods are usually 
equipment/expertise demanding (e.g. thermal cyclers or melting curve analysis in quantitative 
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PCR) and are laborious and time consuming (e.g. gel running and staining). In addition, PCR 
detection of SND is also difficult to achieve. 
There have been attempts to produce better fluorescent probes, such as the Pleiades probes, 
which contain a minor groove binder that improves specificity and reduces background 
fluorescence [Lukhtanov et al, 2007]; or the NABit probe that has green fluorescence only 
upon hybridisation [Kubota et al, 2007]. However, none of these have become mainstream 
methods. Moreover, they lack the power of amplification, hence limiting sensitivity. 
The relatively recent introduction of Molecular Beacons (MB) has significantly improved 
specificity and SNR [Tyagi & Kramer, 1996]. A MB comprises of an oligonucleotide 
conjugated on opposite ends with a fluorescence reporter and a quencher that are 
constitutively close by, and which separate upon binding of target NA and thus generate 
significant fluorescent signal only when hybridised. However the same limitation of 
generating at most 1 fluorescent reporter per copy of target NA exist. 
The environment-Sensing Response System (e-SRS) is a NA sensing and response system that 
could overcome the two intrinsic limitations of conventional hybridisation probes. When used 
as an in vitro gene detection tool with the Reporter Substrate (RS), each e-SRS sensor upon 
activation by the target NA can activate many copies of the RS, resulting in signal (e.g. 
fluorescence) amplification. While each e-SRS sensor activation is initiated by hybridisation 
to the target NA, precise conformational changes of the sensor (that are dependent on proper 
hybridisation) are required for eventual sensor activation, implying that requirement for 
correct hybridisation is higher than conventional probes, resulting in higher specificity. While 
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the typical SND detection precision of the MB can detect SND in 15 nt of probe region 
[Bonnet et al, 1999], we have shown that e-SRS is capable of detecting SND in up to 24 nt of 
probe region. As such, e-SRS with RS offers an alternative to conventional hybridisation 
probes for in vitro gene detection that has both signal amplification and better specificity. 
1.2 Ribozymes 
Nucleic acids do not merely passively “store” genetic information. Many of them, especially 
RNA, are possessed of enzymatic activities and thus are also “executers” of genetic 
instructions. An RNA that is able to catalyse the cleavage and ligation of the RNA backbone 
phosphodiester linkage is called a ribozyme (Rz) [Sun et al, 2000]. 
A Rz has a catalytic domain that usually requires Mg2+ or other divalent cations for its 
enzymatic interaction with the cleavage site on the substrate RNA. Specificity of the location 
of cleavage is usually determined by two factors. 1) A Rz usually has two binding arms that 
bind the sequences flanking the cleavage site on the substrate, via Watson-Crick base-pairing. 
2) The cleavage site on the substrate usually has a consensus sequence requirement, which 
varies according to the type of Rz cleaving it. 
Some common Rz types include the Hammerhead Rz, Hairpin Rz, and the Hepatitis delta 
virus Rz, whose cleavage sites and schematic diagrams are shown in Table 1.2-1 and Figure 
1.2-1 respectively. 
Table 1.2-1 Common ribozymes and their cleavage sites. 
Ribozyme type Cleavage site Example of cleavage site 
Hammerhead ribozyme NUX^ GUC^ (the WT sequence) 
Hairpin ribozyme N^GNN C^GUC 
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Ribozyme type Cleavage site Example of cleavage site 
Hepatitis delta virus ribozyme 5’ of G-U wobble pair on the P1 
stem (G on substrate and U on 
Rz) located at 5’ end of 
cleavage site. 
^GUGGUUU 









Hepatitis delta virus Rz 
Figure 1.2-1 Adapted from [Sun et al, 2000]. Schematic diagrams of three common 
ribozymes. 
Cleavage locations are indicated by arrow. 
Aside from Watson-Crick base-pairing, nucleic acids are also able to interact with ligands via 
other molecular interactions along their three dimensional structures [Nimjee et al, 2005]. 
Aptamers are nucleic acids that bind strongly and specifically to their ligands. In fact, RNA 
aptamers binds their specific ligands with affinity matching and even exceeding (dissociation 
constants in low picomolar to nanomolar range) that of antibodies [Breaker, 2004]. 
The specific binding activity of aptamers can be selected in an in vitro evolution process 
known as SELEX (Systematic Evolution of Ligands by EXponential Enrichment) [Tuerk & 
Gold, 1990; Breaker, 2004]. The process starts with about 1014 to 1015 random sequences that 
are incubated with target molecules immobilised on a surface. Non-binding sequences are 
washed off, and binding sequences are amplified via RT-PCR and then in vitro transcribed to 
produce the candidates of the next selection round. After about 8-12 rounds of selection & 
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amplification, the final RNAs cloned & sequenced as highly selective RNA aptamers. The 
SELEX process is in vitro, fast, and can be used to generate aptamers for almost any target 
biomolecule. 
Aptamers hold many advantages over protein antibodies [Nimjee et al, 2005], including: 1) In 
vitro selection is fast and applicable for any protein target. 2) A specific region of a ligand can 
be targeted. 3) Low or no evidence of immunogenicity. 4) Cross-species reactive aptamers can 
be generated using “toggle” strategy. 5) Uniform quality, regardless of synthesis batch. 6) 
Antidote (neutralising agent) to aptamer can be easily designed via Watson-Crick base 
pairing. 
With both catalytic and specific binding capabilities, the fundamentals are present for nucleic 
acids to take on the role of biomolecular regulation. In fact, many examples already exist, 
both in nature and in the laboratory. 
In nature, an RNA with both an aptamer domain and expression platform is called a 
riboswitch [Soukup & Soukup, 2004]. The aptamer domain (~70-170 nt) is usually located 5’ 
of a nascent mRNA. The expression platform is usually 3’ of the aptamer domain and can 
sometimes overlap with it. When the aptamer domain binds its specific ligand, it undergoes 
conformational changes that are transduced onto and activate the expression platform. The 
activated expression platform controls the expression of the gene downstream via allosteric 
modulation of the 5’ UTR structure, such as by forming Rho-independent transcriptional 
terminators hairpins, by sequestering the ribosome binding site (RBS), or by ribozyme 
cleavage of the mRNA. 
 6 
One example of a riboswitch in nature is the bacterial glmS mRNA that encodes the 
glutamine-fructose-6-phosphate amidotransferase enzyme, which uses fructose-6-phosphate 
and glutamine to generate Glucosamine-6-phosphate (GlcN6P), contains a riboswitch at its 5’ 
UTR [Winkler et al, 2004]. This riboswitch regulates the glmS expression via negative 
feedback as the end product GlcN6P is the metabolite ligand for and activates the riboswitch, 
which then cleaves the glmS mRNA and reduces its translation. In fact, the ribozyme activity 
of the riboswitch is increased up to 1000 fold in the presence of its ligand. Such a ribozyme is 
known as an allosteric Rz as its activator (the ligand) is different from its substrate (glmS 
mRNA). 
In the laboratory, an RNA aptamer had been designed against Human Coagulation Factor IXa 
(FIXa) that could induce dose-dependent reduction of coagulation to less than 1% of normal 
FIXa activity. This aptamer could thus serve as an anticoagulant. However, it is just as 
important to prevent excessive bleeding from an overly high dose of the aptamer, hence an 
antidote was created that consisted of a short RNA complementary to a large section of the 
aptamer. This antidote was able to neutralise more than 95% of the anticoagulation activity of 
a cholesterol modified aptamer within 10 minutes of its bolus injection [Rusconi et al, 2004]. 
In a potentially more far-reaching attempt, a metabolite (theophylline) specific aptamer had 
been designed to regulate the expression of another gene by sequestering its RBS in the 
presence of the metabolite [Bayer & Smolke, 2005]. These “programmable ligand-controlled 
riboregulators of eukaryotic gene expression” could distinguish between metabolites as 
similar as theophylline and caffeine, which differ by only a methyl group. 
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[Bergeron & Perreault, 2005] provided yet further demonstrations that Rz are amenable to 
Watson-Crick base-pairing based adjustment of their structures, and can be modularly adapted 
to suit the desired gene regulation. The wild type Hepatitis delta virus Rz cleaves any RNA 
that can bind correctly to its 7 nt P1 stem. [Bergeron & Perreault, 2005] changed its selectivity 
by adding a SOFA (specific on/off adapter) domain, that “locked” the natural P1 stem. SOFA 
only allowed P1 stem binding to a substrate RNA if the substrate had a 3’ sequence that could 
bind to the biosensor (BS) region within SOFA (see Figure 1.2-2). This effectively improved 
the specificity of the Rz, and changed the specificity requirements from the short P1 stem, into 
a longer, specific sequence. This longer, specific sequence could be changed as desired by 
designing the BS region as the reverse complement of the desired target sequence (P1 stem 
complementarity is still required). The addition of SOFA therefore allows the Hepatitis delta 




Figure 1.2-2 From [Bergeron & Perreault, 2005]. Schematic diagrams of the 
SOFA-ribozyme. 
In A, the addition of the target RNA changes the Rz from an inactive “OFF” conformation 
into an active “ON” conformation. In B, the SOFA domain (highlighted in grey) was shown 
to lock the P1 stem, until the target RNA was added. The cleavage location on the 
substrate RNA was indicated by the bold arrow. 
In summary, RNAs have characteristics that are amenable for development as biomolecular 
sensors. Both in nature and in the laboratory, RNAs have been utilized, and even engineered 
to detect biomolecules. However, most of these RNAs were used to sense metabolites or as 
RNA knock down tools. To the best of our knowledge, there had been no significant work to 
produce an RNA based sensor that could be designed to detect any desired RNA sequence and 
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to subsequently use that information to trigger a response system. This work therefore 
endeavoured to design such an RNA based sense and response sytem that we called the 
environment-Sensing Response System (e-SRS). 
1.3 environment-Sensing Response System (e-SRS) 
1.3.1 Motivation for e-SRS 
The existing limitations of conventional Nucleic Acid (NA) detection, as well as a lack of a 
NA sensing platform that could actually deliver a physical action or response within the 
system being sensed, prompted us to search for a means to provide such a platform. The 
ability to react after sensing (as opposed to merely giving off a hybridisation signal like 
conventional hybridisation probes) enables the e-SRS sensor to serve as a signal transducer, 
which is able to convert a signal of one form from the environment (e.g. presence of a specific 
NA), to that of another form as produced by the Response System (e.g. activation of an 
inducible expression system). A biomolecular signal transducer could function in much more 
diverse ways than just a biomolecular probe, and could be a new and powerful tool in research, 
diagnostics and therapy. 
Ribozymes (Rz), being able to both sense NA (via annealing), and respond (by catalytic 
cleavage of RNA substrates) stood out as prime candidates for the signal transducer in a sense 
and respond system. What was required was to design the Rz secondary structure such that 
target sensing could be used to induce a change in conformation that allows the Rz’s catalytic 
abilities to be activated. Importantly, to be able to act as a signal transducer, we needed a 
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system whereby the NA sensed is not the NA cleaved (the typical case for natural Rz). In this 
way, the system would no longer be just another RNA knock-down tool. 
The outcome of our innovation efforts was the environment-Sensing Response System 
(e-SRS). e-SRS is a nucleic acid sensing and response system with two components: 1) An 
RNA based sensor that changes conformation upon binding of specific Nucleic acid Target 
Sequence (NTS); 2) A Response System that is triggered by the activated sensor to initiate 
some physical response, such as emitting a signal (e.g. fluorescence) to indicate the presence 
of the NTS, or to activate some downstream action such as gene expression. 
e-SRS aimed to provide a highly sequence specific (with resolution down to Single 
Nucleotide Differences, SND) molecular sensor (with signal amplification ability) to detect 
specific RNA or DNA sequences, which could be modularly coupled to various desired 
Response System. The modular use of different Response System, from unquenching of 
fluorescence RS to induction of gene expression, is novel and potentially allows a wide range 
of applications, ranging from gene detection (if the Response System is a RS) to killing of 
malignant cells (if the Response System is an inducible cytotoxic gene). In the existing final 
embodiment, we employed a fluorescence based RS as the Response System and applied 
e-SRS to the detection and resolution of closely related RNA sequences in test tubes. 
1.3.2 Development of e-SRS 
The initial concept was a system named Environment-Sensing Induced Gene Expression 
(e-SIGE). e-SIGE shared a similar principle as e-SRS, but was more complex in its physical 
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implementation. e-SIGE was jointly conceived by the author (Mr. LEONG Shiang Rong) and 
Mr. NG Kwang Loong Stanley on 14th March 2005 at Bioinformatics Institute (BII, 
A*STAR), independently of BII’s core projects. The author and Mr. Ng KL communicated to 
Prof. Mishra SK (then Executive Director of BII) and to Exploit Technologies Pte Ltd (ETPL) 
for Invention Disclosure (ID) on 17th May 2005 (Invention Disclosure, ETPL, 2005). ETPL 
subsequently applied for a US provisional patent application on 08th June 2005. 
The author also applied (as Collaborator/Inventor) jointly with A/Prof. Soong Tuck Wah 
(NUS, Physiology, as PI), A/Prof. Hooi Shing Chuan (NUS, Physiology, as Co-PI), Prof. 
Santosh K. Mishra (then BII-A*STAR, as Co-PI), and Mr. Ng Kwang Loong Stanley (then 
NGS-AGS, as Collaborator/Inventor), and was awarded the 1st SBIC Innovative Grant to 
develop e-SIGE as a bioimaging tool. The Project Title was “A Novel E-SIGE Technology to 
Bioimage Alternative Splicing Activity in Neuron and Muscle” (SBIC Innovative Grant, 
2005). As such, the first two sections of this work endeavoured to develop an environment 
sensing response system based on the physical designs of e-SIGE. 
After the initial tests of RNA test constructs derived from the e-SIGE design, it was realised 
that the e-SIGE design was not feasible for our implementation. As the e-SIGE RNA foldings 
were designed by eye without computational secondary structure prediction, the folding of 
RNA in ways other than as intended was a likely reason for the failure of the e-SIGE design. 
The subsequent use of RNA secondary structure prediction and adaptation of an existing 
allosteric ribozyme, the Maxizymes [Kuwabara et al, 1998], enabled us to successfully design 
and test the new and much simpler e-SRS in test tube environment. In addition, our 
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unsatisfactory experience with RNA cleavage assays via Denaturing Polyacrylamide Gel 
Electrophoresis (D-PAGE) prompted us to search for a new assay method. This was realised 
with our development of the RS, which provided real time fluorescence based reporting of the 
e-SRS sensor activity. Our eventual realisation of the sense and response system was thus a 
combination of the e-SRS sensor with the RS, for fluorescence based real-time detection of 
RNA in the test tube. A more detailed overview of e-SRS development is given in CHAPTER 
2. 
1.4 Dengue 
Dengue fever (DF) is the most prevalent mosquito-borne viral illness in humans with an 
estimated yearly 100 million infections worldwide [Deen et al, 2006]. DF is characterized by 
high fever, chills, body aches and skin rash. Severity ranges from mild, flu-like symptoms to 
the more severe form, the dengue hemorrhagic fever (DHF). DHF affects around 250,000 to 
500,000 individuals a year, with a mortality rate as high as 10% to 20%. However, much of 
these mortality is due to a lack of early diagnosis [Samuel & Tyagi, 2006]. With early 
diagnosis and appropriate management mortality can be kept below 0.5% [Oishi et al, 2007]. 
There is currently no vaccine for dengue [Simmons & Farrar, 2009]. Dengue is now endemic 
in more than 100 countries, with 2.5 billion people living in dengue endemic areas. With the 
dramatic expansion of dengue incidence in recent decades, the World Health Organization has 
classified dengue as a major international public health concern. 
The causative agent is the mosquito-transmitted Dengue virus (DV). Four serologically 
 13 
distinct serotypes DEN-1, DEN-2, DEN-3, and DEN-4 exist. Infection with one serotype 
confers lifelong immunity to the same serotype [Lanciotti et al, 1992] but increases the risk of 
more severe disease including DHF upon infection with a different serotype [Guzmán & 
Kourí, 2004]. DV has a positive strand RNA genome about 10,200 nt long that codes for three 
structural (capsid, membrane and envelope) and seven non-structural proteins (NS1, NS2a, 
NS2b, NS3, NS4a, NS4b, and NS5) [Guzmán & Kourí, 2004]. 
Diagnosis of DV infection plays important roles in prevention, treatment, initiation of control 
measures, and keeping of accurate epidemiological data. Traditional assays for detection of 
DV serotypes includes serum dilution plaque reduction neutralization, complement fixation, 
and hemagglutination inhibition. The serotype is then inferred by detection of at least fourfold 
increase or reduction in serotype specific antibodies. Unfortunately, specific diagnosis is often 
difficult due to widespread antibodies cross-reactivity to flaviviruses, especially between DV 
strains [Lanciotti et al, 1992; Guzmán & Kourí, 2004]. The need for paired serum samples 
also result in a delay in diagnosis and results are usually not straightforward. 
For more definitive diagnosis, virus isolation using cell cultures or mosquitoes can be 
performed from patient serum collected during acute phase of disease or from mosquitoes. 
Sensitive methods include inoculation of adult A. aegypti or Toxorhynchites species 
mosquitoes and subsequently staining the mosquito brain tissues with fluorescent DV 
type-specific monoclonal antibodies [Samuel & Tyagi, 2006]. However, such methods take 
days to weeks and may not be successful due to insufficient viable virus in the inocula, 
virus-antibody complexes, and inappropriate handling of samples [Lanciotti et al, 1992]. 
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There is therefore a strong motivation for the development of DV diagnostic assays that are 
rapid, specific and sensitive so as to improve prevention, treatment, initiation of control 
measures, and the keeping of accurate epidemiological data. Modern molecular biology based 
diagnostic methods have evolved in an attempt to meet this need. DV antigen detection has 
traditionally been of low sensitivity, but in recent years, ELISA based detection of DEN-3 
antigen in serum has reached sensitivity of 90% [Guzmán & Kourí, 2004]. Of greater use for 
laboratory screening and molecular epidemiological studies are the RT-PCR based 
amplification of DV genome using either DV or serotype specific primers [Guzmán & Kourí, 
2004; Lanciotti et al, 1992], followed by gel analysis or melting curve analysis of amplicons. 
Dengue RNA has been detected via PCR from serum, plasma, infected cells, mosquito larvae 
and mosquito pools. Today, a laboratory diagnosis of DV infection can be established by 
detection of genomic sequences via RT-PCR. However, as PCR requires complex equipment 
and sophisticated interpretation skills (for melting curve analysis), a simpler yet fast and 
specific detection format would be greatly useful in field detection or in less development 
areas. As such, e-SRS is tested here as a potentially rapid, simple, and specific way to 
distinguish between the 4 Dengue serotypes RNA sequences. 
1.5 Malaria 
Malaria is a global health concern for which the Who Health Organization estimates 300 to 
500 million cases of infection with over one million deaths globally every year. The 
symptoms of malaria are caused by the asexual blood stages (rings, trophozoites, schizonts) of 
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the Malaria parasites, the Plasmodium species, which are thus the main target of 
chemotherapy. 
There are 4 Plasmodium species that infect humans [Griffith et al, 2007]: 
1) Plasmodium falciparum (Pf) predominates in sub-Saharan Africa, Hispaniola, Papua 
New Guinea (PNG), and includes both Chloroquine Resistant (CQR) and Sensitive 
(CQS) strains. CQR strains are in all endemic areas except Central America west of 
Panama Canal, Mexico, Hispaniola, & parts of China and Middle East. Pf accounts 
for slightly more than 50% of reported cases in US. 
2) Plasmodium vivax (Pv), the second most common species, predominates in South 
Asia, Eastern Europe, Northern Asia, Central and most of South America, and are 
mostly CQS except in PNG and Indonesia. Pv accounts for about 25% of reported 
cases in US. 
3) Plasmodium ovale occurs mostly in West Africa, occasionally in South East Asia and 
PNG., and are all CQS. 
4) Plasmodium malariae occurs at low frequency in patchy distribution worldwide, and 
are CQS. 
In Singapore, about 100 to 300 cases occur each year [Ministry of Health, 2004]. In 2006, the 
distribution of species causing infections are about 68.0 % for Plasmodium vivax, 26.0% for P. 
falciparum (26.0%), 2.2% for P. malariae, and 3.8% for mixed Plasmodium vivax and 
Plasmodium falciparum [Ministry of Health, 2006]. In 2009, there seemed to be a rise in 
Malaria infection, totalling 134 in the first 37 weeks, compared to only 119 for the same 
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period in 2008 [Ministry of Health, 2009]. 
In selecting the proper treatment for Malaria, Plasmodium species differentiation during 
diagnosis is essential [Mangold et al, 2005]. It is particularly important to differentiate P. 
falciparum infections from the rest, as such infections have potential to rapidly progress to 
severe illness or death, and are responsible for most of the deaths worldwide due to malaria. 
In the United States, P. falciparum accounts for about 95% of malaria deaths [Stoppacher & 
Adams, 2003].  
The current gold standard for diagnosis is the microscopic examination of Giemsa-stained 
thick and thin blood films [Murray et al, 2008]. In Singapore, if diagnosis is considered likely 
and initial blood films are negative, they are to be repeated 12 hourly for 48 hours [Ministry 
of Health, 2004]. 
While diagnosis by microscopy is cheap [Jonkman et al, 1995] and can reach a sensitivity of 
about 5 to 10 parasites/μl [Murray et al, 2008], it is time-consuming and requires the 
availability of a well trained microscopist who can distinguish the various Plasmodium 
species. Such expertise is not always readily available, particularly in non-endemic regions. In 
addition, misdiagnosis in blood film examination occurs even with experienced microscopists, 
especially in cases of mixed infection or low parasitaemia [Kilian et al, 2000; Hänscheid, 
2003]. 
There are three levels of diagnostic concerns in places where Malaria is not endemic, such as 
in Singapore: 
1) Firstly, the physician needs to know as quickly as possible if the patient presenting 
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symptoms of Malaria is indeed infected with the plasmodium parasite. If this is the 
case, the patient needs to be quickly isolated from human-vector contact to limit the 
spread of the infecting plasmodium specie(s). 
2) If malaria is confirmed, of particular urgency is the need to diagnose whether P. 
falciparum is present, as this is by far the most lethal of the 4 Plasmodium species 
that infect humans. 
3) If P. falciparum is present, it would be useful to know if it is of the CQS or CQR 
strain as that would determine whether Chloroquine would be used. 
Based on the urgency presented in the above three levels of diagnosis, it would be highly 
desirable to have a fast, kit based diagnostic method with simple reading of results that could 
be used in the general physician’s office. This is particularly so for the containment of new 
infections in non-endemic regions. 
Like in DV diagnosis, the need for more rapid, accurate, and simple assays have pushed for 
the development of molecular detection for Plasmodium diagnosis. One such development is 
that of Malaria Rapid Diagnostic Tests (MRDTs). MRDTs employ lateral-flow 
immunochromatographic methods, which are already commonly used in other diagnostic kits, 
such as pregnancy tests. The clinical sample liquid migrates via capillary action over the 
surface of a nitrocellulose membrane. If the appropriate antigen is present, it would be 
extracted and bound by a capture antibody immobilised on the nitrocellulose membrane. A 
detection antibody conjugated to an indicator (usually gold particles) in the mobile phase will 
then bind to the captured antigen and produce a visual signal on the membrane. Both 
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antibodies can be either monoclonal or polyclonal. The source of antigen used to induce these 
antibodies (i.e., native proteins, recombinant proteins, or peptides) can make significant 
differences in the performance of the MRDT [Murray et al, 2008]. 
Compared to the current gold standard of microscopy, MRDTs offer the much desired 
advantages of minimal operator training due to its ease of use, as well as rapid availability of 
results, usually in less than 1 hour [Murray et al, 2008]. However, MRDTs currently still 
suffer from limitations, such as reports of antigen persistence, particularly that of 
histidine-rich protein II (HRP-II), even after the clearance of malaria parasites [Mens et al, 
2007], poor sensitivities at low but clinically relevant levels of parasitaemia, and the false 
negatives of certain strains that epitope diversity may lead to, especially in MRDTs that use 
monoclonal antibodies [Murray et al, 2008]. 
Another major molecular diagnostic approach is that of PCR based methods using either pan 
human infecting malaria or species specific primers, which have resulted in better species 
discrimination and sensitivity compared to both microscopic or immunochromatographic 
diagnosis. Of note, real-time PCR (as well as NASBA) assays have shown the potential to 
detect low levels of parasitaemia, with resolution up to about 0.02 parasites / μl blood 
[Schneider et al, 2005], identify mixed infections [Mangold et al, 2005], and allow for precise 
differentiation of species via melting curve analysis [Mangold et al, 2005]. However, such 
PCR based methods have their drawbacks, in particular the need for relatively expensive 
[Murray et al, 2008] and complex equipments (thermal cyclers) as well as specialist skills 
(melting curve analysis) when such requirements are often hard to meet in many of the 
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developing countries where Malaria is most devastating [Mens et al, 2007]. As such, PCR 
based methods are excluded from consideration as a field-ready rapid diagnostic kit for 
Malaria [McNamara et al, 2004]. 
In this work, we were thus motivated to show a Proof-of-Concept in the application of e-SRS 
as a potentially rapid and simple way to distinguish 3 strains of Plasmodium falciparum with 
closely related sequences (including single base differences for 2 of them): The Chloroquine 
sensitive strain, denoted here as Mfs (CVMNK haplotype for pfcrt gene), and two 
Chloroquine resistant strains denoted here as Mfr2, Mfr1 (CVIET and SVMNT haplotypes for 
the pfcrt gene). Of note, Mfr1 has only a single base difference with Mfs. 
CHAPTER 2 OVERVIEW 
2.1 Overview e-SRS development. 
e-SRS development can be broadly viewed as 3 major phases, as shown in Figure 2.1-1 
(including major problems and solutions/actions taken). The three phases were: 
1) The initial design and testing of an intelligent gene expression platform known as 
e-SIGE (Environment-Sensing Induced Gene Expression) that would activate upon 
sensing specific Nucleic Acid sequences. As several possibilities exist for the actual 
molecular implementations, we selected a basic design that detects RNA, known as 
the IRC (Integrated RNA silencing Construct) and tested it in test tubes. 
2) The design and testing of the present e-SRS (environment-Sensing Response System). 
As e-SIGE was complex and intial tests could not verify its functionality, we created 
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a much simpler design (e-SRS) using as sensor a modification of an existing 
allosteric ribozyme, the Maxizyme (Mz). A RS concept was conceived and served as 
a (gene reporting) response system that e-SRS could activate. Both in vitro and cell 
line assays were carried out. 
3) Application of e-SRS in the detection of Nucleic Acids in test tubes using RSs. We 
selected 7 targets for detection: 3 strains of Malaria parasites (Plasmodium 
falciparum) and 4 common serotypes of Dengue viruses. A computational algorithm 
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Designed e-SIGE system [4.1] with sequences for a basic design, Integrated RNA 
silencing Construct (IRC). Aim 1a and 1b designed to test key elements of IRC 
mechanisms [4.2]. 
 
Synthesised Aim 1a and 1b contructs [4.2.2]. 
Problem: Assembly PCR yielded many sequence errors. 
Action: “Gene synthesis via oligonucleotide ligation”. 
 
Tested IRC via Ribozyme Cis-cleavage Assays (RCA) [4.2.3]. 
RCA results analysed via Denaturing PAGE were mostly unexpected. 
 
Conclusions: 1) Initial e-SIGE sensor was unworkable. 2) New assay needed for 
analysing RCA that gave clear and immediate signals, and did not involve gel 




based sensors to 
replace e-SIGE. 
Designed e-SRS system [4.3] using modification of allosteric ribozyme, the 
Maxizyme (Mz). Created RS [4.3.2] to assay Ribozyme Trans-cleavage Assays 
(RTA). 
 
Successfully tested e-SRS RTA in vitro with RS [4.3.8]. 
 
Tested e-SRS in cell lines to: 
1. Activate inducible gene system [4.4.1]. 
Problem: Mz-based sensors did not activate e-SRS. 
Action: Focused on using the simpler HH-2 ribozyme instead. 
Problem: Transfected HH-2 RNA did not activate e-SRS. 
Action: Expressed HH-2 with tRNA promoter, T7 RNA Pol promoter. 
2. Activate RS [4.4.2]. 
Problem: RS degraded when transfected. 
Action: Added nuclease protection to RS. 
Problem: RS degraded by DMEM despite nuclease protection. 
Action: Removed DMEM during transfection. 
 
Conclusions: 1) RS likely degraded in cells. 2) Therefore, it was best to develop 
e-SRS for in vitro applications. 
 
e-SRS for in 
vitro nucleic 
acid detection 
using RS [4.5]. 
Designed Mz-based e-SRS sensors for 3 Malaria & 4 Dengue targets [4.5.2]. 
Problem: Too many Mz-based sensor designs to manually generate & assess. 
Action: Computational algorithm to greatly automate the design and 
assessment of Mz-based sensors. 
 
Tested e-SRS RTA [4.5.4, 4.5.5]. 
Problem: Mz-Mfr1 unable to distinguish 1 nt difference. 
Action: Added “competitor nucleotide” to improve specificity. 
 
Tested Malaria e-SRS via NASBA RTA [4.5.6]. 
Problem: NASBA products did not activate RTA. 
Action: Added antisense DNA to remove interfering secondary structures. 
 
Conclusions: 1) Malaria & Dengue RTA works. 2) Malaria NASBA RTA 
specific for 2 strains. 
 
Figure 2.1-1 Overview of e-SRS development (relevant Sections in square brackets). 
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2.2 Initial designs of e-SRS. 
Section 4.1 described a prior system known as e-SIGE (Environment-Sensing Induced Gene 
Expression), which eventually evolved and consolidated into the present e-SRS 
(Environment-Sensing Response System). e-SIGE shared similar principles as e-SRS, which 
was to couple detection of specific biomolecules to some physical response, such as emission 
of fluorescent signals or initiation of gene expression. However, e-SIGE was more complex in 
its physical implementation. 
Section 4.1.1 explained the design of e-SIGE, including an overview of the activation 
mechanism of a basic design that detects RNA, known as the Integrated RNA silencing 
Construct (IRC), and how this basic design could conceptually be extended to detect multiple 
bio-molecules. 
Section 4.1.2 described the RNA structure of IRC, including the various important segments 
and their sequence complementarities, which played putative roles in determining the folding 
of IRC. 
Section 4.1.3 explained how the RNA segments described in the previous section could lead 
to the folding of IRC upon synthesis, and how the IRC would change in conformation upon 
activation by a nucleic acid it is supposed to recognise, the NTS. 
Section 4.1.4 provided the sequence requirements for the various important segments of IRC, 
as well as actual RNA sequences for these segments. 
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2.3 In vitro testing of initial e-SRS constructs. 
Section 4.2 described how we sought to test the activation of our e-SIGE IRC design, in the 
test tube environment, via RCA. As the IRC activation mechanism involved several RNA 
folding and ribozyme (Rz) cleavage processes, we had to first breakdown the whole process 
into smaller individual processes that could be more easily tested, via two aims (Aim 1a and 
Aim 1b). 
Section 4.2.1 explained crucial elements of the folding process and how Aim 1a and Aim 1b 
were designed to fulfil the objectives of testing the activation of IRC. It detailed what the 
RNA test constructs and their respective controls should be, as well as the expected results of 
RCA. 
Section 4.2.2 described how we attempted to synthesise the RNA constructs required for RCA 
in Aim 1a and Aim 1b. Our methodology for RCA was to first construct a DNA template 
inclusive of a T7 RNA polymerase promoter for each construct and then cloned this DNA 
template into plasmids. From these plasmids, PCR would produce many copies of in vitro 
transcription (IVT) templates. The IVT template would be gel purified and used in IVT to 
produce large amount of RNA constucts for RCA. Surprisingly, our attempts to construct the 
DNA templates via assembly PCR yielded many sequence errors, and we had to come up with 
a oligonucleotide ligation method that we called “Gene Synthesis via Oligonucleotide Ligation” 
to get our DNA templates constructed. 
Section 4.2.3 described the results of RCA for Aim 1a and Aim 1b, which we analysed via 
Denaturing Polyacrylamide Gel Electrophoresis (D-PAGE). Much of these results were not 
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what we expected, and we concluded that the IRC design was unsuitable as the RNA-based 
sensor in e-SIGE. We also discovered a need for a new assay method (rather than D-PAGE) 
for analysing RCA as D-PAGE results were not very clear, possibly due to secondary 
structures in RNA that interfered with gel running. 
2.4 Maxizymes based e-SRS. 
Section 4.3 explained how we converted an existing allosteric ribozyme, the Maxizymes (Mz) 
into our new sensor for e-SRS (the new system that replaces e-SIGE). It elaborated on the two 
paradigms of e-SRS application, i.e., as a reporting system for detecting specific nucleic acids, 
and as a way to activate an inducible gene system upon detection of specific nucleic acids. It 
also described a RS system that could be used to better analyse (as compared to D-PAGE) 
RTA, and served as a reporting system in e-SRS application. 
Section 4.3.1 explained how the Mz could be converted to an e-SRS sensor. The Mz is a 
heterodimer with one sensor arm, one catalytic arm, and is catalytic active only when both 
arms bind appropriately to their targeted specific RNA regions. The Mz was designed to 
recognise an RNA at one segment, and cleave the same RNA (i.e. cis-cleavage) at another 
point, for the specialised purpose of knocking down chimera genes. Our novel adaptation of 
the Mz separated the activating segment of the RNA from the cleaved segment, such that the 
activating RNA and cleaved RNA became separate RNA species (i.e., achieving 
trans-cleavage). This allowed us to turn the Mz from a knock down tool to a sensor for e-SRS. 
Section 4.3.2 introduced the RS system, which consisted of a short RNA that would give a 
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signal (e.g. fluorescence) when cleaved. The RS could be created by conjugating a fluorescent 
probe at one end, and a matching quencher at the other end. 
Section 4.3.3 described the new e-SRS system with the Mz-based sensor. 
Section 4.3.4 briefly described the commercial inducible gene expression system, T-REx 
(Invitrogen) that we used to implement the inducible gene system for e-SRS. T-REx provided 
a repressor protein, TetR that could suppress a co-transfected Payload Gene (PLG) until 
activation by the Mz based sensor (which would knock down TetR and thus relieve PLG 
repression). 
Section 4.3.5 described the NTS selected to test the new Mz-based e-SRS and explained how 
3 Substrate Target Sequence (STS) to be tested as RS were selected from the tetR mRNA 
sequence. As positive controls, a Hammerhead ribozyme (HH) that targeted and cleaved the 
each STS were also designed. The sequences of the three STS (RTS-1, RTS-2, and RTS-3) 
and the respective three HH (HH-1, HH-2, HH-3) were provided. 
Section 4.3.6 explained how each Mz-based sensor was systematically designed and how the 
RNA secondary structures of each Mz-based sensor interacting with its NTS and STS were 
predicted (via software RNAstructure 4.5) and assessed to be specific for its NTS and STS. 
Strategies & guidelines for Mz design for achieving desired secondary structures were 
provided. 
Section 4.3.7 provided the sequences of 3 Mz-based sensors (Mz-1, Mz-2, and Mz-3) that we 
designed. 
Section 4.3.8 described the first RTA success obtained with the Mz-based sensor, Mz-2. 
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2.5 Cell line testing of Maxizyme based e-SRS. 
Section 4.4 described our attempt to apply the Mz-based e-SRS in cell lines (HEK 293) for 
two paradigms: 
1) To activate an inducible gene expression system (provided by T-REx) with 
fluorescent reporter genes (ECFP and EGFP) as the PLG , if and only if NTS was 
present 
2) To activate RS, if and only if NTS was present. 
Section 4.4.1 described the test of paradigm 1 (e-SRS to activate inducible gene system). First, 
we optimised the transfection ratio of Tet repressor R1 expressing pcDNA6/TR plasmid (pTR) 
to PLG expressing plasmid (pPLG, which is a pcDNA4/TO/myc-His plasmid with a PLG 
cloned into the provided MCS), using LacZ as the PLG. Using this ratio as a guide, we then 
optimised the pTR to pPLG ratio using ECFP and EGFP as PLG, which turned out to be 8:1. 
We thus established an e-SRS inducible gene system by transient transfection of 8:1 pTR and 
pECFP or EGFP. One day after, Mz and NTS or HH were transfected. Fluorescence of the 
PLGs were monitored for a few days. If e-SRS inducible gene system worked, the presence of 
both Mz and NTS would activate the Mz to cleave and knock down the TetR mRNA, thus 
relieving the repression of the PLG and allow fluorescence to be observed. No fluorescence 
should be observed if NTS was not present. Despite using various concentration of RNA, we 
were unable to observe activation of the PLGs. 
As the Mz-2 design proved successful in test tubes, we focused on testing HH-2 (the wild type 
Hammerhead ribozyme designed to cleavage the same STS as Mz-2), as it did not require an 
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NTS to activate, was simpler, and thus more likely to work. Since transfected HH-2 RNA did 
not work previously, we cloned HH-2 into a plasmid and transfected it to express HH-2 within 
cells. We employed a proven tRNA expression system (tRES), and later added a T7 RNA Pol 
III promoter to enhance the expression of HH-2 within cells. RT-PCR showed that HH-2 RNA 
was expressed within cells. However, we were still unable to activate PLGs. 
Section 4.4.2 described the test of paradigm 2 (e-SRS to activate RS) in cells. The concept 
was similar to that of RTA in test tubes except that the RNA (including Mz, NTS, RS, and HH) 
were transfected into cells. Unlike the case of the inducible gene system (where e-SRS did not 
activate PLG under any conditions), RS was non-specifically activated under all conditions. 
This led us to suspect that RS was degraded in the process of transfection. We discovered that 
DMEM in transfection medium could degrade and thus activate RS. We tried adding to the RS 
nuclease resistant modifications, such as using phosphorothioate bonds and addition of 2’-O- 
methyl groups. We also tried removing DMEM from the transfection mix. However, these 
measures did not work and we concluded that the RS was also degraded after transfection, 
probably by nucleases present within the cells. 
Based on the negative cell line results, and considering the time and resources available, we 
decided it was best to develop e-SRS for in vitro applications. 
2.6 Applications in Nucleic Acid in vitro detection. 
Section 4.5 described how we applied e-SRS in the detection of Nucleic Acids in test tubes 
via RTA using RS. We selected 7 new NTS for detection: The 1st category consisted of 
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Malaria parasites, which were 3 strains of Plasmodium falciparum, denoted here as Mfs, Mfr1, 
and Mfr2. The 2nd category consisted of Dengue viruses, which were 4 common serotypes 
denoted here as D1, D2, D3, D4. To design an Mz-based e-SRS sensor specific for each of 
these NTS, we created a computational algorithm that automated the design process. These 
e-SRS sensors were then optimised to specifically detect their NTS in vitro. This was 
successful for both Malaria and Dengue at the short NTS (sNTS) level. For Malaria, we were 
able to amplify using NASBA from genomic DNA and have specific detection for Mfs and 
Mfr2. 
Section 4.5.1 listed the NTS sequence and strain information for both Dengue and Malaria. 
The NTS ranged from 19 to 24 nt. 
Section 4.5.2 described in detail the automation process of Mz-based e-SRS sensor design. We 
developed in Perl 5.8.8 a computational algorithm that (using RNAstructure 4.5 for secondary 
structure prediction) greatly automated the 3 processes of: 1) designing sequences for specific 
e-SRS Mz-based sensor(s) for each NTS, 2) generating their resultant secondary structures, 
and 3) assessing these structures for appropriate specificity. 
Section 4.5.3 listed the valid designs of Mz-based e-SRS sensors provided by our algorithm. 
Section 4.5.4 described the results of Dengue sNTS detection. 
Section 4.5.5 described the results of Malaria sNTS detection. Of note, the addition of a 24 nt 
“competitor nucleotide” (sNTS-Mfr2) allowed Mz-Mfr1 to distinguish a single base 
difference between Mfs and Mfr1. 
Section 4.5.6 described how we used NASBA (Nucleic Acid Sequence-Based Amplification), 
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an isothermal amplification technique that amplifies DNA or RNA into RNA) to amplify a 
120 nt segment from Malaria genomic DNA and detect them via RTA. We discovered that the 
use of antisense oligonucleotides (AS) allowed the otherwise undetectable NASBA products 
to be detected in RTA. Mfs and Mfr2 were specifically detected, while Mfr1 specific detection 
required further work to establish. 
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CHAPTER 3 MATERIALS AND METHODS 
3.1 Cloning 
3.1.1 PCR 
3.1.1.1 Standard PCR 
Standard PCR was used to amplify DNA targets (usually with known PCR conditions) for 
purposes such as cloning and IVT template generation. Reactions were scaled up or down as 
needed proportionately. Thermocycler used were the Biometra T3 Thermocycler and the 
Hybaid PCR Express. 
3.1.1.1.1 Taq polymerase 
PCR using Taq polymerase from Promega was normally employed for targets with no 
expected secondary structures. A 100 μl PCR reaction mix was set up as follows: Deionised 
H2O to top up to 100 μl, 10 μl 10X PCR buffer, 4 μl dNTP mix (5 mM each), 0.2 μl Taq 
polymerase (5 U/μl, Promega), 8 μ.l Mg2+ (25 mM), 4 μl of each primers (5 μM), and ~10 to 
60 ng of template DNA. 
Thermocycling conditions were: Initial denaturation at 94 C for 5 minutes, 30 cycles of 
amplification (denaturation at 94 C for 30 seconds, annealing for 30 seconds, and extension 
at 72 C with 1 minute for every 1000 bp of amplicon), and a final extension at 72 C for 5 
minutes. 
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3.1.1.1.2 Elongase Enzyme Mix 
PCR using Elongase Enzyme Mix from Invitrogen was normally employed for targets with 
slightly greater requirement of sequence fidelity, such as those with predicted secondary 
structures. A 100 μl PCR reaction mix was set up as follows: Deionised H2O to top up to 100 
μl, 20 μl 5X PCR Buffer B (with 10 mM MgSO4), 4 μl dNTP mix (5 mM each), 2 μl Elongase 
Enzyme Mix, , 4 μl of each primers (5 μM), and at least 0.05 ng of template DNA. 
Thermocycling conditions were: Initial denaturation at 94 C for 5 minutes, 30 cycles of 
amplification (denaturation at 94 C for 30 seconds, annealing for 30 seconds, and extension 
at 68 C with 1 minute for every 1000 bp of amplicon), and a final extension at 68 C for 5 
minutes. 
3.1.1.1.3 PfuTurbo DNA polymerase 
PCR using PfuTurbo DNA polymerase from Stratagene was normally employed for targets 
with strict requirement of sequence fidelity, including those that turn out to be difficult to 
amplify accurately with Taq and Elongase enzymes, usually with predicted secondary 
structures. PCR for IVT template generation employed PfuTurbo. 
A 100 μl PCR reaction mix was set up as follows: Deionised H2O to top up to 100 μl, 10 μl 
10X PfuTurbo reaction buffer (with 20 mM Mg2+), 4 μl dNTP mix (5 mM each), 2 μl 
PfuTurbo DNA Polymerase, 4 μl of each primers (5 μM), and ~60 to 100 ng of template 
plasmid DNA. For the production of IVT template, 25 μl reaction volumes were used. 
Thermocycling conditions were: Initial denaturation at 94 C for 5 minutes, 35 cycles of 
amplification (denaturation at 94 C for 30 seconds, annealing for 30 seconds, and extension 
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at 72 C with 60 seconds for every 1000 bp of amplicon), and a final extension at 72 C for 5 
minutes. For the production of IVT template, annealing temperature of 55.2 °C was used. 
3.1.1.1.4 PfuUltra II Fusion HS DNA polymerase 
PCR using PfuUltra II Fusion HS DNA polymerase from Stratagene was normally employed 
for targets with greatest requirement of sequence fidelity, such as those that turn out to be 
difficult to amplify accurately with Taq and Elongase enzymes, usually with predicted 
secondary structures. PCR in the cloning of PLGs and HH-2-2_tRES employed PfuUltra II. 
A 100 μl PCR reaction mix was set up as follows: Deionised H2O to top up to 100 μl, 10 μl 
10X PfuUltra II Reaction Buffer (with 20 mM Mg2+), 5 μl dNTP mix (5 mM each), 2 μl 
PfuUltra II Fusion HS DNA Polymerase, 4 μl of each primers (5 μM), and ~40 ng of template 
DNA. 
Thermocycling conditions were: Initial denaturation at 95 C for 2 minutes, 30 cycles of 
amplification (denaturation at 95 C for 20 seconds, annealing for 20 seconds, and extension 
at 72 C with 15 seconds for every 1000 bp of amplicon, with minimum of 15 seconds), and a 
final extension at 72 C for 3 minutes. 
3.1.1.2 Gradient PCR 
Gradient PCR was used for optimising annealing temperatures of new PCR targets. PCR 
reaction mixes were set up using one of the standard PCR procedures described above, 
typically either Taq polymerase (Promega) or Elongase Enzyme Mix (Invitrogen), depending 
on anticipated requirement of sequence fidelity. Thermocycler used was the Hybaid PCR 
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Express with gradient block. 
Thermocycling conditions were similar to those of standard PCR for the specific enzyme 
system, except that 8 to 12 annealing temperature, spaced out 5 to 10 degrees around the 
predicted TM of amplicon were used. 
3.1.1.3 Colony screening via colony PCR 
Colony screening of pGEM-T Easy vectors generally benefitted from blue/white selection, in 
which well-spaced white colonies were selected for colony PCR. Colony PCR was used to 
ensure DNA (cloned into plasmids) transformed into selected single bacteria colony were of 
the right PCR amplicon size before processing such colonies for DNA sequencing. 
Thermocyclers used were the Biometra T3 Thermocycler and the Hybaid PCR Express. 
PCR reaction mix was set up using either the Taq polymerase (Promega) or Elongase Enzyme 
Mix (Invitrogen) protocols describe above with the following differences: 1) Reaction volume 
per tube was scaled to 12.5 μl, 13 μl, or 15 μl. 2) Template DNA were replaced with equal 
volumes of deionised H2O. 3) For each reaction, DNA template was provided by dotting an 
autoclaved toothpick into the selected well-spaced colony and then rubbing the tip of the 
toothpick in the PCR reaction mix for the colony. The same toothpick was then dabbed onto a 
defined grid on an Luria-Bertani (LB) agarose with ampicillin (100 μg/ml) master plate which 
would be incubated at 37 °C overnight. After incubation, master plate would be sealed with 
parafilm and stored at 4 °C. 
Thermocycling conditions were similar to those of standard PCR for the specific enzyme 
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system, except that 35 cycles of amplification were used. 
Results of PCR were analysed via agarose gel electrophoresis and clones with the specific 
colony PCR amplicon size would be selected. Selected clones would be retrieved from the 
master plate (after it had grown) with an autoclaved toothpick, inoculated for plasmid 
miniprep and then sent for DNA sequencing. Where desired, a glycerol bacteria stock would 
be created for clones with the right DNA sequence for future use. 
3.1.2 Agarose gel electrophoresis 
DNA were mixed with about 20% volume of 6X DNA loading buffer for loading into wells. 
Electrophoresis buffer used was TAE (Tris-acetate-EDTA, with 40 mM Tris acetate, 1 mM 
EDTA.). Agarose gels were prepared by dissolving agarose in TAE buffer, with Ethidium 
Bromide added at 100 μg / 100 ml gel volume. After gel running, DNA band(s) were 
visualised under UV illumination. 
3.1.3 Gel purification of DNA 
After Agarose gel electrophoresis, DNA bands of the desired size as visualised under UV 
illumination were excised using a clean razor blade and purified using the QIAquick Gel 
Extraction Kit from Qiagen, essentially following the manufacturer’s microcentrifuge 
protocol. After a gel was dissolved, one gel volume of Isopropanol was added if the DNA was 
shorter than 500 bp. Before washing with Buffer PE, 0.5 ml of Buffer QG was added to each 
QIAquick column and centrifuged for 1 minute to remove all traces of agarose. For the elution 
step, after adding water and before centrifugation, QIAquick spin columns were allowed to 
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stand for 1 minute to improve yield DNA concentration. DNA for RNA related use (e.g. as 
in-vitro transcription template) were eluted with 30 μl of DEPC treated water per column, 
otherwise 30 μl of deionised water was used. Purified DNA samples were stored at -20 °C. 
3.1.4 Ligation for TA cloning 
Gel purified PCR amplified DNA were usually ligated into pGEM-T Easy vectors (Promega) 
via TA ligation. Each 5 μl ligation mix contained: 2.5 μl pGEM-T Easy 2X Rapid Ligation 
Buffer, 1.75 μl gel purified DNA, 0.25 μl pGEM-T Easy vectors (12.5 ng), and 0.5 μl T4 DNA 
Ligase (1.5 Weiss units). Ligation mix was incubated at either room temperature for 2 hours, 
or 16 °C overnight. 
3.1.5 Bacteria Transformation 
Competent cells DH10B, a substrain of E. coli that is RecA and RecB negative, was used to 
replicate plasmid DNA. 
3.1.5.1 Via Heat Shock 
For each transformation, 1 tube of 125 to 200 μl E. coli was first thawed on ice and kept at 4 
°C. 5 μl of pGEM-T Easy ligation mix or plasmid DNA was mixed gently into thawed 
bacteria in autoclaved 1.5 ml microcentrifuge tube and incubated on ice for 30 minutes. 
Mixture was then incubated at 42 C in a water–bath for 45 seconds, and quickly returned to 
ice for 2 minutes. 900 μl of LB media was added, and the mixture was incubated at 37C with 
shaking at 220 rpm for about 1.5 hour. E. coli was then pelleted by centrifugation on a desktop 
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microcentrifuge at 8000 rpm for 2 minutes. Supernatant was removed until about 100 – 200 μl 
remained. Bacteria were resuspended by flicking and then plated onto an LB agarose plate 
with appropriate antibiotics (e.g. 100 μg/ml ampicilin for pGEM-T Easy vectors) and IPTG 
and X-Gal added for blue/white screening (e.g. for pGEM-T Easy vectors). Plate was then 
incubated at 37 C overnight. 
3.1.5.2 Via Electroporation 
For each transformation, one 0.5 ml microcentrifuge tube of 20 μl electroporation competent 
E. coli was first thawed on ice and kept at 4 °C. 0.3 μl out of a 5 μl pGEM-T Easy ligation 
mix or plasmid DNA was mixed gently into thawed bacteria and incubated on ice for 1 
minutes, and then transferred into a sterile disposable electroporation cuvette which had been 
pre-chilled on ice. The mixture was then quickly electroporated. The parameters for 
electroporation were Resistance: 200 Ohms, Capacitance: 25 μF, Voltage: 2.5 kV. 500 μl of 
LB media was quickly added, and the mixture was incubated at 37C with shaking at 220 rpm 
for about 1 hour. Various volumes (usually 100 μl) of the mixture were plated onto an LB 
agarose plate with appropriate antibiotics (e.g. 100 μg/ml ampicilin for pGEM-T Easy vectors) 
and IPTG and X-Gal added for blue/white screening (e.g. for pGEM-T Easy vectors). Plate 
was then incubated at 37 C overnight. 
3.1.6 Miniprep Plasmid Purification 
Minipreped DNA were usually used for DNA sequencing of selected bacteria colonies that 
passed colony screening. 
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Selected colonies (usually from the master plate) were inoculated for overnight culture in 2 to 
5 ml LB media supplemented with appropriate antibiotics (e.g. 100 μg/ml ampicillin for 
pGEM-T Easy vectors). Tubes were incubated at 37 C with shaking at 220 rpm for 9-16 
hours. Plasmid purification was performed using the Wizard Plus SV Minipreps DNA 
Purification System (Promega), essentially following the manufacturer’s centrifugation 
protocol. DNA was eluted with 50 μl of deionised water per column. DNA concentrations 
were measured by the NanoDrop ND-1000 full-spectrum (220-750nm) spectrophotometer, 
using 1 μl of DNA sample. Purified DNA samples were stored at -20 °C. 
3.1.7 Midiprep Plasmid Purification 
Midiprep DNA were usually used for transfection. Each selected colony (usually from the 
glycerol bacteria stock or master plate) was inoculated for starter culture in 2 to 5 ml LB 
media with appropriate antibiotics (e.g. 100 μg/ml ampicillin for pGEM-T Easy vectors). 
Starter cultures were incubated at 37C with shaking at about 300 rpm for 8 hours. Overnight 
cultures were prepared by mixing 50 to 100 μl of the starter cultures with 50 ml LB media 
with appropriate antibiotics in 250 ml conical flasks, and incubated at 37 C with shaking at 
300 rpm for 12 to 16 hours. Plasmid purification was performed using the Qiagen Plasmid 
Midi Kit (QIAGEN), essentially following the manufacturer’s centrifugation protocol. Unless 
otherwise stated, all centrifugation was done using the BECKMAN COULTER Avanti JA-25 
Centrifuge with the JA-14 rotor for 6000 g and JA-20 rotor for 20,000 g, with 
non-polycarbonate Oakridge centrifuge tubes at 4 C. Initial bacteria cultures were split into 
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25 ml fractions for pelleting After DNA precipitation by isopropanol, DNA pellets were 
washed and transferred to 2 ml microcentrifuge tubes by two volumes of 0.75 ml of 70% 
ethanol, and then centrifuged at 15,000 g for 10 minutes. Supernanants were quickly 
discarded to minimise DNA losses. DNA pellets were air-dried by standing at room 
temperature for about 10-20 minutes. 50 μl of deionised water per 25 ml of bacteria culture 
processed was added to each tube to redissolve DNA, at either room temperature for 30 
minutes or 4 °C overnight. DNA concentrations were measured by the NanoDrop ND-1000 
full-spectrum (220-750nm) spectrophotometer, using 1 μl of DNA sample. Purified DNA 
samples were stored at -20 °C. 
3.1.8 Glycerol Bacteria Stock 
To create a glycerol bacteria stock, an overnight LB media bacteria culture with appropriate 
antibiotics (e.g. 100 μg/ml ampicillin for pGEM-T Easy vectors), such as that used in 
miniprep of the desired clone would be thoroughly mixed with sterile 87% glycerol to achieve 
a final concentration of glycerol of at least 20%. Glycerol bacteria stocks were stored at -20 
°C. 
3.1.9 Gene Synthesis via Oligonucleotide Ligation. 
Gene Synthesis via Oligonucleotide Ligation was a method that we employed to create double 
stranded DNA of a desired (usually synthetic) DNA sequence (“gene”). We divided our 
desired DNA sequence into overlapping fragments (overlaps of around 15 nt), with the 3’ 
fragment having an extra 3’ A, and ordered each fragment as unpurified synthesized single 
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stranded oligonucleotides called “Ligation Oligonucleotides”. Ligation Oligonucleotides are 
therefore the starting material for Gene Synthesis via Oligonucleotide Ligation, which on proper 
overlapping with each other, form the double stranded sequence of the desire gene. 
For each construct, the Ligation Oligonucleotides (each 10 μM) were mixed in an annealing 
buffer (Annealing Buffer, pH 7.89: 10mM Tris, pH 7.5 - 8.0, 50mM NaCl, 1mM EDTA) at 95 
°C for 2 mins, then cooled to 25 °C at 0.02 °C/s using a thermocycler. This created double 
stranded DNAs with the sequence of the desired gene, although still with breaks in the sugar 
phosphate backbones, called “Annealed Oligonucleotides”. 
Approximately 1 μg of the annealed DNA was ligated overnight at 16 °C with 400U of T4 
DNA Ligase (NEB) in a total volume of 10 μl. The Annealed Oligonucleotides that were fully 
ligated in all their sugar phosphate backbone breaks became the double stranded DNA version 
of the desired gene, and were also known as “Ligated Annealed Oligonucleotides”. The 
Ligated Annealed Oligonucleotides were subsequently extracted from the ligation mix via 
agarose gel electrophoresis, excision of the desired sized band, and then gel purification. The 
gel purified Ligated Annealed Oligonucleotides was then cloned via TA cloning into pGEM-T 
Easy vector, minipreped with DH10B, and sequenced for accuracy. 
3.1.10 DNA Sequencing 
Plasmid DNA and gel purified DNA samples were sent for DNA sequencing at National 
Neuroscience Institute (NNI) Core Analytical Laboratory Services. Sequencing was done 
using the ABI Prism 3100 Genetic Analyzer with the BigDye Terminator v3.1 Cycle 
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Sequencing Kit (Applied Biosystems). A 20 μl sequencing reaction mix had the following 
components: 8 μl Terminator Ready Reaction Mix, 3.2 pmol primer, template DNA, and 
deionised H2O to top up to 20 μl. The amount of DNA template used followed the guidelines 
as shown in Table 3.1-1. 
For a gel purified PCR DNA sample, a 6 μl sequencing sample was sent to NNI as follows: 1 
μl of sequencing primer (5 μM), 0.5 μl of DMSO, template DNA, and deionised H2O to top 
up to 6 μl. 
For a plasmid DNA sample, a 12 μl sequencing sample was sent to NNI as follows: 1 μl of 
sequencing primer (5 μM), 0.5 μl of DMSO, template DNA, and deionised H2O to top up to 
12 μl. 
For sequencing of constructs cloned into pGEM-T Easy vectors, either the M13 (24nt) Fwd or 
M13 (22nt) Rvs primers as shown in Table 3.1-2 would be used, sometimes both if the 
construct was long or if the presence of secondary structures was expected.  
Table 3.1-1 Amount of DNA template used in sequencing reactions. 
Sample Type Template length Quantity (ng) 
PCR product 100 - 200 bp 1 – 3 
PCR product 200 - 500 bp  3 - 10 
PCR product 500 - 1000 bp 5 - 20 
PCR product 1000 - 2000 bp 10 - 40 
PCR product > 2000 bp 40 - 100 
Plasmid - 200 - 500 
 
Table 3.1-2 Sequencing primers used. 
Primer Sequence (5’ to 3’) Length (nt) 
M13 (24nt) Fwd  CGCCAGGGTTTTCCCAGTCACGAC 24 
M13 (22nt) Rvs  TCACACAGGAAACAGCTATGAC 22 
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3.1.11 Nucleic acid concentration determination 
Measurement of DNA or RNA concentration was done mainly by the NanoDrop ND-1000 
full-spectrum (220-750nm) spectrophotometer, usually using 1 μl of DNA or RNA sample, 
always ensuring that the liquid sample column was formed. Measuring samples were 
discarded and not reused. Blanking samples used were the solutions that the DNA or RNA 
samples were diluted in (deionised water or DEPC treated water). The detection limits were 
from 2 ng/μl to 3700 ng/ul (dsDNA), 3000 ng/ul (RNA), 2400 ng/ul (ssDNA). If measured 
concentrations were above detection limits, nucleic acid solutions were diluted and measured 
until a steady concentration was obtained well within detection limits. via UV 
spectrophotometry. Absorbance values at 260 nm (OD260), 280 nm (OD280), and 230 nm 
(OD230) were taken. Ratio of OD260 to OD280 were checked to be around or above 1.8 for DNA 
and 2.0 for RNA for a sample to be used subsequently. Nucleic acid concentrations in ng/μl 
were calculated as OD260 x dilution factor x [50 (dsDNA) or 40 (RNA) or 33 (ssDNA)]. 
3.2 Cell Culture 
3.2.1 Cell Culture Materials 
3.2.1.1 Cell lines 
Two types of cell lines were used in this study. Initially, PC12 (a pheochromocytoma of the rat 
adrenal medulla) with high endogenous expression of Cav2.1 (37b) was used. Subsequently, 
HEK 293 (a transformed cell line from cultured Human Embryonic Kidney cells) with no 
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endogenous expression of Cav2.1 was used. 
3.2.1.2 Cell line maintenance 
PC12 cells were cultured with RPMI 1640 medium supplemented with 5% fetal bovine serum 
(FBS), 10% fetal bovine serum (HS), 1% Sodium pyruvate, and 1% Penicillin / Streptomycin 
(P/S), adjusted to pH 7.1 (with Concentrated HCl and/or 10 N NaOH). HEK293 cells were 
cultured with Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal 
bovine serum (FBS) and 1% Penicillin / Streptomycin (P/S). 
All cells were in T25 or T75 culture flasks with 3.5 or 12 ml of media, kept in incubation at 
37C, with 5% CO2, and passaged when confluency reached about 80% or more (around 2 to 
4 days) by trypsinisation (Trypsin/EDTA composition: 0.25% Trypsin, 0.02% EDTA in PBS) 
and replateing at approximately 10% confluency. 
3.2.2 Cell counting 
Cell counting was done by making appropriate dilutions (usually 10 to 20 times) in PBS of 
trypsinised and resuspended cells, and counting under light microscope using hemocytometer. 
Cells in 2 opposite large squares were counted such that at least 80 cells were counted for 
each sample. Cell concentration was given by the average number of cells counted in each 
large square multiplied by 104 and the dilution factor. 
3.2.3 Transfection 
Cells were harvested for transfection seeding about 2 days after passage, with a maximum 
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confluency of 75% in order to ensure cells were in the log phase of growth for best 
transfection efficiency. Cells were seeded in culture vessels (6, 12, 24, and 96 well plates) in 
normal culture medium less antibiotics. Seeding density of cells were between 1 to 2 x105 
cells per well for a 24 well plate, and adjusted proportionately according to well surface areas 
for other plates (as shown in Table 3.2-1). Seeded cells were allowed to grow for 1 to 2 days 
until they were about 75% to 95% confluent before transfection. 
Table 3.2-1 Approximate surface areas of culture vessels. 






Plasmid DNA and RNA were transfected into cells using Lipofectamine 2000 from Invitrogen, 
essentially following the manufacturer’s protocol for plasmid DNA and siRNA transfection 
respectively. The following reagent volumes were used for transfection of a single well for a 
24 well plate, and were adjusted proportionately according to well surface areas for other 
plates (as shown in Table 3.2-1). 
For plasmid DNA transfection, DNA was diluted in 50 μl of Opti-MEM (from Invitrogen) 
with no serum added. 2.5 μl of Lipofectamine 2000 per 1 μg of DNA transfected was diluted 
in 50 μl of Opti-MEM and incubated for 5 to 25 minutes at room temperature. The diluted 
DNA and diluted Lipofectamine 2000 were then mixed and incubated for about 30 minutes 
(between 20 minutes and 6 hours) to create the transfection complex. 
For RNA transfection, RNA was diluted in 12.5 μl of Opti-MEM with no serum added. 2.0 μl 
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of Lipofectamine 2000 per 40 pmol of RNA transfected was diluted in 12.5 μl of Opti-MEM 
and incubated for 5 to 25 minutes at room temperature. The diluted RNA and diluted 
Lipofectamine 2000 were then mixed and incubated for about 30 minutes (between 20 
minutes and 6 hours) to create the transfection complex. 
Cells were transfected by gently pipetting the transfection complex onto the edge of well, 
followed by several gentle pipetting up and down of existing medium onto the edge of well to 
ensure proper mixing of the entire transfection complex into the well while minimising 
disturbance to cells. Medium were usually replaced with normal culture medium with 
antibiotics 6 to 24 hours after transfection. 
For harvesting of cells, medium was removed, cells were washed in PBS, trypsinised, pelleted, 
and washed again with PBS. Cell pellets were frozen at –80C if not immediately used for the 
next step. 
3.2.4 Fixation of cells 
Cells were either fixed within their culture vessels or for some samples grown on coverslips, 
were removed to an empty well of similar culture vessels. One volume (Vol) was defined as 
about 0.6 times that of the normal volume of culture medium used for such culture vessels, 
and was able to just cover the cells in a thin layer. One Vol for a well in a 24 well plate would 
be about 0.3 ml. To reduce the loss of cells, all introduction and removal of media in wells 
were done by gentle pipetting at walls of wells, minimising contact with cells to be fixed. All 
introduction of media and aspiration of formaldehyde were performed with a Gilson Pipetman 
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P200. 
For fixation, culture media (if present) were aspirated and cells were gently washed with 1 Vol 
1X PBS. Cells were then fixed by covering them with 1 Vol of 3% formaldehyde for about 10 
minutes. Formaldehyde was removed and cells were washed twice with 1 Vol of 1X PBS. 
If cells were to be observed in wells, they were overlaid with about 1 Vol of 1X PBS or 
deionised water. For storage, such plates would be sealed with parafilm and kept at 4 C. To 
view cells grown on coverslips on microscope slides, the coverslips were mounted on slides in 
2.5 μl of FluorSave Reagent (from Calbiochem), dried at room temperature, and stored at 4 
°C. 
3.3 Inducible gene system, T-REx 
For the e-SRS inducible gene system, we used an inducible gene expression system, T-REx 
from Invitrogen. The T-REx system comprised of 2 plasmids and an extra control vector: 
1) pcDNA6/TR was a 6662 bp high copy number plasmid that over-expressed the Tet 
repressor (tetR), a repressor protein via a human cytomegalovirus immediate-early 
(CMV) promoter. 
2) pcDNA4/TO/myc-His was an approximately 5.1kb high copy number plasmid that 
expressed a PLG via a CMV promoter (with 2 tetracycline operator 2 sites 
embedded), which could be constitutively repressed by an appropriate ratio of 
cotransfected tetR. tetR repression could be relieved by application of tet of about 1 
μg/ml in culture medium. 
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3) pcDNA4/TO/myc-His/lacZ was a 8198 bp high copy number plasmid containing the 
LacZ gene that expressed β-galactosidase as a PLG within a pcDNA4/TO/myc-His, 
and was provided as a control vector. 
In the e-SRS inducible gene system, the repressor R1 was provided by the T-REx tetR 
reporessor protein. R1 would suppress a PLG cloned into pcDNA4/TO/myc-His. Activation of 
the Mz based e-SRS sensor would knock down R1 (relieving PLG repression), and thus 
induce PLG expression. 
3.3.1 Cloning of PLGs 
We cloned three PLGs, EGFP (enhanced green fluorescent protein), ECFP (enhanced cyan 
fluorescent protein), and EYFP (enhanced yellow fluorescent protein) into the 5151 bp 
version A of pcDNA4/TO/myc-His. 
pcDNA4/TO/myc-His A was cut twice by restriction enzyme digest at two unique sites within 
the provided Multiple Cloning Site (MCS), Xho I and Xba I. The restriction sites for Xho I 
and Xba I were C|TCGAG and T|CTAGA respectively, with “|” indicating the cut position. In 
the choice of restriction sites, care was taken to ensure they were not present in the intended 
PLGs. 
Since the PLG sequences cloned into pcDNA4/TO/myc-His A did not contain Xho I and Xba 
I, we used PCR to add short tags to both ends of all PLG sequences that contained the 
restriction sites for Xho I (5’ end) and Xba I (3’ end). The plasmid templates for EGFP, ECFP, 
and EYFP were respectively pEGFP-Cav2.1EFa (a plasmid that expressed the Cav2.1EFa or 
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NTS-37a with an EGFP tag), pECFP-C1, and pEYFP-C1 (both from CLONTECH 
Laboratories, Inc.). For both ECFP and EYFP, gradient PCR was performed using PfuUltra II 
Fusion HS DNA Polymerase from Stratagene, with 12 annealing temperatures spread between 
49.1 °C and 64.2 °C. Each 13 μl reaction volumes contained about 5.4 ng of template DNA 
and primers were as shown in Table A 1. 
The entire range of annealing temperature used was successful and a similar PCR was done 
for EGFP using 26 μl reaction volume with 5 ng of template DNA. 
PCR products of the right sizes were gel purified, and were subjected to double restriction 
digest using Xho I and Xba I, similarly to pcDNA4/TO/myc-His A. A restriction digest mix 
was set up as follows: Deionised water to top up to final volume, 0.1 volume of 10X 
NEBuffer 2 (NEB), 0.01 volume of 100X BSA (NEB), DNA (about 1 to 2 μg of gel purified 
PCR DNA or 4 μg of pcDNA4/TO/myc-His A), 20 U of Xho I restriction enzyme (NEB), and 
20 U of Xba I restriction enzyme (NEB). The restriction digest volumes were 40 μl for EGFP, 
50 μl for ECFP and EYFP, and 10 μl for pcDNA4/TO/myc-His A. All restriction digest mixes 
were incubated at 37 °C for 1 hour, and then 65 °C for about 20 to 25 minutes to heat inactive 
the restriction enzymes. All restriction digest products were gel purified for products of the 
right sizes.
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Gel purified digested inserts (EGFP, ECFP, EYFP) were ligated into gel purified digested 
pcDNA4/TO/myc-His A using T4 DNA Ligase. Each 20 μl ligation mix contained: Deionised 
water to top up to final volume, 2 μl 10X T4 DNA Ligase Buffer (NEB), gel purified cut 
pcDNA4/TO/myc-His A vectors (~0.6 to 2 nM), gel purified cut inserts (~1.8 to 6 nM), and 1 
μl T4 DNA Ligase (400 U, NEB). Molar ratio of insert to vector was designed to be about 3:1. 
Ligation mix was incubated at 16 °C overnight (~17 to 21 hours). 
Ligation mix were transformed into E. coli via electroporation (ECFP and EYFP) using about 
0.55 to 0.75 ng DNA in 20 μl competent cells or heat shock (EGFP) using about 54 ng DNA 
in 200 μl competent cells. Colony screening was performed using forward primers CMV 
Fwd_1 (CGCAAATGGGCGGTAGGCGTG) and reverse primer BGH Rvs_1 
(TAGAAGGCACAGTCGAGG) which primes respectively at the CMV Forward priming site 
and BGH Reverse priming site to produce a 1131 bp amplicon. Promising clones were 
sequenced in both directions using CMV Fwd_1 and BGH Rvs_1, and clones of the right 
sequence and orientation were used for subsequent experiments. 
The inducible EGFP, ECFP, and EYFP plasmids thus created were named 
pcDNA4/TO/EGFP/myc-His A, pcDNA4/TO/ECFP/myc-His A and 
pcDNA4/TO/EYFP/myc-His A, abbreviated respectively as iEGFP, iECFP, and iEYFP. 
3.3.2 PLG induction via addition of Tetracycline 
TetR represses the transcription of PLG cloned into pcDNA4/TO/myc-His by forming a 
homodimer that binds with extremely high affinity to each tetracycline operator (TetO2) 
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sequence (two of which were embedded in the promoter of the PLG in pcDNA4/TO/myc-His). 
In the presence of tetracycline (Tet) each TetR binds one molecule of Tet, which induces a 
change in conformation of the TetR homodimer that causes it to lose the ability to bind TetO2, 
dissociate from TetO2 and thus allows normal transcription of the PLG. Addition of Tet thus 
induces PLG expression and could be provided by addition to cell culture medium at the final 
medium concentration of 1 μg/ml. 
100 mg of Tet was thoroughly dissolved in 100 ml of sterile water and stored at -20 °C, with 
aluminium foil wrapping to protect from light. To prevent degradation via multiple freeze 
thaw cycles, 1 ml aliquots were made and used for each experiment. For induction, old 
medium was removed and 1 μl of Tet (1 mg/μl) was added to each ml of fresh medium used. 
Tet inductions were performed at least one day after transfection of inducible gene system, 
and the effects were assayed at least one day after induction. 
3.4 RNA methods 
3.4.1 Total RNA Isolation from HEK 293 cells 
HEK 293 cells in 6 well plates were harvested for RNA isolation by trypsinisation. Briefly, 
media was aspirated and cells were washed with 1X PBS. Cells were incubated in 0.5 ml T/E 
at 37 C for 1 min, and then neutralised with 1.5 ml of culture medium. Cells were pipetted up 
and down 10 times with 1 ml Gilson pipette to facilitate dissociation. Cells were transferred to 
2 ml microcentrifuge tubes and pelleted for 3 minutes at 300 g. Cells were resuspended in 1X 
PBS and repelleted for 3 minutes at 300 g. Supernatants were removed and cells were stored 
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at -80 C. 
On the day of RNA isolation, pelleted cells were thawed and loosened by gentle flicking. 
RNA was isolated, using RNeasy Mini Kit (Qiagen), essentially following the manufacturer’s 
microcentrifuge protocol for “Purification of Total RNA from Animal Cells Using Spin 
Technology”. 10 μl of -Mercaptoethanol was added to every ml of Buffer RLT prepared for 
use. Cells in each tube were homogenised by adding 600 μl of Buffer RLT and passing 
through a 22½ gauge needle at least 10 times, until homogenous lysate was obtained. After the 
washing steps with Buffer RPE, each RNeasy spin column was placed in new 2 ml collection 
tube and centrifuged at full speed for 1 minute to prevent carry over of Buffer RPE. RNA was 
eluted with 50 μl RNase free water per column. RNA concentrations were measured by the 
NanoDrop ND-1000 full-spectrum (220-750nm) spectrophotometer, using 1 μl of RNA 
sample. RNA samples were stored at –80 C. 
3.4.2 RT-PCR 
Two steps conventional RT-PCR was performed to confirm the expression of HH-2-1_tRES in 
transfected HEK 293 cells, using β-Actin (βA) as a positive control. Reverse transcription was 
performed using Superscript II Reverse Transcriptase (RT) from Invitrogen. 
3.4.2.1 1st strand cDNA synthesis 
A 10 μl 1st strand cDNA synthesis reaction mix was set up as follows. First, a 6 μl reaction 
mix was set up as follows: DEPC treated water to top up to 6 μl, 1 μl each of 5 μM gene 
specific primers HH-2-1 tRES Rvs L1 (for HH-2-1 tRES) and Actin_B Rvs (for βA), 0.5 μl 
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dNTPs (10 mM), and 2.5 μl total RNA (300 to 1725 ng) or DEPC treated water for RT-PCR 
samples and water control respectively. Primer information was as shown in Table 3.4-1. This 
reaction mix was denatured at 65 C for 5 minutes, followed by immediate incubation on ice. 
To this mix was added: 2 μl 5X First-Strand Buffer, 1 μl 0.1 M DTT, and 0.5 μl DEPC treated 
water. This reaction mix was incubated at 42 C for 2 minutes. Immediately after, 0.5 μl of 
SuperScript II RT (Invitrogen) or DEPC treated water was added for RT-PCR samples and 
“minus RT” (-RT) control respectively. This final 10 μl reaction mix was incubated at 42 C 
for 50 minutes for 1st strand cDNA synthesis and heat inactivated at 70 C for 15 minutes. 1st 
strand cDNAs were stored at –20 C. 
3.4.2.2 PCR 
PCR of HH-2-1_tRES and βA was performed with each 12.5 μl PCR reaction mix set up as 
follows: Deionised H2O to top up to 12.5 μl, 2.6 μl 5X PCR Buffer B (with 10 mM MgSO4), 
0.52 μl dNTP mix (5 mM each), 0.26 μl Elongase Enzyme Mix, 0.52 μl of each primers (5 
μM), and 0.5 μl cDNA (as obtained above). Primer information was as shown in Table 3.4-1. 
Thermocycling conditions were: Initial denaturation at 94 C for 30 seconds, 30 cycles of 
amplification (denaturation at 94 C for 30 seconds, annealing at 55.5 °C for 30 seconds, and 
extension at 68 C for 39 seconds), and a final extension at 68 C for 5 minutes. 
The expected product sizes were 134 bp for HH-2-1_tRES and 643 bp for βA. RT-PCR 
products were analysed by agarose gel electrophoresis in 1.5% gel at 120 V for about 20 
minutes. 
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Table 3.4-1 Primers used in RT-PCR. 
Primers Role Sequence (5’ to 3’) Length 
(nt) 
HH-2-1_tR















βA forward primer. GACCCAGATCATGTTTGAG 19 
Actin_B 
Rvs 
βA reverse primer. AGGAGGAGCAATGATCTTG 19 
 
3.4.3 Ribozyme Cis-cleavage Assays 
For the initial designs of e-SRS sensors, RNA sensor constructs were designed to self-cleave, 
i.e. cis-cleave. This process can occur either 1) without trigger, known as RCA, as in the cases 
of T1a, HP-LR-CS, and DT-LR-CS; or 2) with an allosteric RNA trigger, known as Ribozyme 
Cis-cleavage Allosteric Assay (RCAA)as in the case of T1b. 
3.4.3.1 In Vitro Transcription with RCA or RCAA 
In Vitro Transcription (IVT) and RCA or RCAA processes occurred concurrently with the 
species incubated at 37C for various durations. All RCA test constructs underwent IVT and 
RCA with no other RNA species in the same environment. T1b and T1b(-) underwent IVT and 
RCAA together with sNTS-37a. IVT DNA templates were gel purified PCR products except 
for sNTS-37a and sNTS-37b, which were Annealed Oligonucleotides, obtained as described in 
Gene Synthesis via Oligonucleotide Ligation (Section 3.1.9). 
IVT was performed using the MAXIscript Kit from Ambion, essentially following the 
manufacturer’s protocol. A 6 μl IVT reaction mix was set up as follows: DEPC treated or 
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Nuclease free water to top up to 6 μl, 0.6 μl 10X Transcription Buffer (9 U), 1.2 μl NTP mix 
(10 mM each), 0.6 μl T7 Enzyme Mix, and 1 to 2 μl IVT DNA template (to final 
concentrations of ~5 nM for T1a, C1a, C1a(-), T1b and T1b(-), ~16 nM for sNTS-37a and 
sNTS-37b, ~3 nM for HP-LR-CS, ~9 nM for DT-LR-CS). 
IVT mixes were incubated for about 3 hours at 37 °C. Reactions were terminated by addition 
of an equal volume of 2X Gel Loading Buffer II provided in the MAXIscript Kit (95% 
Formamide, 0.025% xylene cyanol, 0.025% bromophenol blue, 18 mM EDTA, 0.025% SDS) 
and stored at -20 °C. 
3.4.3.2 Denaturing Polyacrylamide Gel Electrophoresis (D-PAGE) 
The end products of RCA and RCAA were analysed on Denaturing Polyacrylamide Gel 
Electrophoresis (D-PAGE). Before loading into gel, the products (with Gel Loading Buffer II 
added) were denatured by incubation at 95 °C for 3 mins, and then quickly cooled on ice (4 
C). 
D-PAGE was conducted at in 1X TBE (Tris, Boric Acid, EDTA) gel running buffer, at 100 V 
for about 100 minutes, using 1.5, 0.75, and 0.5 mm 15% polyacrylamide TBE Urea (7 M) 
denaturing gels. A stock D-PAGE gel casting solution of 7 M Urea, 15% polyacrylamide was 
prepared by dissolving urea (42 g per 100 ml) in deionised water at 60 °C with magnetic 
stirring for about 50 minutes, followed by addition of 0.1 volume of 10X TBE, 0.375 volume 
of 40% polyacrylamide solution, and deionised water to top up to final volume. For casting of 
1.5 mm gels, 10 ml gel casting solution was used, while 0.75 and 0.5 mm gels used 5 ml gel 
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casting solutions. Gels were solidified by addition of 4 μl TEMED and 0.01 volume 10% APS 
(100 mg ammonium persulfate in 1 ml deionised water). 
To improve gel solidification, gels were allowed to set for about 45 minutes at room 
temperature, and then left over night at 4 °C, covered with lens paper soaked in 1X TBE and 
wrapped in Saran wrap. 
After D-PAGE, gels were stained in SYBR Gold for about 45 to 55 minutes with gentle 
rocking and visualised under UV. SYBR Gold staining solutions were prepared by diluting the 
stock 10,000X SYBR Gold stain from Invitrogen into 1X concentration in 1X TBE, within a 
plastic container protected form light. Staining solutions were kept at 4 °C and reused several 
times as long as staining results were satisfactory. 
3.4.4 RTA for Mz-based e-SRS 
For the Mz based e-SRS sensors, RNA sensor constructs were designed to cleave a different 
RNA strand, i.e. trans-cleave, upon activation. This process of trans-cleavage can occur either 
with or without triggers (e.g. the control HH ribozymes), and was tested in RTA. 
RTA protocols were modified from Mz [Tanabe et al, 2000]. Basically, Rz (either Mz or HH) 
were incubated with the substrate (STS), and activator, at 37 C in RTA buffer, and results 
were monitored over time. The activator could be NTS, Nucleic acid Non-targeted Sequence 
(NNS, typically an RNA sequence that is close to the NTS, and needs to be distinguished from the 
NTS by e-SRS), or nothing (i.e. water). 
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3.4.4.1 RS RTA 
All RS used for fluorometer measurement were labelled at 5’ with 6-FAM, and at 3’ with 
BHQ1. 
3.4.4.1.1 RTA for Mz-1, Mz-2, Mz-3, and Mz-4 
For the cases of Mz-1, Mz-2, Mz-3, and Mz-4, RTA buffer was 50 mM Tris (pH 8.0), 10 mM 
MgCl2. Concentration of reactants were 0.2 μM Mz or HH, 2 μM NTS/NNS, 1 μM STS 
(RTS-1, RTS-2, RTS-3, RTS-4 respectively). 5 μl aliquots would be manually removed at 
intended time points. For each aliquot, RTA was terminated quickly by addition of 50 μl of 50 
mM EDTA and incubation on ice. Aliquots were placed in 96 well plates and RTA results 
were assessed by fluorometer reading via the Tecan GENios Plus. Excitation and emission 
filter wavelengths were set at 485 nm and 520 nm respectively. 
3.4.4.1.2 RTA for Mz-based e-SRS sensors for Dengue and Malaria 
For the remaining Mz-based e-SRS sensors, RTA were assessed by the fluorometer Tecan 
Infinite M200. 50 μl RTA reaction mixes were prepared in 96 well plates. 25 μl per reaction 
master mix(es) of STS and RTA buffer was prepared on ice and protected from light, and 
quickly dispensed into the remaining RTA components (25 μl) already prepared in 96 well 
plates. Upon constitution of RTA mixes, the 96 well plate was protected from light and 
quickly placed within the Tecan Infinite M200, which had been prepared and warmed to 37 
°C, so that measurements could start quickly. Measurement intervals were about 20 to 30 
seconds and the RTA would typically span about 1.5 to 3 hours, until the fluorescent readings 
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had peaked. Other parameters used were as shown in Table 3.4-2. 
Table 3.4-2 RTA parameters for Tecan GENios Plus. 
Parameter Value 
Mode Fluorescence Top Reading 
Excitation Wavelength 490 
Emission Wavelength 525 
Excitation Bandwidth 9 
Emission Bandwidth 20 
Gain 100 
Number of Flashes 3 
Integration Time 20 
RTA buffer contained 50 mM Tris (pH 8.0), and concentrations of reactants included 0.2 μM 
Mz or HH, and 1 μM STS (RTS-2). The remaining conditions were as shown in Table 3.4-3. 
Antisense oligonucleotides (AS) were used for NASBA RTA (Section 3.4.4.2). 
Table 3.4-3 RTA conditions for Mz-based e-SRS sensors for Dengue and Malaria. 







sNTS 10 mM 0.2 μM Nil. 
Mfs sNTS 2 mM 0.2 μM Nil. 
Mfr1 sNTS 3 mM 0.2 μM 2 μM sNTS-Mfr2. 
Mfr2 sNTS 3 mM 0.2 μM Nil. 
Mfs NASBA NTS 2 mM 3 μl NASBA NTS AS. 
Mfr1 NASBA NTS 3 mM 3 μl NASBA NTS AS, 2 μM 
sNTS-Mfr2. 
Mfr2 NASBA NTS 3 mM 3 μl NASBA NTS AS. 
3 μl of NASBA NTS with 15 μM of each AS (Mal Rvs 194-215 for Mfr2 / Mal Rvs 206-214 for 
Mfs and Mfr1, and Mal Rvs 242-271 for all) in a 5 μl volume was denatured at 70 C for 2 mins 
followed by quick chill on ice. This 5 μl mix was then used for NASBA RTA. 
3.4.4.2 NASBA RTA 
3.4.4.2.1 Genomic DNA 
Genomic DNA of 3 Plasmodium falciparum strains as shown in Table 3.4-4 were kindly 
provided by Dr Cheng Qin, Laboratory Head of Molecular studies, Australian Army Malaria 
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Institute, Brisbane. 
Table 3.4-4 Plasmodium falciparum strains from which genomic DNA were obtained. 
pfcrt haplotypes Pf Strain Chloroquine Denoted here as 
SVMNT S99 Resistant Mfr1 
CVIET Dd2 Resistant Mfr2 
CVMNK 3D7 Sensitive Mfs 
3.4.4.2.2 NASBA reaction 
NASBA reactions were performed using reagents from the NucliSENS EasyQ Basic Kit v2 
from bioMérieux. Reactions were scaled up or down as needed proportionately. 
A NASBA Enzyme Solution was prepared as follows: A red Enzyme Sphere was mixed with 
45 μl of Enzyme Diluent and incubated at room temperature for 5 minutes. The solution was 
then mixed by tapping and spun down. A Reagent Premix was prepared as follows: A blue 
Reagent Sphere was mixed with 64 μl of Reagent Sphere Diluent and vortexed until solution 
cleared. If solution remained cloudy, it was incubated at 65 °C for 5 minutes and vortexed 
again. Solutions with precipitates were not used. Both the Reagent Premix and Enzyme 
Solution were sufficient for 16 NASBA reactions with 10 μl reaction volumes. They were 
aliquoted as required for 1 freeze-thaw cycle each within 2 weeks and stored at -80 °C quickly 
after preparation. NASBA KCl Water Mix (80 mM KCl) was prepared as follows: 16 ul KCl 
Stock Solution was mixed with 14 μl NASBA Water (nuclease free) and stored at -20 °C for 
multiple uses. 
A 10 μl NASBA reaction mix was set up as follows. First, a 7 μl NASBA Primer-Reagent mix 
was set up as follows: NASBA Water to top up to 7 μl, 1.25 μl NASBA KCl Water Mix, 3.33 
μl Reagent Premix, and 0.2 μl each of 10 μM NASBA primers Mal Fwd 03 and Mal Rvs 01. 
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Primer information was as shown in Table 3.4-5. The NASBA Primer-Reagent mix was 
treated like the Reagent mix until it was clear of precipitate (otherwise it was not used). 
To NASBA Primer-Reagent mix (within 30 minutes of its preparation) was added: 0.5 μl 
NASBA template (about 6 x 109 copies). This reaction mix was incubated at 65 C for 2 
minutes, and 41 C for 2 minutes. Immediately after, 2.5 μl Enzyme Solution was added to 
complete the 10 μl NASBA reaction mix. This was given a quick spin, mixed by tapping, 
given a quick spin again, and incubated at 41 °C for 90 minutes. NASBA products were stored 
at –80 C. 
Table 3.4-5 Oligonucleotides used in NASBA. 
Oligonucleo
tides 
Role Sequence (5’ to 3’) Length (nt)











5’ AS for Mfr2. CATACACTTAAATAAATAATAC 22 
Mal Rvs 
206-214 











3.4.4.2.3 NASBA product denaturation via antisense oligonucleotides 
(AS) action 
NASBA products were used as NTS or NNS (known as nNTS) in NASBA RTA. For a 50 μl 
NASBA RTA, a 5 ul nNTS denatured with antisense oligonucleotides (AS) was used. 
Reactions were scaled up or down as needed proportionately. 
A 5 μl nNTS was set up as follows: 3 μl NASBA product, 0.75 μl each of 100 μM 5’ and 3’ 
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AS (final concentration of 15 μM), and 0.5 μl of DEPC treated water. AS information was as 
shown in Table 3.4-5. This nNTS mix was denatured at 70 C for 2 minutes, followed by 
immediate incubation on ice before use. 
3.5 Bioimaging 
Fluorescence microscopy was carried out with parameters as shown in Table 3.5-1. Live cells 
were viewed in their culture vessels using the Olympus FV500 or Olympus IX81. Cells grown 
on coverslips and mounted on microscope slides in FluorSave Reagent (from Calbiochem) 
were viewed using the Zeiss LSM. 
Table 3.5-1 Excitation and emission parameters for fluorophores. 
Excitation (nm) Emission (nm)  Fluorophores Microscope 
Laser Fluorophores Filter Fluorophores 
Olympus FV500 405 ECFP ECFP 




Olympus FV500 488 488 EGFP EGFP 
Olympus IX81 450 - 480  >515 (FITC) 
507 
6-FAM Olympus IX81 450 - 480 495 >515 (FITC) 520 
EYFP Olympus FV500 515 513 EYFP 527 
Zeiss LSM 633 LP 650 Cy5 





3.6 Software used 
RNAstructure 4.5 was used to predict secondary structure of RNA contructs. Perl 5.8.8 was 
used to implement the automation of the design of e-SRS Mz-based sensors. 
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CHAPTER 4 RESULTS 
4.1 Initial designs of e-SRS. 
Section 4.1 elaborates on the original designs and motivation of e-SRS. 
4.1.1 Design Overview of Environment-Sensing Induced Gene 
Expression (e-SIGE) 
e-SIGE aimed to achieve similar objectives (as an environment sensing response system) as 
e-SRS, but was more complex in its physical implementation. e-SIGE was a generic platform 
that could be further distinguished into such forms as r-SIGE, p-SIGE, m-SIGE, l-SIGE, 
s-SIGE, and d-SIGE that sense RNA (and thus potentially DNA) sequence, protein, 
metabolite, lipid, sugar, and drug, respectively. In this work, e-SIGE is taken to refer 
essentially to r-SIGE. As detailed in the 2005 Invention Disclosure to ETPL (Invention 
Disclosure, ETPL, 2005), e-SIGE is an environment sensing gene expression platform that 
was designed to achieve the following objectives: 
1) e-SIGE plasmid can be transfected into all cells of any tissues without problem of 
side effects in non-targeted cells. No specific delivery to any cell was needed because 
e-SIGE construct discriminate cells with unique target RNA sequence(s). 
2) If e-SIGE sensor identifies the specified unique target RNA sequence(s), it can 
initiate expression of engineered genetic system. 
3) If e-SIGE sensor does not identify any specified unique target RNA sequence(s), it 
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can initiate auto-degradation of the e-SIGE plasmid. 
4) e-SIGE plasmid can also be degraded as desired by administering drug or agents 
Within the e-SIGE sensor is one or more RNA domain(s) known individually as a 
Environment-sensing induced Conformation changing domain (EC), which couples the 
sensing of specified component(s) (essentially RNA in this work) of the intracellular 
environment with the initiation of e-SIGE sensor conformational change. Due to the ability of 
RNA to be potentially designed to bind specifically almost any biomolecular compound 
(Hermann, T. and Patel, D.J., 2000), ECs can potentially be created to sense for virtually any 
kind of biomolecule, including (but not limiting to) nucleic acids (RNA or DNA) sequences, 
proteins, peptides, metabolites, lipids, sugars, synthetic small molecular compounds, such as 
drugs, and dyes, etc.  
Of the five embodiments of e-SIGE described in the Invention Disclosure, this work focused 
on the first embodiment, where the sequence to be detected, the NTS activates RNA silencing 
via the e-SIGE sensor known as the Integrated RNA silencing Construct (IRC). 
To summarise, e-SIGE (like e-SRS) has two main components: 1) An RNA based sensor (the 
IRC in this case) that changes conformation upon binding of specific NTS; 2) A Response 
System that is triggered by the activated sensor to initiate some physical response, such as 
driving the expression of an exogenous gene known as the PLG or emitting a signal (e.g. 
fluorescence) to indicate the presence of the NTS. Both components can be encoded in 
plasmids that are transfected into cells. For simplicity, both components are encoded in a 
plasmid called the e-SIGE plasmid. 
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4.1.1.1 Mechanism of e-SIGE activation 
The mechanism of e-SIGE activation is summarized in Figure 4.1-1 and can be described as 
follows: (1) Upon transfection of the e-SIGE plasmid into a cell, IRC is constitutively 
transcribed and is present in the cell in an inactive conformation. IRC consists of various 
domains, including Ribozyme Catalytic (RC) domains and Cleavage Site (CS). Each RC is a 
Ribozyme Catalytic domain that is able to recognize and cleave at its specific sequence, i.e., 
its own CS. Each Cleavage Site harbours a particular sequence that its RC can recognize and 
cleave at only when it is single stranded (i.e. when IRC is in active conformation). (2) A 
repressor (R1) is also constitutively transcribed and inhibits the transcription of the PLG(s). (3) 
Upon recognition of NTS based on (but not limiting to) Watson-Crick complementary base 
pairing principle, IRC is activated via conformational changes, which involves two sequential 
RNA cleavage events. (4) RC2 first cleaves at CS2, releasing the Antisense and Ribozyme 
RNA (ARR). ARR mediates silencing of R1 via antisense and ribozyme cleavage. (5) RC1 
next cleaves at CS1, releasing the short hairpin siRNA (SHR). This short hairpin siRNA 




Figure 4.1-1 Mechanism of e-SIGE (taken from Innovative Grant application [SBIC 
Innovative Grant, 2005]. 
NTS activates RNA-based sensor to initiate expression of PLG in 7 steps. (1) Sensor is 
constitutively transcribed and exists in an inactive conformation. (2) R1 is constitutively 
transcribed and inhibits the transcription of the PLG. (3) Recognition of NTS results in an 
activation of sensor via conformational changes, which triggers two sequential cleavage events. 
(4) RC2 first cleaves at CS2, releasing the ARR. (5) RC1 next cleaves at CS1, SHR. (6) SHR and 
ARR mediate silencing of R1. (7) In the absence of R1, PLG is expressed. 
4.1.1.2 Extensibility of e-SIGE 
Due to the modular nature of e-SIGE activation, the e-SIGE sensor and thus the entire 
platform can be extended in a modular nature as illustrated in Figure 4.1-2. Each EC is a 
specific sequence of RNA that can sense a specific bio-molecule, e.g. EC1 can sense mRNA, 
EC2 can sense Protein. Such combinatorial e-SIGE requires all of EC1, EC2, and EC3 to 




Figure 4.1-2 Extensibility of e-SIGE. 
4.1.2 Structure of e-SIGE components 
4.1.2.1 RNA Segments of e-SIGE components 
Referring to Figure 4.1-1, the structure of e-SIGE components can be broken down into 
modular segments (and sub-segments) of RNA as follows: 
Segment A – Sense sequence of the RTSI segment of the RNA silencing Target Sequence 
(RTS) (Found in Inactivating Repressor (R1) and e-SIGE plasmid Degradation Entity (DE)) 
(no homolog in Homo sapiens transcriptome). 
1) Segment A1 – 3’ part of A, ~ 10 bp 
2) Segment A2 – Middle part of A, ~ 5 bp 
3) Segment A31 (=A32) – 5’ of C, ~ 4 bp 
4) Segment A32 (=A31) – 5’ part of A2, ~ 4 bp 
Segment B – Antisense sequence of STS (no homolog in Homo sapiens transcriptome). 
1) Segment B1 – 5’ part of B, ~ 10 bp 
2) Segment B2 – Middle part of B, ~ 5 bp 
3) Segment B3 – 3’ part of B, ~ 4 bp 
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4) Segment B2 + B3 = C 
Segment C – Reverse complement of A32 + A2. 
Segment D (NTS’) – Reverse complement sequence of NTS. 
1) Segment D1– 3’ part of D, ~ 10 bp (which can have flexible length) 
2) Segment D2 – 5’ part of D, ~ 10 bp (which can have flexible length) 
Segment E – Reverse complement of D1, found on the 3’ part of NTS. 
Segment F – Reverse complement of RTSA (F’), which is found on the RTS (which can have 
flexible length). This binding of segment F to RTSA can mediate antisense silencing of the 
RTS containing gene. 
NTS - Nucleic Acid Target Sequence. 
Segment D1’– 5’ part of NTS, ~ 10 bp (which can have flexible length) 
Segment D2’ – 5’ part of NTS, ~ 10 bp (which can have flexible length) 
RTS - RNA silencing Target Sequence. 
1) RTSI (= A) – 3’ of RTS, ~ 19 bp 
2) RTSA (= Reverse complement of F) – Middle part of RTS, may be part of the RTSI 
(flexible length, no homolog in Homo sapiens transcriptome). 
3) RTSC – 5’ of RTS, serves as recognition and cleavage sequence of RC2. 
4) RTSI-A – Linker sequence between the RTSI and RTSA (which can have flexible 
length). 
5) RTSA-C – Linker sequence between RTSA and RTSC (this length may affect RC2 
catalysis efficiency). 
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Segment MS – Mutant Sequence within NTS that is specific to the mutant copy and not found 
in the wild type copy of the targeted mRNA. It could be more than one nucleotide in length, 
but is usually one nucleotide. 
Segment MS’ - Reverse complement of MS, could exist at the middle or 3’ end of D2, or 5’ 
end of D1. 
Segment RC - Ribozyme Catalytic (RC) domain that is able to recognize and cleave at a 
specific sequence. There are two RC within IRC: RC1 and RC2, which may or may not bear 
the same sequences. RC1 exists at the 5’ end of the construct, while RC2 exists at the 3’ end of 
the construct. 
Segment CS – Cleavage Site (CS) that harbours a particular sequence that the RC can 
recognize and cleave at only when it is single stranded (i.e. when IRC is in active 
conformation). There are two CS within IRC: CS1 and CS2, which may or may not bear the 
same sequences, and are recognized by RC1 and RC2, respectively. CS1 is located at the 5’ of 
A3 (while remaining on the same strand of the hairpin stem), paired with the complementary 
CS1’ on the opposite stem. CS2 is located at the 3’ of B3, 5’ of F, paired with the 
complementary CS2’ on the opposite stem. 
4.1.2.2 Complementarities of Segments 
The following segments exhibit Watson-Crick complementary base pairing: 
1) A ↔ B 
2) A1 ↔ B1 
3) A2 ↔ B2 
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4) A3 ↔ B3 
5) (A3 + A2) ↔ C 
6) D1 ↔ E 
7) CS1 ↔ CS1’ 
8) CS2 ↔ CS2’ 
 
4.1.3 Design of RNA folding mechanism in e-SIGE 
4.1.3.1 e-SIGE Sensor (IRC) Conformation upon Synthesis 
As mRNA synthesis occurs from 5’ to 3’, the segments will be synthesized in the following 
order: RC1, D2, D1, CS2’, A31, C, CS1’, CS1, A32, A2, A1, B1, B2, B3, CS2, F, E, and RC2. C 
will be synthesized before B2 and B3, while A2 and A32 will be synthesized in between. 
Although the sequences of C and B2 + B3 are identical, A32 + A2 will base-pair with C first, 
leaving B2 unpaired, and B3 pair to A31 immediately after synthesis. Since D1 is also paired 
with E, CS2 is not available to the RCs as well. Hence, r-SIGE IRC is inactive upon synthesis. 
4.1.3.2 Proposed RNA folding mechanism for NTS activation of the 
e-SIGE IRC into functional siRNA 
The activation process of IRC can be structured into the following RNA folding steps. 
1) Activation of EC. 
Presence of NTS provided specifically by the targeted (possibly mutant or specific 
splice variant) mRNA will allow first D2 and then D1 (after successful competition 
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with E) to base-pair with NTS, forming a transient [IRC – NTS] hetero-duplex 
complex T1. The formation of T1 releases F and E into an unbound conformation that 
hinges at CS2. 
2) Cleavage of CS2 by RC2. 
Conformation of T1 exposes CS2 as the 3’ end of a double stranded region, which 
thus increases significantly the probability that CS2 will spontaneously unpair from 
CS2’. This can be facilitated by introduction of mismatches between CS2 and CS2’. 
Once this occurs, there is a chance that RC2 will recognize and cleave the single 
stranded CS2, forming the transient IRC complex T2. The formation of T2 results in 
the release of Segments F, E, and RC2, as the Antisense and Ribozyme RNA (ARR).  
ARR binds to the RTSA segment of RTS via Segment F. This binding alone can 
mediate antisense silencing of the RTS containing gene. In addition, as the RC2 
recognition and cleavage site, RTSC has been engineered into RTS, the RC2 domain 
of ARR can also mediate the silencing of the RTS containing gene by cleaving at 
RTSC. 
3) Formation of A-B hairpin stem (consisting of A3, A2, A1, and B1, B2, B3 on each 
strand). 
The formation of T2 exposes B3 as the 3’ end of a double stranded region (as well as 
of the present construct), and thus increases significantly the probability that B3 will 
spontaneously unpair from A31. This can be facilitated by introduction of mismatches 
between B3 and A31. Once this occurs, there is a chance that the free B2 + B3 will 
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compete successfully with C for pairing with A3 + A2, forming the transient IRC 
complex T3, which contains the A-B hairpin stem. This can be facilitated by 
introduction of mismatches between A3 + A2 and C. 
4) Cleavage of CS1 by RC1. 
The formation of T3 forms the A-B hairpin stem that hinges at CS1. This exposes 
CS1’ as the 5’ end of a double stranded region, which thus increases significantly the 
probability that CS1 will spontaneously unpair from CS1’. This can be facilitated by 
introduction of mismatches between CS1 and CS1’. Once this occurs, there is a 
chance that RC1 will recognize and cleave the single stranded CS1, releasing the A-B 
hairpin stem, which is a short hairpin siRNA that will mediate the RNAi knockdown 
of the RTS containing gene. 
 
4.1.4 IRC e-SIGE segment sequences. 
In order to satisfy RNA folding requirements of IRC, the conditions as shown in Table 4.1-1 
were imposed for generating sequences for the various RNA segments of IRC e-SIGE listed in 
Section 4.1.2.1. Several variants were planned for most segments in order to allow for RNA 
folding optimisation. 
Table 4.1-1 Conditions for IRC e-SIGE segments. 
Segments Conditions 
A1, A2, A3 (as 1 segment) Random sequence (fixed 60% GC content) 
3 variants. 
20 nt in length. 
Blasted against Human, Mouse, and Rat Refseq to 
ensure no matches. 
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Segments Conditions 
B3 2-5nt in length. 
4 variants. 
C 0,1,2 opening mismatches 
3 variants. 
E, D2 Sequence determined by NTS. 
2 variants. 
E: 5, 8nt in length. 
D2: 15, 12nt in length. 
F Random sequence (fixed 60% GC content) 
3 variants. 
12, 15, 17nt in length. 
Blasted against Human, Mouse, and Rat Refseq to 
ensure no matches. 
NTS Cav2.1 alternatively spliced sequences (Exon 37a 
or 37b) from Human, mouse and rat. 
CS (1 and 2) Ribozyme cleavage signal flanked by specific 
sequences. 
3 variants per ribozyme. 
5-7nt in length 
Suitable segment sequences (with several variants in many cases) are shown in Table A 2. 
Core ribozyme sequences and their consensus cleavage site sequences were assembled by 
consulting various references [Ananvoranich and Perreault, 1998; Bergeron et al, 2005; 
Berzal-Herranz et al, 1992; Chowrira et al, 1991; Chowrira et al, 1994; Fujitani et al, 1993; 
Hertel et al, 1996; Pérez-Ruiz et al, 1999; Quan, 1999; Wrzesinski, 2001]. 
4.2 In vitro testing of initial e-SRS constructs. 
The first phase of development was to test the ability of the IRC to fold and activate as we 
designed, in the simple test tube environment. This section details the design and synthesis of 
e-SIGE IRC test constructs for in vitro tests. 
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4.2.1 e-SIGE test constructs required to show appropriate 
RNA folding in NTS activation of IRC. 
4.2.1.1 Key elements in RNA folding steps in NTS activation of IRC. 
As the IRC activation by NTS is a complex process, it was desirable to breakdown the 
activation process into individual RNA folding steps (as detailed in section 4.1.3.2) and 
identity crucial elements and design simpler test constructs for groups of these elements. 
By analysing the steps in section 4.1.3.2, two key elements for the IRC activation process was 
identified: 
1) Cleavage of CS1 and CS2 had to occur readily if and only if the CS were single 
stranded (SS), and not if they were double stranded (DS). 
IRC activation steps have two irreversible check points given by the cleavage of CS1 
and CS2. The paradigm would fail if these CS were to be readily cleaved even when 
they were DS (i.e., IRC not activated). Likewise, the CS had to be readily cleaved 
when they were SS (i.e., IRC activated). 
2) NTS (but not NNS) must be able to activate the EC by displacing segment E, which 
must be sufficient to result in cleavage of CS2, in order to start the whole process of 
activation. 
4.2.1.2 e-SIGE IRC activation test constructs. 
In order to verify the two key elements in IRC activation, two groups of test constructs were 
designed as follows. The design of test constructs created new segments based on the original 
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IRC segments. In order to keep a systematic list of segment names, the nomenclature in Table 
4.2-1 was used. 
Table 4.2-1 Nomenclature for segments. 
Symbol Meaning Types Examples 
Underscore 
“_”, as used 
in X_M. 
Denotes a 




sequence of X. 
 
X_D: “Dead” CS 
sequence. CS with 
sequence modified such 
that it is not recognised by 
its Rz 
C_R means a segment with 
the randomised sequence 
of C. 
CS1_D means CS1 
sequence altered such that 
it is not cleaved by its 
RC1. 
Denotes a variant V of 
X. 




NTS-A: NTS sequence of 
A. 
HP-1 means variant 1 of 
HP (there were 3 variants 
of HP, differing slightly in 
binding arm sequence. 
NTS-D1 means NTS 
sequence of D1. 
Dash “-”, as 
in X-V. 
 X-Rn/X-Mm/X-Hs: 
Segment X for species 
Rat, Mouse, Human 
respectively. 
sNTS-37a1-Rn/Mm means 
sNTS-37a of variant 1a, 
representing both Rat and 
Mouse variants. 




sequence of X. 
Thus, X and X’ can 
have perfect 
base-pairing. 
X’: Reverse complement 
of X. 
CS2-1’ means the reverse 
complement of variant 1 of 
CS2. 
Vertical bar 
“|”, as in 
X|Y|Z. 
Denotes a field 
separator, to delineate 
consecutive segments, 
especially when its use 
could improve clarity. 
X|Y|Z: Segments X, Y, Z 
joined consecutively in 
that order. 
CS|Linker|RC means 
the segments CS, 
Linker, and RC joined 
consecutively in that order. 
 
4.2.1.2.1 Aim 1a constructs to show that RC1 can cis-cleave CS1 if and 
only if CS1 was single stranded. 
Aim 1a served to verify the first key element that CS must be readily cleaved if and only if it 
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was SS. Specifically, the constructs (as illustrated in Figure 4.2-1) were designed to show that 
RC1 can cis-cleave CS1 if and only if CS1 was SS. 
 
 
Figure 4.2-1: Illustration of Aim 1a constructs. 
Aim 1a was to show that RC1 could cis-cleave CS1 if and only if CS1 was SS. 
The list of Aim 1a constructs are as follows: 
1) Test 1a (T1a) 
This construct aimed to emulate the crucial parts of complex T3, where A3 + A2 has 
been unpaired from C, in order to show that RC1 cleaves CS1 readily IF CS1 is SS. 
In T3 CS1’ was exposed as the 5’ end of a double stranded region. The IRC activation 
model assumed critically that such conformation of CS1 increased significantly the 
probability that CS1 would spontaneously unpair from CS1’, allowing RC1 to cleave 
CS1 readily. T1a allowed a further simplification of the T3 model by allowing CS1 to 
be SS by default. The expected result would be that T1a would be readily cleaved. 
Note that for simplicity, segments B2 and B3 was not included. 
T1a was able to emulate unpaired A3 + A2 as the pairing segment C in IRC had been 
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replaced with segment C_R, which being a randomised sequence of C would not base 
pair with A3 + A2. Likewise, CS1 would be SS by default as CS1’ had been replaced 
by CS1’_R. 
2) Control 1a (C1a) 
This construct aimed to show that when CS1 is DS, it cannot be cleaved readily by 
RC1. It therefore would provide a basal level of cleavage in Test 1a and Control 1a 
due to self unwinding of the C-A3_2A2 stem, or unwinding starting at the middle of 
the loop. 
This is possible as this construct is Test 1a but with A3+A2 paired and CS1 DS by 
default, as in the case of the unactivated IRC. 
3) Control 1a(-) (C1a(-)) 
This construct aimed to show the basal level of “cleaved band” intensity due to 
systematic error, e.g. background intensity due to fragmented nucleotides. 
This is possible as this construct is Control 1a with CS_D instead of CS, and would 
not be cleaved by RC1. 
4) HP-LR-CS 
This construct aimed to provide a +ve control to ensure reaction conditions are 
suitable for Hairpin (HP) ribozyme (Rz) cleavage. 
This is possible as this construct contained only HP (hairpin Rz), LR (Linker: Rz), 
and CS (for HP, same as those used in T1a, C1a, C1a(-)). If reaction conditions were 
suitable, HP should cis-cleave readily at the nearby CS, producing two fragments 
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smaller than the original HP-LR-CS. This assay would also show how much of the 
CS would be cleaved by a wild type HP in a given time, and allow us to judge the 
cleavage efficiency of our test constructs. 
Based on the experimental requirements outlined above, segments for Aim 1a constructs 
were designed as given in Table A 3. Based on the Aim 1a constructs given in Table A 3, the 
experiments and predicted results are outlined in Table 4.2-2. 
Table 4.2-2 Experiments for Aim 1a constructs. 
Lane 
No. 






5’ Fragment 119 
1 Test 1a IVT + RCA 
3’ Fragment 48 
High % cleavage. 
2 Control 1a IVT + RCA As Lane 1. Low % cleavage. 
3 Control 
1a(-) 





5’ Fragment 63 
4 HP-LR-CS IVT + RCA 
3’ Fragment 9 
Highest % 
cleavage. 
Serves as positive 
control. 
IVT, In-vitro Transcription; RCA, Ribozyme Cis-Cleavage Assay. 
4.2.1.2.2 Aim 1b constructs to show that sNTS-37a but not sNTS-37b can 
activate EC and lead to cleavage of CS2. 
Aim 1b served to verify the second key element that NTS (but not NNS) must be able to 
activate the EC by displacing segment E, which must be sufficient to result in cleavage of CS2, 
in order to start the whole process of activation. 
Specifically, the constructs (as illustrated in Figure 4.2-2) were designed to show that 
sNTS-37a but not sNTS-37b (the NNS in this case) can trigger activation of EC by displacing 
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segment E and lead to cleavage of CS2. 
 
Figure 4.2-2: Illustration of Aim 1b constructs. 
Aim 1b was to show that a short hairpin RNA (with RC1 to A3_1 on 5’, and B3 to RC2 on 3’) 
would be cleaved if and only if sNTS was present. 
The list of Aim 1b constructs are as follows: 
1) Test 1b (T1b) 
This construct aimed to emulate the crucial parts of IRC that were responsible for the 
formation of complex T1, where 1) D2 and then D1 (after successful competition 
with E) base-pair with NTS, 2) releasing F and E into an unbound conformation that 
hinged at CS2 leading to cleavage of CS2 by RC2, in order to show that sNTS-37a 
but not sNTS-37b can activate EC and lead to cleavage of CS2. 
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In T1, CS2 was exposed as the 3’ end of a double stranded region. The IRC EC 
activation model assumed critically that such conformation of CS2 increased 
significantly the probability that CS2 would spontaneously unpair from CS2’, 
allowing RC2 to cleave CS2 readily. If this assumption was true, the expected result 
would be that T1b would be readily cleaved if and only if sNTS-37a is present, and 
the same cannot be achieved by substitution of sNTS-37b. Note that for simplicity, 
segments between A3_1 and B3 (which were not responsible for the activation of EC) 
were not included. 
This construct thus provides a simple way to test the formation of complex T2 and 
ARR due to EC activation by sNTS. 
2) sNTS-37a 
This construct aimed to emulate the NTS37a containing mRNA by representing a 
crucial 22 nt segment of it that differed slightly from NTS37b. It should be able to 
trigger unwinding of D1-E stem in Test 1b. 
3) sNTS-37b 
This construct aimed to emulate the NTS37b containing mRNA by representing a 
crucial 22 nt segment of it that differed slightly from NTS37a. It should not be able to 
trigger unwinding of D1-E stem in Test 1b. 
4) Test 1b(-) (T1b(-)) 
This construct (used together with sNTS-37a) aimed to show the basal level of 
“cleaved band” intensity due to systematic error, e.g. background intensity due to 
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fragmented nucleotides. 
This is possible as this construct is Test 1b with CS_D instead of CS, and would not 
be cleaved by RC2. 
5) DT-LR-CS 
This construct aimed to provide a +ve control to ensure reaction conditions are 
suitable for Delta (DT) ribozyme (Rz) cleavage. 
This is possible as this construct contained only DT (Delta Rz), LR (Linker: Rz), and 
CS (for DT, same as those used in T1b, T1b(-)). If reaction conditions were suitable, 
DT should cis-cleave readily at the nearby CS, producing two fragments smaller than 
the original DT-LR-CS. This assay would also show how much of the CS would be 
cleaved by a wild type DT in a given time, and allow us to judge the cleavage 
efficiency of our test constructs. 
Based on the experimental requirements outlined above, segments for Aim 1b constructs were 
designed as given in Table 4.2-3. 
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Table 4.2-3 Aim 1b construct segments. 
Construct Segment Variants Sequence 
RC1 HP-1 AAACAGagaaGTCAACCAGAGAAACACACGTTGTGGTATA
TTACCTGGTA 
D2D1 1a TACATGTCCTTATAGTGAAT 
CS2’ DT-1 aaaccac 
A3_1 1 AA 
L3 1 TTCAAGAGA 
B3 1 TT 
CS2 DT-1 gtggttt 
F 1 CCAATACTTACGCGTCG 







D2D1 1a TACATGTCCTTATAGTGAAT 
CS2_D’ DT-1 aaaggaa 
A3_1 1 AA 
L3 1 TTCAAGAGA 
B3 1 TT 
CS2_D DT-1 ttccttt 
F 1 CCAATACTTACGCGTCG 
E 1 ATTCACTATA 




D1’ 1a ATTCACTATA sNTS-37a1-R
n/Mm 
(sNTS-37a) 
D2’ 1a AGGACATGTA 
D1’ 1b ATGCCTTACC sNTS-37b1-R
n/Mm 
(sNTS-37b) 
D2’ 1b CGGACATGTA 
L3 1 TTCAAGAGA 
B3 1 TT 
CS2 DT-1 gtggttt 






Based on the Aim 1b constructs given in Table 4.2-3, the experiments and predicted results are 
outlined in Table 4.2-4. 
Table 4.2-4 Experiments for Aim 1b constructs. 
Lane 
No. 





1 Uncleaved 183 
 5’ Fragment 92 




IVT + RCAA 
sNTS 22 
High % cleavage. 
2 Test 1b 
sNTS-37b 
IVT + RCAA As Lane 1.  Low % cleavage. 










4 Uncleaved 79 
 5’ Fragment 13 
 
DT-LR-CS IVT + RCA 
3’ Fragment 66 
Highest % 
cleavage. 





4.2.2 Synthesis of e-SIGE test constructs. 
4.2.2.1 e-SIGE test constructs sequences. 
The required Aim 1a and 1b constructs (Test 1a, Control 1a, Control 1a(-), HP-LR-CS, Test 1b, 
Test 1b(-), sNTS37a, sNTS37b, DT-LR-CS) were first constructed de novo (using gene 
synthesis via oligonucleotide ligation) as double stranded DNA templates with protruding 3’ A 
and then inserted via TA-cloning into pGEM-T Easy vectors. As large quantity of RNA test 
constructs (longer than commercially available for synthesis) were required for RCA, each of 
the construct had an IVT promoter appended at 5’ end so that their RNA transcripts could be 
produced in bulk via IVT. The 5’ appended T7 RNA Pol III promoter minimum sequence (-17 
to +2, -17 TAATACGACTCACTATA -1 +1 GG +2) was the minimum sequence required for 
efficient transcription. Transcribed RNA starts at +1, hence adding “GG” to 5’ end of 
construct sequences. Sequences of the test constructs with IVT promoter added are given in 
Table 4.2-5. Construct sequences cloned into pGEM-T Easy vectors were verified by DNA 
sequencing using vector primers. 
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Table 4.2-5 Sequences of Aim 1a and 1b test constructs with 5’ IVT promoter. 































sNTS-37a TAATACGACTCACTATAGGATTCACTATAAGGACATGTA 39 




Underlined sequence, Appended T7 promoter minimum sequence (-17 to +2) required for 
efficient transcription. Transcribed RNA starts at +1, hence adding “GG” to 5’ end of construct 
sequences. 
4.2.2.2 De novo synthesis of constructs DNA template via PCR. 
We initially attempted to synthesise our required constructs via assembly PCR. Instructions 
for assembly PCR were as given in [Rydzanicz et al, 2005]. A web-based tool 
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(http://publish.yorku.ca/~pjohnson/AssemblyPCRoligomaker.html) was used to design 
assembly PCR oligonucleotides. However, it turned out that DNA templates synthesized by 
this technique often contained missing regions. After many optimization attempts, including 
optimization of annealing temperatures, primer concentrations, assembly oligonucleotide 
sequences, addition of DMSO, and switch from the use of Taq polymerase (Promega) to use 
of high fidelity DNA polymerases (Elongase Enzyme Mix from Invitrogen and PfuTurbo 
DNA polymerase from Stratagene), we were still unable to synthesise proper products, and 
had to try a different approach. 
The only success in DNA template synthesis via PCR was for HP-LR-CS. HP-LR-CS was 
purchased as a single stranded synthesized oligonucleotide without special purification. A 
forward primer (containing T7 promoter sequence) and reverse primer was used to amplify 
and construct the full length double stranded DNA template in two rounds of PCR using Taq 
polymerase (Promega). The list of oligonucleotides used in synthesis of HP-LR-CS is given in 
Table 4.2-6. The PCR product was gel purified and cloned into pGEM-T Easy vector, 
miniprep with DH10B, and sequenced for accuracy. However, attempts to use this method for 
T1a (even with PAGE purification of synthesized oligonucleotide) produced similar problems 
as in assembly PCR. 
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Table 4.2-6 Oligonucleotides used in synthesis of HP-LR-CS. 
Oligonucleotide Length 
(nt) 
Sequence (5’ to 3’) 
HP-LR-CS (SN) 70 AAACAGagaaGTCAACCAGAGAAACACACGTTGTGGTATATTACCTG
GTAAGATCTTGACagtcCTGTTT 
HP-LR-CS Fwd 30 TAATACGACTCACTATAGGAAACAGagaaG 
HP-LR-CS Rvs 25 AAACAGgactGTCAAGATCTTACCA 
 
4.2.2.3 De novo synthesis of DNA templates of constructs using gene 
synthesis via oligonucleotide ligation. 
Upon exhaustion of all available avenues to synthesise the DNA template via PCR based 
methods, we tried a new technique we termed “gene synthesis via oligonucleotide ligation”. 
The designed constructs were broken into overlapping fragments (known as “ligation oligos” 
with overlaps of around 15 nt), with the 3’ fragments having an extra 3’ A, as shown in Figure 
4.2-3 and Figure 4.2-4. 
We were able to obtain clones with correct sequence for every construct. In addition, this 
technique yielded a large percentage of plasmids with correct inserts. As “gene synthesis via 
oligonucleotide ligation” totally avoided the process of PCR from incomplete templates (i.e. 
semi-double stranded DNA templates that have single stranded regions), as used in assembly 
PCR, we suspect that highly structure constructs like ours might be inappropriate for PCR 
from incomplete templates. 
Ligation oligos and their sequences for the respective test constructs (with IVT promoter 
added) are given in Table 4.2-7 and Table A 4. 
 85 
 




Figure 4.2-4 Ligation oligos configurations for Aim 1b constructs. 
 
Table 4.2-7 Ligation oligos for Aim 1a and 1b constructs. 






T1a T/C1a Fwd L1 72 T1a Rvs L1 57 
 T1a Fwd L2 40 T1a Rvs L2 70 
 T1a Fwd L3-A-3’ 73 T/C1a Rvs L3-A-3’ 58 
C1a T/C1a Fwd L1 72 C1a Rvs L1 57 
 C1a/Cla(-) Fwd L2 40 C1a Rvs L2 70 
 C1a Fwd L3-A-3’ 73 T/C1a Rvs L3-A-3’ 58 
C1a(-) T/C1a Fwd L1 72 C1a(-) Rvs L1 57 
 C1a/Cla(-) Fwd L2 40 C1a(-) Rvs L2 70 
 C1a(-) Fwd L3-A-3’ 73 T/C1a Rvs L3-A-3’ 58 
T1b T1b/T1b(-) Fwd L1 77 T1b/T1b(-) Rvs L1 62 
 T1b Fwd L2 46 T1b Rvs L2 76 
 T1b/T1b(-) Fwd 
L3-A-3’ 
78 T1b/T1b(-) Rvs 
L3-A-3’ 
63 
T1b(-) T1b/T1b(-) Fwd L1 77 T1b/T1b(-) Rvs L1 62 
 T1b(-) Fwd L2 46 T1b(-) Rvs L2 76 
 T1b/T1b(-) Fwd 
L3-A-3’ 
78 T1b/T1b(-) Rvs 
L3-A-3’ 
63 
DT-LR-CS DT-LR-CS Fwd L1 56 DT-LR-CS Rvs L1 56 
 DT-LR-CS Fwd L2-A-3’ 41 DT-LR-CS Rvs L2-A-3’ 41 
sNTS-37a sNTS 37a Fwd-A-3’ 40 sNTS 37a Rvs-A-3’ 40 
sNTS-37b sNTS 37b Fwd-A-3’ 40 sNTS 37b Rvs-A-3’ 40 
 
4.2.2.4 IVT template synthesis. 
After obtaining the test constructs in the form of inserts within plasmids, we needed to 
generate large quantities of in vitro transcription (IVT) templates for the production of RNA 
test constructs. Our first attempt was to amplify the constructs via PCR using insert primers. 
We were unsuccessful in sequencing these PCR products to verify their sequence fidelity as 
most products were quite short (~ 200 nt or less). 
As we could not be sure that IVT templates obtained via PCR from plasmid inserts were free 
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of PCR errors, we tried to obtain IVT templates by restriction digesting the inserts out of the 
plasmids (the circular plasmids could not be used as templates as run-off transcriptions were 
to be employed). However, after considerable optimization, using as much as 20 U of EcoR V 
on 3 μg of plasmid, we were unable to purify enough released template for IVT. 
We returned to using PCR using the Elongase enzyme to generate IVT template, and this time 
sequenced the PCR products by cloning them back into pGEM-T Easy vectors. DNA 
sequencing of these clones could be performed, but most of the IVT templates showed 
missing regions similar to those in assembly PCR DNA template generation, except for the 
two positive controls, HP-LR-CS and DT-LR-CS, which could be successfully amplified 
without error via PCR with Elongase. Some of these errors might have been due to 
recombination within DH10B, however, there were many cases of single nucleotide mutations, 
which were likely due to the PCR process. 
To rule out the possibility of recombination induced errors, we used M13 vector primers to 
yield products large enough to sequence directly after PCR, with PfuTurbo enzyme (to reduce 
mutations) to amplify the remaining IVT templates (aside from sNTS-37a and sNTS-37b) 
from plasmids via PCR. DNA sequencing of the gel purified PCR products showed no errors 
in sequence. 
As sNTS-37a and sNTS-37b IVT templates were very short (~40 bp), we decided to use their 
synthesized oligonucleotides that have been annealed as IVT templates. 
Since DNA sequencing showed that PCR using PfuTurbo was able to produce reliable IVT 
template, we finalised on using PfuTurbo PCR to generate large quantity of IVT template. 
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After PCR, products were separated on agarose gel, and the correct sized bands were excised 
and gel purified for use as IVT template. Primers (listed in Table 4.2-8 and Table 4.2-9) used 
for PfuTurbo PCR consisted of one vector based primer (depending on orientation of cloned 
insert), and a reverse primer located at the 3’ end of each construct. 
Table 4.2-8 Primers used to synthesise IVT template for Aim 1a and 1b constructs. 
Constructs Forward Primer Reverse Primer 
 
T1a pGEMTE Rvs_1 Test/Control 1a Rvs_2 
C1a pGEMTE Fwd_1 Test/Control 1a Rvs_2 
C1a(-) pGEMTE Fwd_1 Test/Control 1a Rvs_2 
HP-LR-CS pGEMTE Rvs_1 Test/Control 1a Rvs_2 
T1b pGEMTE Fwd_1 T1b/DT Rvs_1 
T1b(-) pGEMTE Fwd_1 T1b/DT Rvs_1 
DT-LR-CS pGEMTE Fwd_1 T1b/DT Rvs_1 
 
Table 4.2-9 Sequences and characteristics of primers used in IVT template synthesis for 
Aim 1a and 1b constructs. 
Primer Length (nt) Tm Sequence (5’ to 3’) 
 
pGEMTE Fwd_1 15 46.6 °C CGCGGGAATTCGATT 
pGEMTE Rvs_1 15 41.7 °C GCCGCGAATTCACTA 
Test/Control 1a Rvs_2 22 56.8 C GTTCGGCAGCTCTCTTGAAGCT 
T1b/DT Rvs_1 18 54.1 °C GGGTCCCTTAGCCATCCG 
 
4.2.3 RNA cleavage assays of e-SIGE test constructs. 
4.2.3.1 Optimisation of Denaturing Polyacrylamide Gel 
Electrophoresis (D-PAGE). 
Using the gel purified IVT templates synthesised (as described above), RNA versions of Aim 
1a and 1b constructs were transcribed by In Vitro Transcription (IVT) using the Ambion 
MAXIscript Kit, following the prescribed protocol. The IVT and RCA processes occurred 
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concurrently with the species incubated at 37C for various durations. Except where stated, 
each test construct was allowed to undergo IVT and RCA with no other RNA species in the 
same environment. Subsequently, the RCA products were subjected to denaturing 
polyacrylamide gel electrophoresis (D-PAGE) and the gel was stained with SYBR Gold and 
visualised under UV. 
We were unable to obtain RNA ladders for sizes below 100 nt, and had to estimate our gel 
bands sizes from single stranded DNA (ssDNA) ladders. This left some uncertainty in our gel 
interpretation as RNA migrates slower than DNA. 
We had problems getting good resolution of RNA bands on our D-PAGE, and partially 
improved resolution by optimising gel thickness (1.5 mm, 0.75 mm, and 0.5 mm), reducing 




4.2.3.2 Aim 1a constructs to show that RC1 can cis-cleave CS1 if and 
only if CS1 was single stranded. 
After optimisation of RCA protocols and D-PAGE running conditions, our designs of Test 1a 
and HP-LR-CS seemed to yield the Rz cleavage intended. The optimised RCA results of Test 
1a and HP-LR-CS are shown in Figure 4.2-5, and the observations given in Table 4.2-10. 
 
Figure 4.2-5 RCA results for Test 1a and HP-LR-CS. 
Gel was stained with SYBR Gold for 45 min. Time stated refers to IVT incubation duration. 
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Table 4.2-10 Observations for Aim 1a Constructs. 
Lanes Samples Observations, Comments. 
1,10 DNA 10/60 Single stranded DNA ladder with 8 bands: 60, 50, 40, 30, 
25, 20, 15, 10 nt. 
2,9 DNA 20/100 Single stranded DNA ladder with 9 bands: 100, 90, 80, 70, 
60, 50, 40, 30, 20 nt. 
3,8 RNA Low Single stranded RNA ladder with 7 bands: 1000, 800, 600, 
400, 300, 200, 100 nt. 
4-6 Test 1a 
1:25, 3:15, 6:20 hr 
 
Possible bands: 
Uncleaved 167 nt 
5’ Fragment 119 nt 




Major band(s) observed: 3 
<200 nt – Could be uncleaved 167 nt. 
>100 nt – Could be cleaved 5’ 119 nt fragment. 





Uncleaved 72 nt 
5’ Fragment 63 nt 




Major band(s) observed: 2 
<90 nt – Could be uncleaved 72 nt. 
<70 nt – Could be cleaved 5’ 63 nt fragment. 
 
Note that ladders used for sizing in this case were DNA 
ladders, which migrate faster than RNA. As such, actual 
sizes of product bands should be smaller than the ladders 
here indicate (i.e. 80-90 band could actually be 72 nt). 
3’ fragment of 9 nt was not apparent here, possibly due to 
small fragment size. 
As shown in Figure 4.2-5 and Table 4.2-10., after optimisation, RCA of Test 1a and 
HP-LR-CS seemed to yield the intended Rz cleavage. However, there was significant 
smearing in Test 1a. 
4.2.3.3 Aim 1b constructs to show that sNTS-37a but not sNTS-37b 
can activate EC and lead to cleavage of CS2. 
Upon the successful RCA testing of T1a and HP-LR-CS, we proceeded to optimise RCA for 
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the remaining Aim 1a and Aim 1b constructs. The optimised RCA results were shown in 
Figure 4.2-5, and the observations given in Table 4.2-10. Both T1b and T1b(-) constructs 
underwent IVT and RCAA together with sNTS-37a. 
 
Figure 4.2-6 RCA results for remaining A1a and Aim 1b Constructs. 
IVT incubation duration was 40 min. 
 
Table 4.2-11 Observations for remaining Aim 1a and Aim 1b Constructs. 
Time stated refers to IVT incubation duration. 
Lanes Samples Observations, Comments. 
1,15 DNA 10/60 Single stranded DNA ladder with 8 bands: 60, 50, 40, 30, 25, 20, 15,10 
nt. 
2,14 DNA 20/100 Single stranded DNA ladder with 9 bands: 100, 90, 80, 70, 60, 50, 40, 
30, 20 nt. 
3, 13 RNA Low Single stranded RNA ladder with 7 bands: 1000, 800, 600, 
400, 300, 200, 100 nt. 
 93 





Uncleaved 167 nt 
5’ Fragment 119 nt 




Major band(s) observed: 4 
<200 nt – Could be uncleaved 167 nt. 
>100 nt – Could be cleaved 5’ 119 nt fragment. There appeared to be 2 
closely-spaced bands, which might correspond to variants in secondary 
structures. 
~ 90 nt – Could be dimer (96 nt) of 3’ 48 nt fragment. 
<50 nt – Could be cleaved 3’ 48 nt fragment. Band was very faint, but 





Uncleaved 167 nt 
5’ Fragment 119 nt 




Major band(s) observed: 3 
>200 nt – Could be a dimer (238 nt) of 5’ 119 nt fragment. This seemed 
supported by the absence of this band for T1a, for which the 5’ 119 nt 
had less potential pairing region and so less likely to dimerise. 
>100 nt – Could be cleaved 5’ 119 nt fragment. 
~ 90 nt – Could be dimer (96 nt) of 3’ 48 nt fragment. 
 
The expected products sizes were as for T1a (Lane 4), but with much 
lower intensity, due to the proposed ability of DS CS1 to prevent 
cleavage. However, observed products seemed no less intense, 











Major band(s) observed: 3 
>200 nt – Could be a dimer (238 nt) of 5’ 119 nt fragment. 
>100 nt – Could be cleaved 5’ 119 nt fragment. 
~ 90 nt – Could be dimer (96 nt) of 3’ 48 nt fragment. 
 
The bands observed were essentially similar to that of C1a, which 
should not have been possible since CS1 here has been mutated to a 
non-functional sequence (“dead”). 
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Uncleaved 72 nt 
5’ Fragment 63 nt 




Major band(s) observed: 2 
<90 nt – Could be uncleaved 72 nt. Band was very faint, but was 
visible under long exposure. 
<70 nt – Could be cleaved 5’ 63 nt fragment. 
 
Note that ladders used for sizing in this case were DNA ladders, which 
migrate faster than RNA. As such, actual sizes of product bands should 
be smaller than the ladders here indicate (i.e. 80-90 band could actually 
be 72 nt). 






Uncleaved 183 nt 
5’ Fragment 92 nt 
3’ Fragment 91 nt 




Major band(s) observed: 3 
~200 nt – Could be uncleaved 183 nt. This was a thick band that 
appeared to be 2 closely-spaced bands, the higher band could 
correspond to dimers of the uncleaved with sNTS-37a (222 nt). 
~119 nt – Could be dimers of cleaved 5’ fragment with sNTS-37a (114 
nt). The size was similar to T1a cleaved 5’ 119 nt fragment. 
~90 nt – Could be cleaved 5’ & 3’ fragments (92, 91 nt). The low 
intensity of this band need not imply low cleavage if the majority of 5’ 
fragments dimerised with sNTS-37a to form ~119 nt band. 
 
sNTS-37a of 22 nt was not apparent here, possibly due to small 
fragment size. In addition, some of these could have dimerised with the 
uncleaved as well as cleaved 5’ fragment. 
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Uncleaved 183 nt 





Major band(s) observed: 3 
~200 nt – Could be uncleaved 183 nt and dimers of the uncleaved with 
sNTS-37a (222 nt). 
~119 nt – Could be dimers of cleaved 5’ fragment with sNTS-37a (114 
nt). 
~90 nt – Could be cleaved 5’ & 3’ fragments (92, 91 nt). 
 
The bands observed were essentially identical to those of T1b, which 
should not have been possible since CS here has been mutated to non 
functional sequence (“dead”). 









Major band(s) observed: Nil 
sNTS-37a of 22 nt was not apparent here, possibly due to small 
fragment size. 









Major band(s) observed: Nil 
sNTS-37a of 22 nt was not apparent here, possibly due to small 
fragment size. 
 96 





Uncleaved 79 nt 
5’ Fragment 13 nt 





Major band(s) observed: 3 
<100 nt – Could be dimers of uncleaved and cleaved 3’ fragment (92 
nt). 
~90 nt – Could be uncleaved 79 nt. 
~75 nt – Could be 3’ fragment 66 nt. The relative higher intensity of 
this band compared to the other two implied high cleavage. 
 
5’ fragment of 13 nt was not apparent here, possibly due to small 
fragment size. 
Note that ladders used for sizing for the cases of ~90 nt and ~75 nt 
bands were DNA ladders, which migrate faster than RNA. As such, 
actual sizes of product bands should be smaller than the ladders here 
indicate (i.e. ~90 nt band could actually be 79 nt, and ~75 nt band 
could be 66 nt). 
Cleavages for T1a, C1a, HP-LR-CS (i.e. all constructs with HP Rz cleavage) seemed complete 
within the 0:40 hr incubation. Cleavage for T1b seemed significant within the 0:40 hr 
incubation although it less than that for DT-LR-CS (which uses the same DT Rz and CS). In 
addition, previous time course optimisation for T1b seemed to show similar level of cleavage 
from 20 min to 6 hr. This indicated that the secondary structure of T1b could have protected 
the CS2 to some degree. 
These results thus showed that T1a and T1b were cleavable as expected, and which were 
corroborated by the correct cleaving of the two positive controls, HP-LR-CS and DT-LR-CS. 
However, the constructs that were not to be cleaved (at least not to high levels), namely C1a, 
C1a(-), T1b, and T1b(-) were also cleaved. For C1a, cleavage of comparable levels to T1a 
indicated that the secondary structures meant to protect CS1 were insufficient, perhaps due to 
the DS region meant to protect the CS1 not being long enough. What was more disturbing 
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were the cleavage activities for C1a(-) and T1b(-), both of which were designed with dead CS 
that should not have been cleavable at all. 
The above unexpected RCA results were likely indications that that RNA foldings did not 
occur as intended, which was likely as the foldings were designed by eye without 
computational design. As such, these initial designs were unsuitable for use as the RNA-based 
sensor in e-SIGE. 
In addition, secondary structures in ssRNA may interfere with gel running, leading to 
inaccurate separation of otherwise correct sized fragments. Despite spending significant 
amount of time and resources optimising D-PAGE protocol, it was often difficult to accurately 
infer the sizes or even number of species of RCA products, which was an important 
requirement if we were to accurately pin point cleavage errors in order to improve construct 
designs. 
In view of the above difficulties, and our limited time and resource, we decided to make two 
targeted changes: 
1) We needed to design a new sensor. Since de novo design of properly activating RNA 
structure was difficult, there should be a higher chance of success if we were to adapt 
from the structures of existing allosteric ribozymes in the literature for the design of 
our e-SRS sensor. 
2) We needed to adopt or create a new methodology of RCA reporting that did not 
involve gel running and that gave unambiguous signals of cleavage occurrence. 
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4.3 Maxizymes based e-SRS. 
4.3.1 New e-SRS sensor based on the Maxizyme (Mz) 
Our three guiding principles for obtaining a new design for the e-SRS sensor were to 1) select 
from existing allosteric Rz (those that recognise at one site and cleavage at another) that 2) 
had been shown to work both in vitro and in cell lines, and 3) which would require only minor 
modifications to suit our sensor purposes, for ease of implementation. 
Eventually, we decided on the Maxizyme (Mz), which were a class of allosteric synthetic Rz 
shown to work both in vitro and in cell lines [Kuwabara et al, 1998; Taira et al, 2004]. These 
two facts fulfilled our first two guiding principles. 
Each Mz is a heterodimer of 2 modified Hammerhead Rz (HH) such that each of the two HH 
have no catalytic activity individually, and can only be catalytically active when paired as a 
heterodimer, with the appropriate (i.e. “active”) 3D conformation. As shown in Figure 4.3-1, 
the Mz has one sensor arm, and a catalytic arm. To attain the active 3D conformation, the 
sensor arm has to bind to a target RNA (of defined sequence), and the catalytic arm has to 
bind to a substrate RNA. Appropriate binding of the sensor and catalytic arms allows the 
catalytic core (at the centre of the Mz) to capture a Mg2+ that activates the catalytic capability 
of the Mz, at which point, the substrate RNA bound to the catalytic arm will be cleaved. 
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Figure 4.3-1 Traditional use of Mz as an allosteric knock down tool. 
 
The Mz was an ingenious tool designed to recognise an RNA at one point, and cleave the 
same RNA (i.e. cis-cleavage) at another point (often far away), for the specialised purpose to 
knock down chimera genes which do not have a Rz recognition sequence near the junction of 
the chimera gene. The Rz recognition sequence of Mz is that of HH, which is the triplet NUX, 
where N stands for A, G, C, or U, and X stands for A, U, or C (i.e. any base but G). One 
common Rz recognition sequence for HH is the triplet GUC. 
The rationale for developing such a mechanism is to knock down chimera genes is that for a 
chimera gene, the only point of specific recognition is around the chimeric junction, since 
sequences on either side (alone) of the junction also matches the respective parent genes that 
created the chimera gene. If a Rz is targeted at the non-chimera specific region of the chimera 
RNA, the normal mRNA that comprises that part of the chimera gene would also be cleaved, 
resulting in damage to cells. 
 100 
The advantage that the Mz thus brought to bear was to enable recognition of a chimera gene 
specifically at the chimeric junction, while allowing cleavage of the RNA to occur elsewhere 
on the RNA where a Rz recognition sequence could be found. In this case, the normal RNA 
will not be cleaved as it does not have the chimera specific junction sequence, which the Mz 
must bind in order to become active. An example is the BCR-ABL fusion mRNA associated 
with the Philadelphia chromosome that causes chronic myelogenous leukemia (CML). For the 
b2a2 chimera gene (BCR exon 2 fused with ABL exon 2 via reciprocal chromosomal 
translocations), there were no recognition sequences for HH within 2-3 nucleotides of the 
chimeric junction. One GUC triplet was located 45 nucleotides from the junction, which could 
then be specifically targeted by a Mz. If a normal HH was used to cleave this GUC, normal 
ABL RNA would also be cleaved as it shared this part of the sequence of with the b2a2 
mRNA, with resultant damage to cells. 
Our novel adaptation of the Mz required only a minor physical alteration, which was to 
separate the activating segment of the substrate RNA from the cleaved segment, such that the 
activating RNA and cleaved RNA were now two separate RNA species. Since the main 
alteration to the existing Mz mechanism involved only the interaction with substrates (from 
being cis-cleaved to trans-cleaved), rather than the general structure of the Mz itself, we were 
quite confident that the Mz foldings should not be affected. By following closely to original 
designs (for both Mz and most required features of substrates), we felt that it should not take 
long to tell if the major paradigm shift of substrate cis-cleavage to trans-cleavage was feasible. 
This fulfilled our third guiding principle. 
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While the physical alteration was minor, the paradigm shift in changing the cis-cleavage 
mechanism to a trans-cleavage mechanism was significant, as instead of being a knock down 
tool, the Mz could now be used as a signal transducer, i.e. a sensor that upon detection of a 
specific RNA, is able to initiate certain actions (e.g. activation of a gene expression system by 
knocking down a repressor as previously conceptualised in e-SIGE, or cleavage of a RS (see 
next section) to release fluorescence for bioimaging). To our knowledge, such a modification 
of Mz utility has never been reported, and that Mz has always been designed and used as a 
RNA knock down tool. 
4.3.2 RS to provide new methodology of RCA reporting 
In order to have a new system of reporting successful substrate cleavage in RCA that 1) did 
not involve gel running and 2) that gave unambiguous signals of cleavage occurrence, we 
decided to create a substrate would release fluorescence immediately upon cleavage. Since 
such a substrate could report on the activity of its ribozyme, we termed it a “Reporter 
Substrate”. 
All RNA substrates to be cleaved would be designed with a fluorescent probe (e.g., 6-FAM) 
conjugated at one end, where the fluorescence signal would be constitutively quenched by a 
quencher (e.g., BHQ-1) conjugated at the other end. Upon activation of Rz, and thus cleavage 
of RS, the probe would be separated from its quencher and thus release intense fluorescence 
that could be assessed quantitatively by a fluorescence plate reader. Each activated Mz-based 
sensor can cleave many RS as long as the target nucleic acid is present, resulting in 
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amplification of signal (i.e. multiple fluorescent reporter per copy of target nucleic acid 
detected). 
The e-SRS RS gene detection is thus suitable for all forms of existing gene detection 
applications, such as detection of pathogenic genes, mRNA, small RNA expression, etc. This 
RS system had the additional advantages of enabling both real time and quantitative 
measurements of cleavage events. 
4.3.3 New design of e-SRS based on Maxizymes 
With the creation of a new sensor and RCA reporting methodology, we essentially created a 
new system of e-SRS (environment-Sensing Response System). The new system had a much 
simpler and tested sensor (thus more robust), and was designed to be easily applied in a 
modular way for bioimaging. 
The new e-SRS (as shown in the schematic diagram in Figure 4.3-2) is a nucleic acid sensing 
and response system with two components: 1) A Maxizyme based sensor that changes 
conformation and becomes active upon binding of specific NTS; 2) A Response System that is 
triggered by the activated sensor to initiate some physical response, such as emitting a signal 
(e.g. fluorescence) to indicate the presence of the NTS, or to activate some downstream action 
such as gene expression. 
The new RNA substrate to be cleaved could either be a RS or other nucleic acids, such as a 
repressor mRNA, and is known as STS, to distinguish it from that of the old (e-SIGE) version. 
Conceptually, the new e-SRS could have two major applications: 
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1) RS based bioimaging, which was the imaging of targeted nucleic acids via the 
cleaving of RS. 
2) Induction of PLG , which was the induction of a PLG in cells containing a target 
nucleic acid. 
 
Figure 4.3-2 The new e-SRS uses a Mz based sensor and is easily applied in bioimaging. 
Note that the Reporter Substrate when uncleaved is most likely not straight but exist in 
various dynamically changing shapes that put the quencher in close proximity with the 
FAM. 
4.3.4 Inducible Gene Expression System 
For ease of implementation, we decided to use a commercial inducible gene expression 
system, T-REx (Invitrogen). It provided the repressor R1 (via the TetR repressor protein) that 
could suppress a co-transfected PLG until activation by the Mz based sensor (which would 
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knock down R1 and thus relieve PLG repression). 
The T-REx system comprises of 2 plasmids: 1) pcDNA6/TR, which was a pCMV driven TetR 
(as R1) over-expression plasmid; 2) pcDNA4/TO/myc-His, which was a pCMV (with 2 
tetracycline operator 2 sites embedded) driven expression plasmid that expressed a PLG that 
can be constitutively repressed by an appropriate ratio of cotransfected TetR. TetR repression 
can be relieved by application of Tet of about 1 μg/ml in culture medium. 
However, instead of using tetracycline to relieve repression of PLG, an activated Mz-based 
sensor designed to cleave the tetR mRNA can knock down tetR expression and hence induce 
PLG expression if and only if the desired target nucleic acid was detected. Hence e-SRS can 
induce the expression of a desired exogenous gene when a target gene is detected. In such an 
embodiment, e-SRS can be used, amongst many other possibilities, to selectively kill 
malignant cells by targeting an mRNA specific to the malignant cell (e.g. a gene with a 
mutation), with the PLG being a cytotoxic gene. 
4.3.5 NTS/NNS and selection of STS, STS 
In this new e-SRS, we decided to keep the NTS and corresponding NNS of before, i.e. the 
NTS was sNTS-37a and its corresponding NNS was sNTS-37b. We also included a b1a2 
model 2 Mz [Tanabe et al, 2000] from the Mz literature as a positive control. Its NTS and 
NNS were sNTS-b1a2_NTS and sNTS-b1a2_NNS respectively. NTS/NNS sequences were as 
shown in Table 4.3-1. 
Table 4.3-1 Sequences of NTS and NNS. 
Constructs Sequence (5’ to 3’) Length (nt) 
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Constructs Sequence (5’ to 3’) Length (nt) 
sNTS-37a AUUCACUAUAAGGACAUGUA 20 
sNTS-37b AUGCCUUACCCGGACAUGUA 20 
sNTS-b1a2_NTS UCCAUGGAGACGCAGAAGCCCUUC 24 
sNTS-b1a2_NNS AUCUGGAAGAAGCCCUUC 18 
 
For both applications (i.e., RS based bioimaging and induction of PLG) of e-SRS, a STS was 
required. In order to have a STS that could satisfy both applications, we decided to select the 
STS from our R1 mRNA, i.e., the tetR mRNA. 
3 STS, RTS-1, RTS-2, RTS-3 (RTS meaning Repressor Target Sequence) were chosen from 
the tetR mRNA sequence. RTS-b1a2 for the b1a2 model 2 Mz was taken from the Mz 
literature [Tanabe et al, 2000]. The selection criteria for our STS were as follows: 
1) A region of tetR mRNA containing HH recognition sequence (GUC, CUC, AUC). 
2) Predicted to be accessible (not hidden in secondary structure) using RNA folding 
software, RNAstructure 4.5 
3) Had no Blast hit against Human, Mouse, and Rat Refseq genes (excluding 
predicted/hypothetical genes). 
In order to test the effectiveness of each STS, we had had to design one Mz based sensor for 
each STS (Mz-1, Mz-2, Mz-3). In addition, for each STS, we also designed a corresponding 
wild type Hammerhead Ribozyme (HH-1, HH-2, HH-3, HH-b1a2) that was supposed to 
cleave it with high efficiency to compare the cleavage efficiency of our Mz based sensors. 
Sequences of the STS and HH designed are shown in Table 4.3-2. 
Table 4.3-2 Sequences of STS and HH. 
Constructs Sequence (5’ to 3’) Length (nt) 
RTS-1 GCAUCAAGUCGCUAAAG 17 
RTS-2 UAUGAAACUCUCGAAAA 17 
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Constructs Sequence (5’ to 3’) Length (nt) 
RTS-3 CUCGAAAAUCAAUUAGC 17 
RTS-b1a2 AAAACCUUCUCGCUGGACCCA 21 
HH-1 CUUUAGCCUGAUGAGGCCGAAAGGCCGAAACUUGAUGC 38 
HH-2 UUUUCGACUGAUGAGGCCGAAAGGCCGAAAGUUUCAUA 38 
HH-3 GCUAAUUCUGAUGAGGCCGAAAGGCCGAAAUUUUCGAG 38 
HH-b1a2 UGGGUCCAGCCUGAUGAGGCCGAAAGGCCGAAAGAAGGUUUU 42 
Underlined sequence, HH recognition sequence. Cleavage occurs immediately 3’ of 
recognition sequence. 
4.3.6 Design of Mz based sensors 
4.3.6.1 Conditions for a specific Mz based sensor 
We designed a specific Maxizyme for each of the above STS sequences (RTS-1, RTS-2, 
RTS-3). Each Mz is comprised of a Mz Left (MzL) and a Mz Right (MzR) strand, defined 
according to the convention shown in the configuration of the b1a2 model 2 Mz [Tanabe et al, 
2000], as shown in Figure 4.3-3. Mz were designed to have secondary structures that were 
active if and only if the specific NTS and STS were both present. This meant that if the NTS 





Figure 4.3-3 Illustration of Mz activation, obtained from [Tanabe et al, 2000], Figure 6. 
(A) b1a2 model 2 Mz is active in the presence of BCR-ABL fusion (b1a2) mRNA (i.e., the NTS) 
at the bottom and the substrate RNA (i.e., the STS) at the top. (B) Mz is inactive in the absence 
of the NTS, even though the STS is present (top). (C) Mz is also inactive in the presence of the 
NNS (the ABL mRNA in this case, at the bottom). (D) Active wild-type HH with STS (top). 
With RNA sequences of Mz, NTS/NNS, and STS defined, secondary structures were 
predicted using the software, RNAstructure 4.5 for three combinations of RNA species: 
1) Mz with NTS and STS (Mz+NTS+STS). 
2) Mz with NNS and STS (Mz+NNS+STS). 
3) Mz and STS with nothing else (Mz+STS). 
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Each combination of RNA species would sometimes have more than one predicted secondary 
structure (some may be active and some maybe inactive). Each predicted structure would have 
a corresponding free energy, which indicated its stability – the lower (more negative) the free 
energy, the more stable the structure. In general, the more stable a secondary structure, the 
greater the proportion of such structures amongst a pool of RNA structures that may 
dynamically fluctuate between various secondary structures. We considered a particular Mz 
design as valid (specific for its NTS) when the conditions in Table 4.3-3 were achieved. 
Table 4.3-3 Conditions for a Mz to be considered specific for its NTS. 
Predicted free energy for Mz and STS in the presence of 
Inactive form Active form 
Nothing else Lowest High or not predicted 
NNS Lowest High or not predicted 
NTS High or not predicted Lowest 
Values (e.g. “Lowest” or “High”, etc) were defined relative to values in the same row, i.e. for the 
same combination of RNA species. 
4.3.6.2 RNA regions that make up a Mz based sensor 
Structurally, each Mz is comprised of two RNA strands – a Mz Left (MzL) and a Mz Right 
(MzR) strand. However, the objective of Mz design is to create a Mz that will fold into 
appropriate secondary structures as described in Table 4.3-3. Hence, in Mz design, the Mz is 
instead conceptually divided into regions (contributed by both MzL and MzR) that are 
relevant in the determination of secondary structures. 
As described in section 4.3.1, the key for a Mz to attain an active 3D conformation is for the 
catalytic core to capture a Mg2+ that then activates the catalytic capability of the Mz. This 
process requires the catalytic core to first be available in a conducive conformation, which is 
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facilitated when the sensor arm binds to an RNA with the intended NTS. The binding of the 
catalytic arm to an RNA with the STS may also facilitate the adoption of the catalytic core, 
but this alone (without the binding of NTS by the sensor arm) is ensured (during the Mz 
design process) not to cause the activation of catalytic core. The catalytic core is a conserved 
RNA loop region enclosed by the Stem II (a mid section RNA stem), and the junction of the 
catalytic arm-STS duplex, both of which are double stranded in an active Mz. 
 
Therefore, as shown in Figure 4.3-4, tor the purpose of design, the Mz can be conceptually 
divided into 4 regions: 
1) Sensor arm 
2) Stem II 
3) Catalytic core 




Figure 4.3-4 Regions in e-SRS design of Mz. 
 
4.3.6.2.1 Sensor arm 
The sensor arm sequence is determined by the NTS, and is the reverse complement of the 
NTS (i.e. NTS’). The MzL segment of the sensor arm is separated from the MzR segment at 
the Sensor Arm Split (SAS). The SAS is defined numerically as the number of sensor arm 
nucleotides that exist on the MzR. This would also define the corresponding number for MzL 
as the total length of the sensor arm is predefined by the length of NTS. As such, the sensor 
arm sequence can be divided into a 5’ segment (MzR) and 3’ segment (MzL) by the SAS. The 
corresponding point of the SAS on the NTS that separates the segment that binds to MzL and 
the segment that binds to MzR is known as the SAS’. 
By varying the SAS, the resulting Mz secondary structure can be altered, giving different 
specificities for the given NTS (and STS). 
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4.3.6.2.2 Stem II and catalytic core 
For sequences of Stem II and catalytic core, we compared 6 functional Mz from the literature 
(Table 4.3-4) to identify a consensus for these two segments. Based on these observations, we 
derived the catalytic core consensus sequence and some potential Stem II sequences (which 
had no consensus sequence) for our Mz as shown in Table 4.3-5. As Stem II sequences were 
highly variable (in the literature examples), and were often modified in our Mz design in order 
to attain the right secondary structures, only the pair used eventually for our Mz for in vitro 
detection was shown. 
Table 4.3-4 Mz selected from the literature. 
Mz Target Strand Sequence (5’ to 3’) 
PML-RARα 



















b1a2 model 1 









b1a2 model 2 
(Tanabe et al, 2000. Soda 






























Highlighted sequence, Catalytic core and Stem II sequence; Underlined sequence, Catalytic 
core sequence; ^, Cleavage position on the STS; Red font, Rz recognition sequence. 
Table 4.3-5 Catalytic core and Stem II sequences. 
Region Strand Sequence (5’ to 3’) 









4.3.6.2.3 Catalytic arm 
The catalytic arm sequence is determined by the STS, and is the reverse complement of the 
STS (i.e. STS’). The MzL segment of the catalytic arm is separated from the MzR segment at 
the Catalytic Arm Split. The Catalytic Arm Split is defined numerically as the number of 
catalytic arm nucleotides that exist on the MzR. This would also define the corresponding 
number for MzL as the total length of the catalytic arm is predefined by the length of STS. As 
such, the catalytic arm sequence can be divided into a 5’ segment (MzL) and 3’ segment (MzR) 
by the Catalytic Arm Split. The corresponding point of the Catalytic Arm Split on the STS that 
separates the segment that binds to MzL and the segment that binds to MzR is known as the 
Catalytic Arm Split’. 
By varying the Catalytic Arm Split, the resulting Mz secondary structure can be altered, 
giving different specificity for the given NTS (and STS). 
4.3.6.3 Joining RNA regions to create a Mz based sensor and 
predicting secondary structures of RNA combinations. 
When the sequences for the 4 regions (sensor arm, Stem II, catalytic core, and catalytic arm) 
have been obtained, a Mz based sensor can be obtained by creating the MzL and MzR 
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sequences. 
4.3.6.3.1 Creating a MzL sequence 
To create a MzL sequence, join from 5’ to 3’, the following regions: 
1) 5’ segment of the catalytic arm. 
2) Catalytic core sequence for MzL (CUGAUGAG). 
3) Stem II sequence for MzL (e.g. UGA) 
4) 3’ segment of sensor arm. 
4.3.6.3.2 Creating a MzR sequence 
To create a MzR sequence, join from 5’ to 3’, the following regions: 
1) 5’ segment of sensor arm. 
2) Stem II sequence for MzR (e.g. AGCA). 
3) Catalytic core sequence for MzR (CGAA). 
4) 3’ segment of the catalytic arm. 
 
4.3.6.3.3 Folding combinations of RNA strands in RNAstructure 4.5 
As explained in section 4.3.6.1, each potential Mz has to be assessed for specificity via 
secondary structure prediction using RNAstructure 4.5, before it would be sent for RNA 
synthesis and subsequent experimental validation. Three combinations of RNA species (Mz 
with NTS and STS; Mz with NNS and STS; Mz and STS with nothing else) had to be tested 
to fulfil the conditions in Table 4.3-3. 
However, RNAstructure v4.5 can only fold a single strand of RNA at a time. In order to 
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predict the secondary structures of multiple RNA strands at the same time, we had to join 
separate strands into one long strand using the unfolded linker sequence “gaaa”. “gaaa” was a 
commonly used linker sequence that Taira et al used to connect their Mz and other RNA for 
computational foldings. By using lower cases (“gaaa” instead of “GAAA”), these linkers were 
prevented from participating in base pairing in RNAstructure 4.5. 
It was initially thought that more repeats of “gaaa” would be better, as that might produce 
more obvious boundaries of each strands as well as confer more flexibility to the positioning 
of different strands. However, after trying up to 10 repeats of “gaaa”, it was discovered that 
the more repeats introduced, the less stable (higher free energy value predicted) the folded 
structures, indicating that such additions might create more spurious effects on the RNA 
folding, and thus best to be kept to a minimum. Also the secondary structure output was 
actually easier to visualise with 1 repeat, than with 10 repeats of gaaa. Hence, we eventually 
kept to using just one repeat of “gaaa” between adjacent RNA strands. 
4.3.6.3.4 Order of joining RNA strands 
RNAstructure 4.5 does not predict pseudoknot secondary structures. A pseudoknot (Figure 
4.3-5) is an RNA secondary structure that has at least two stem-loop structures in which each 
stem has one half embedded in the enclosed loop of the other stem. 
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Figure 4.3-5 A pseudoknot RNA secondary structure. 
 
As a result, the order in which the strands were joined in the three combinations must be 
properly sequenced in order for it to be possible to predict the active structure without 
requiring the formation of pseudoknots. The strand sequences used for our Mz design were as 
shown in Table 4.3-6. 
Table 4.3-6 Strand sequences used in Mz based sensor design. 
RNA combinations Strand sequences (5’ to 3’) 
Mz with NTS and STS. STS, MzL, NTS, MzR. 
Mz with NNS and STS. STS, MzL, NNS, MzR. 
Mz and STS with nothing else. STS, MzL, MzR. 
Note that for strand sequences, each comma indicated the addition of a linker “gaaa”. 
 
4.3.6.4 Assessment and modification of Mz based sensor secondary 
structures using RNAstructure 4.5 
4.3.6.4.1 Assessment of active and inactive structures 
Upon obtaining the secondary structures of the three RNA combinations for each potential Mz 
design, we needed to assess whether such potential designs met the conditions for a valid Mz 
design, as given in Table 4.3-3. To be able to perform such assessments, we needed to define 
what constituted active and inactive secondary structures. 
We placed priority on specificity over sensitivity as the strength of e-SRS lies in its ability to 
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distinguish between closely related nucleic acid sequences. Sensitivity, on the other hand, 
could be improved by using better detection or amplification systems. As such, there was a 
need to avoid accepting false positives of specific Mz designs, i.e. where RNA combinations 
without NTS (intended and predicted to be inactive) were actually active. Hence, it was 
decided to establish the bare minimum criteria needed for defining a structure to be active – as 
long as the Mz can cleave STS. For the purpose of our work, we defined the sufficient 
conditions for an active secondary structure as follows: 
1) The NUX triplet must pair correctly. This means that the first and second bases of 
NUX must pair respectively with the MzR bases two and one position 3’ of the 
Catalytic Arm Split. For the 17 nt STS and 16 nt catalytic arm used here, these 
positions would be Length minus 7 and Length minus 8 on the combined RNA 
(where Length refers to total length of combined RNA, including linkers). 
The third base of NUX must be unpaired. 
2) 1st base 3’ of the NUX on the STS (whose 5’ bond is cleaved) must be paired to MzL 
at a position of the catalytic arm one base 3’ of the Catalytic Arm Split. For the 17 nt 
STS and 16 nt catalytic arm used here, with a “gaaa” linker between STS and MzL, 
this position would be 28 on the combined RNA. 
3) Loop structure of the catalytic core (for binding Mg2+) must be correct. This means 
that 
a. The first 7 of the 8 MzL catalytic core bases must be unpaired. 
b. The 8th base must pair with the first base of MzR catalytic core. 
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c. The last 3 of the 4 bases of the MzR catalytic core must be unpaired. 
In summary, in e-SRS Mz based sensor design for the three proposed STS (RTS-1, RTS-2, 
RTS-3), the sufficient conditions for an active secondary structure required the pairing 
conditions of only 15 bases (counting only one base of a matched pair) to be defined as shown 
in Table 4.3-7. For each secondary structure predicted, the conditions in Table 4.3-7 were 
checked by visually examining the secondary structures figures created by RNAstructure 4.5. 
Table 4.3-7 Sufficient conditions for an active secondary structure. 
S/no. Base Base position Base position of partner 
1 1st base of NUX. 008 L-7 
MzR catalytic arm. 
2 2nd base of NUX. 009 L-8 
MzR catalytic arm. 
3 3rd base of NUX. 010 0 
4 Base 3’ of NUX. 011 028 
MzL catalytic arm. 
5 1st of MzL catalytic core. 029 0
6 2nd of MzL catalytic core. 030 0
7 3rd of MzL catalytic core. 031 0
8 4th of MzL catalytic core. 032 0
9 5th of MzL catalytic core. 033 0
10 6th of MzL catalytic core. 034 0
11 7th of MzL catalytic core. 035 0
12 8th of MzL catalytic core. 036 L-12 
(1st base of MzR catalytic core.) 
13 2nd of MzR catalytic core. L-11 0 
14 3rd of MzR catalytic core. L-10 0 
15 4th of MzR catalytic core. L-9 0 
L, Length of combined RNA (including linkers); 0, No pairing partner, i.e., base is unpaired.; L-n 
means “Length minus n”, for e.g. L-8 means “Length minus 8”. Note that “Base position” here 
referred to base position on the combined RNA, including linkers. 
4.3.6.4.2 Strategies & guidelines for achieving desired structures. 
Deciding on the appropriate sequences of MzL and MzR to use given the required NTS and 
STS sequences was a rather time consuming “trial and error” based task. In general, we would 
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start with Catalytic Arm Split and SAS at around the middle of the catalytic or sensor arms, 
and perfectly matched three base pairs long Stem II. Based on the secondary structures 
generated, we would then try to guess the best adjustments to make in the Catalytic Arm Split, 
SAS, or Stem II sequence, and then fold the new structures. The process would repeat until we 
obtain valid Mz designs. 
Through this process, we obtained a few strategies or pointers that appeared useful, as 
follows: 
1) The first focus should be on creating a Stem II that is unstable in absence of NTS. 
This was because the main challenge was usually getting Mz+STS to fold with no 
Stem II while Mz+STS+NTS does. Mz+STS+NNS usually folded in an inactive 
manner. 
2) To create unstable Stem II in absence of STS: 
a. Design one or both half of Stem II to base pair with either part of the 
catalytic core or sensor arms, by designing some complementary sequences 
in the respective areas. 
b. Create mismatches in Stem II. 
c. Start with 3 base pair Stem II, then increase (not necessarily evenly on both 
strand) if needed. 
3) Sometimes, sequences designed to form a stem simply refused to do so. This could be 
due to the loop not being favourable. A loop looking like GAAA is probably more 
favourable. Hence, inserting an unpaired G at the area of the intended loop could 
 119 
precipitate the formation of the desired stem-loop structure. 
4) Should all else fail, change the SAS and start again with above strategies. The 
Catalytic Arm Split was usually not changed as there is usually only one cleavage site 
on STS, where changing the STS would then require changing the STS sequence. 
 
4.3.7 Sequences of Mz based sensors 
For each STS, a specific Mz based sensor was designed according to the methodology above. 
The MzL and MzR sequences and their respective STS are as shown in Table 4.3-8. All RNA 
oligonucleotides (including STS, MzL, MzR, NTS, NNS) were synthesised commercially 
with HPLC purification. 
Table 4.3-8 MzL and MzR sequences. 
STS Constructs Sequence (5’ to 3’) Length (nt) 
RTS-1 MzL-1 CUUUAGCCUGAUGAGUCAuauagugaau 28 
RTS-2 MzL-2 UUUUCGACUGAUGAGUGAuauagugaau 28 
RTS-3 MzL-3 GCUAAUUCUGAUGAGUCAuauagugaau 28 
RTS-b1a2 MzL-b1a2 UGGGUCCAGCCUGAUGAGGAGCGUCUCCAUG 31 
RTS-1 MzR-1 UACAUGUCCuAGGACGAAACUUGAUGC 27 
RTS-2 MzR-2 UACAUGUCCuAGCACGAAAGUUUCAUA 27 
RTS-3 MzR-3 UACAUGUCCuAGGACGAAAUUUUCGAG 27 
RTS-b1a2 MzR-b1a2 GAAGGGCUUCUUCCGAAAGAAGGUUUU 27 
Highlighted sequence, Catalytic core and Stem II sequence; Underlined sequence, Catalytic 
core sequence. 
4.3.8 In vitro test of Mz based sensors 
We tested the new Mz based RNA sensors in test tubes via RTA, using sNTS or NNS (sNTS 
or sNNS) that were short ~20 nt RNA that represented the region on NTS or NNS to be 
recognised by Mz. RTA protocols were modified from Mz [Tanabe et al, 2000]. Basically, Rz 
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(either Mz or HH) were incubated with the substrate (STS), and activator (NTS, NNS, or 
nothing), at 37 C in RTA buffer (50 mM Tris (pH 8.0), 10 mM MgCl2) over a duration, 
during which aliquots would be removed at various time points and RTA terminated by 
addition of EDTA. 
At the initial stages of RTA testing (before the advent of the RS system) RTA products were 
analysed via D-PAGE with pre-cast TBE-Urea gels from Biorad. However, repeated runs of 
RTA did not show the expected cleavage of RTS-1 and that of RTS-b1a2 (taken from the 
literature to serve as positive control). A major reason suspected was that the cleaved STS was 
in too small a quantity to be detected on D-PAGE stained with SYBR Gold. 
To resolve this issue, we came up with the RS system and synthesised the 4 STS with a 
fluorescent probe (e.g., 6-FAM) conjugated at one end, where the fluorescence signal would 
be constitutively quenched by a quencher (e.g., BHQ-1) conjugated at the other end. Upon 
activation of Mz, and thus cleavage of STS, the probe would be separated from its quencher 
and thus release intense fluorescence that could be assessed quantitatively by a fluorescence 
plate reader. 
Of the 3 STS selected, RTS-2 performed well (was able to detect the 20 nt NTS specifically 
against NNS, a similar sequence) and eventually, cell line tests focused on its corresponding 
Mz-2 and HH-2. 
Figure 4.3-6 shows combined results of Mz-2 from two RTA experiments. Fluorescence 
values for each RTA time point were normalised with respect to values at 0 min, and 
expressed as a percentage of HH-2 fluorescence signal at 60 min. Both experiments showed 
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similar desired trends, which was that HH-2 (Yellow) gave the maximum fluorescence (i.e., 
substrate cleavage), followed closely by Mz with sNTS (Blue), while Mz with sNNS (Red) or 
nothing (Black) gave little or no substrate cleavage. Essentially, Mz-2 was activated if and 




















Mz-2, sMTS, RTS Mz-2, sMNS, RTS Mz-2, RTS HH-2
 
Figure 4.3-6 RTA results for Mz-2 from two experiments. 
4.4 Cell line testing of Maxizyme based e-SRS. 
In this Section, we tested the functional Mz based e-SRS sensors in cell line (HEK293) for 
two paradigms: 
1) To activate inducible gene expression system if and only if NTS is present, using the 
T-REx system with reporter genes (ECFP or EGFP) as PLG. 
2) To activate RS if and only if NTS is present. 
For paradigm 1, the cell line tests were unsuccessful, despite optimisations of 1) inducible 
gene system; 2) Expression of RNA (including using a tRES, and addition of a T7 RNA Pol 
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III promoter). 
For paradigm 2, we attempted to transfect both e-SRS sensors and RS into cells to allow 
detection of specific RNA within cells. However, the RS degraded when transfected into 
culture vessels with cells grown and were thus not usable. The problem was not resolved by 
the use of nuclease resistant modifications, such as phosphorothioate bonds and addition of 
2’-O- methyl groups. These issues lead us to redirect e-SRS for in vitro development. 
4.4.1 Inducible Gene System. 
4.4.1.1 Optimisation of the Inducible Gene System for the ratio of 
pTR to inducible PLG. 
As explained in Section 4.3.4, for ease of implementation, we used a commercial inducible 
gene expression system, T-REx (Invitrogen). The repressor, R1 was provided by the pTR, and 
the PLG (activated by the Mz based sensor knock down of R1) would be cloned into the 
provided the pPLG. 
As each pPLG has two operator sites for R1 to bind in order to suppress the cloned PLG, 
greater ratio of pTR to pPLG transfected implied stronger PLG suppression and smaller ratio 
of pTR to pPLG trasnfected implied weaker PLG suppression. There is thus a need to 
establish an optimum ratio of pTR to pPLG in transfecting the inducible gene system, for 
which there are two main considerations: 
1) When the Mz-based sensors are inactive, R1 must be expressed at high enough level 
to ensure PLG is suppressed. 
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2) When Mz-based sensors are active, the level of R1 must be low enough for it to be 
knocked down sufficiently to allow detectable expression of PLG. 
 
4.4.1.2 pcDNA4/TO/myc-His/lacZ as PLG in PC-12. 
As a quick optimisation of ratio of pTR to pPLG, we used the provided 
pcDNA4/TO/myc-His/lacZ as the pPLG with the PLG being LacZ. We tested a range of ratio 
of pTR to pPLG from 1:1 to 9:1, with the ratio for pTR incrementing by 1 per step (thus 
testing nine different ratios). Total mass of transfected DNA was kept at 800 ng for all wells. 
On Day -1, PC-12 cells were seeded at 3 x 106 cells / well in 24 well plate and grown with 
RPMI+++. 
The next day, Day 0, the inducible gene system (i.e. pTR and pPLG) were transfected at 
various ratio of pTR to pPLG. The next day, Day 1, cells from each well were split into two 
wells and allowed to grow for another day. On Day 2 media were replaced with fresh 
RPMI+++ and cells for one well of each ratio were induced by an addition of tet (1μg/ml) in 
the media. 
On Day 3, formaldehyde fixation was carried out for all wells, followed by Β-Galactosidase 
Staining (using the protocol from Invitrogen Β-Galactosidase Staining Kit in general). Wells 
were covered and left overnight in 37 °C incubator for further staining. 
On Day 4, after staining had been carried out at 37 C for ~ 22 hr, the intensity of blueness of 
cells, which represented the degree of LacZ activity in those cells, were assessed visually via a 
light microscope, and assigned a numerical score. The score for intensity of blueness range 
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form 0 to 10, where 0 represented minimal intensity of blueness (that which could be seen in 
cells transfected with only EGFP, which was a very slight blueness in the background but not 
in the cells), and 10 represented the intensity of blueness in wells transfected with only pPLG 
(with no pTR, and hence freely expressing LacZ without repression). The data were as shown 
in Table 4.4-1. 
The conclusion derived from this optimisation was that a ratio of 8:1 pTR to pPLG seemed 
like the lowest ratio for stable repression with tet (1μg/ml) inducibility of pPLG in PC-12 
cells. 
Table 4.4-1 Optimisation of pTR to pPLG (pcDNA4/TO/myc-His/lacZ ) for PC-12. 
Ratio of pTR 
to pPLG. 
  
No induction. Induction with tet 
(1μg/ml). 
Comments 
pTR pPLG Well Intensity of 
blueness. 
Well Intensity of 
blueness. 
 
1 1 1 8 13 6  
2 1 2 8 14 6  
3 1 3 8 15 6  
4 1 4 8 16 4  
5 1 5 8 17 4  
6 1 6 8 18 3  
7 1 7 8 19 3  
8 1 8 8 20 2 Seemed to be lowest ratio for stable 
repression with tet (1μg/ml) 
inducibility of pPLG. 
9 1 9 5 21 1  
1 0 10 0 22 0 
 
Only 800 ng of pTR was 
transfected. 
0 1 11 10 23 10 Only 800 ng of pPLG was 
transfected. 
- - 12 0 24 0 Only 800 ng of pEGFP was 
transfected. All cells exhibited 
green fluorescence (GF), although 




4.4.1.3 ECFP and EYFP as PLG in HEK293. 
With a guide on the optimum ratio of pTR to pPLG, we proceeded to test fluorescent proteins 
(FP) as PLG, which was our objective for a Proof-of-Concept for the inducible gene 
expression system paradigm of e-SRS. For FP, we tested both ECFP (enhanced cyan 
fluorescent protein) and EYFP (enhanced yellow fluorescent protein). We iECFP and iEYFP 
by restriction digest of the respective FP sequences from pECFP and pEYFP and cloning them 
within the MCS of pcDNA4/TO/myc-His A. 
Using a similar transfection schedule as the pcDNA4/TO/myc-His/lacZ above, we optimised 
for ratio of pTR to pPLG for 6:1, 7:1, 8:1, 9:1. 
It was discovered that yellow fluorescence was hard to detect, and that 8:1 ratio of pTR to 
pPLG gave us the best result for iECFP, where the amount of cyan fluorescence (CF, detected 
in the ECFP Channel) observed was readily distinguished on Day 3 for wells with tet (1μg/ml) 
induction (on Day 1), compared to those without tet induction (Figure 4.4-1). It was thus 






Channels: ECFP, DIC. 
 
Tet not added. 
Channels: ECFP. 
 
Channels: ECFP, DIC. 
 
Figure 4.4-1 8:1 ratio of pTR to iECFP with and without Tet (1μg/ml) induction. 
DIC, Differential Interference Contrast. 
4.4.1.4 Test of Mz-1,2,3 to activate inducible system. 
After determining a functional ratio of pTR to pPLG for iECFP, we proceeded to test the 
ability of Mz-1, Mz-2, Mz-3 to activate iECFP. At this stage, before the use of RSs, we had 
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yet to determine which of these Mz based sensor had the best ability to specifically activate in 
the presence of NTS-37a. As such, we started with testing Mz-1. 
4.4.1.4.1 Test of Mz-1 (with pEGFP-Cav2.1EFa / sNTS-37a, or 
pmCherry-Cav2.1EFb / sNTS-37b) and HH-1 to activate 
inducible system (8:1 pTR to pcDNA4/TO/ECFP/myc-His A) in 
HEK293. 
We conducted the first cell line test of e-SRS using HEK293 with iECFP as the PLG, Mz-1 as 
the Mz-based e-SRS sensor, and pEGFP-Cav2.1EFa (which expresses the full length NTS-37a 
with an EGFP tag) or sNTS-37a as NTS, and pmCherry-Cav2.1EFb (which expresses the full 
length NTS-37b with an mCherry tag) or sNTS-37b as NNS. In addition, we used HH-1, the 
wild-type Hammerhead Rz which recognised the same target as the activated Mz-1. For more 
details on the relationships between the various Mz based sensors, targets, and HH, please see 
Sections 4.3.5 and 4.3.7. 
Parameters tested were as follows: 
Test ability to activate 500 ng of iECFP (8:1 pTR to pcDNA4/TO/ECFP/myc-His A) using 
1) Mz-1 (20 pmol) with  
a. pEGFP-Cav2.1EFa (500 ng) 
b. pEGFP-Cav2.1EFa (500 ng) and sNTS 37a (20 pmol, 100 pmol) 
2) Mz-1 (20 pmol) with  
a. pmCherry-Cav2.1EFb (500 ng) 
b. pmCherry-Cav2.1EFb (500 ng) and sNTS 37b (20 pmol) 
3) HH-1 at 
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a. 20 pmol 
b. 100 pmol 
 
We used a similar transfection schedule as the optimisation of iECFP above, we tested the 
ability of Mz-1 to activate a 8:1 ratio of pTR to pPLG. 
On Day -1, HEK293 cells were seeded at 2 x 105 cells / well in 24 well plate and grown with 
DMEM (10 % FBS, w/o P/S ). The next day, Day 0, the inducible gene system (i.e. pTR and 
pPLG), and pEGFP-Cav2.1EFa or pmCherry-Cav2.1EFb were transfected. 
On Day 1, wells designated as positive control by tet were induced by an addition of tet 
(1μg/ml) in the media. Wells designated for RNA transfection (i.e. sNTS/sNNS or Mz-1/HH-1) 
were also transfected. On Day 2 media were replaced with fresh DMEM (10 % FBS, 1% P/S), 
with tet (1μg/ml) where required. 
On Day 3, cells were viewed via confocal microscopy for Cyan and Green fluorescence (CF 
and GF, as detected in the ECFP and EGFP Channels respectively), and pictures were taken 
(some representative pictures were as shown in Figure 4.4-2). 
The data showed that presence of NTS, sNTS, and HH-1 (both at 20 pmol and 100 pmol) did 
not seem to produce a visually significant difference for ECFP, compared to Mz-1 alone or 
Mz-b1a2 alone (Mz-b1a2 does not recognise any NTS and also does not target the R1 mRNA, 
thus acting as a negative control). 
The conclusion derived was that the failure of NTS, sNTS, and HH-1 to increase ECFP 
indicated failure of Mz-1 to specifically activate the inducible system in HEK293. 
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Mz-1 (20 pmol), NTS-37a (500 ng). 
Channels: ECFP, DIC. 
 
Channels: EGFP, DIC. 
 
Mz-1 (20 pmol), sNTS-37a (100 pmol). 
Channels: ECFP, DIC. 
 
Channels: EGFP, DIC. 
 
Mz-1 (20 pmol). 
Channels: ECFP, DIC. 
 







Mz-b1a2 (20 pmol). 
Channels: ECFP, DIC. 
 
Channels: EGFP, DIC. 
 
HH-1 (100 pmol). 
Channels: ECFP, DIC. 
 
Channels: EGFP, DIC. 
 
Tet (1μg/ml). 
Channels: ECFP, DIC. 
 
Channels: EGFP, DIC. 
 
Figure 4.4-2 Mz-1 was unable to specifically activate the inducible system in HEK293.
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4.4.1.4.2 Test of Mz-1,2,3 (with sNTS 37a) and HH-1,2,3 to activate 
inducible system (iECFP) in HEK293. 
As the full length NTS used in the previous experiment had to be properly expressed after 
trasnfection and could have secondary structures that complicated the process of detection by 
the Mz based e-SRS sensors, we decided to first reduce the complexity involved and optimise 
other aspects of the detection process before reverting to full length NTS. As such we focused 
on using transfected sNTS (sNTS-37a and sNTS-37b). 
Using a similar experimental protocol as the previous experiment, we tested different 
parameters as shown in Table 4.4-2. Briefly, on Day -1, HEK293 cells were seeded at a 
density equivalent to about 1 x 105 cells / well in 24 well plate. On DAY 0, the inducible gene 
system were transfected. On Day 1, RNA transfection as well as tet (1μg/ml) induction were 
carried out. On Day 2 old media were replaced with fresh media. Confocal microscopy were 
used to evaluate iECFP activation starting from Day 2, and pictures were taken on at least one 
day. 
Despite the testing of many conditions, we were unable to obtain significant activation of 
iECFP by either the Mz based sensors or HH used. Only once on Day 4 for one of the 
experiments did the overall ECFP activation for Mz-3 and HH-3 (all RNA at 13.3 pmol) seem 
to fit desired patterns. Unfortunately, these results were not repeatable on subsequent testing 
of a greater range of concentration for HH-3 (some representative pictures were as shown in 
Figure 4.4-3). iECFP was inducible for cells induced with Tet (1 μg/ml). 
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Table 4.4-2 Paremeters and conditions tested for iECFP. 
Parameters Conditions tested 
Mz-1. 6.7, 8, 13.3, 20.0, 26.7, 33.3 pmol. 
Mz-2, Mz-3. 8, 13.3, 26.7 pmol. 
HH-1, HH-2. 8, 13.3, 26.7, 40 pmol. 
HH-3. 8, 13.3, 26.7, 53.3, 106.7 pmol. 
sNTS-37a / sNTS-37b. 6.7, 8, 13.3, 20.0, 26.7, 33.3 pmol. 
Ratio of pTR:pPLG. 8:1, 7:1, 3:1, 1:1. 
Mass of inducible system transfected for 
equivalent of one well in 24 well plate. 
1, 2 μg. 
 
HH-3 (26.7 pmol). HH-3 (53.3 pmol). 
Channels: ECFP, Cy5, DIC. Channels: ECFP, Cy5, DIC. 
HH-3 (106.7 pmol).  




Tet (1μg/ml) Tet not added. 
Channels: ECFP, DIC. Channels: ECFP, DIC. 
Figure 4.4-3 HH-3 was unable to specifically activate iECFP in HEK293 as CF was not 
significantly more intense than cells not transfected with HH-3 (Tet not added). 
Cells induced with Tet (1 μg/ml) served as positive control for functional iECFP. HH-3 used here 
was 5’ labelled with Cy5 (Red), as such increasing HH-3 transfection concentration increased 
the amount of HH-3 transfected into cells but did not increase iECFP activation. 1 μg (per well 
of 24 well plate) of Inducible system was transfected at 7:1 ratio of pTR:pPLG. 
4.4.1.5 Switch to the use of HH. 
To further focus our efforts to activate the inducible gene system in cell lines, we focused on 
the use of HH rather than Mz based sensors as HH were simpler constructs with high catalytic 
activities, and this reduced the need to activate the sensor with sNTS. 
4.4.1.5.1 Use of tRNA expression system. 
In previous experiments, transfection of HH into HEK293 apparently had no effect in 
activating the inducible gene system (iECFP). This could have been due to difficulties in 
maintaining appropriate secondary structures of HH (for e.g. if they form lasting complexes 
with transfection reagents) after transfection into cells. 
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As such, we decided to try to express HH-2 from within HEK293, by cloning HH-2 into an 
expression vector (at this stage, in-vitro experiments as described in Section 4.3.8 had 
confirmed the better specificity of Mz-2 over Mz-1 and Mz-3). Going through the literature, 
we discovered that a tRES had been successfully used to express Mz [Oshima et al, 2003] 
with several advantages compared to a pol II expression system, namely 1) high expression 
levels of one to three order of magnitude higher than pol II system [Sano & Taira, 2004], 2) 
ability to transport the expressed RNA into the cytoplasm (where they perform their function) 
via a tRNA nuclear export system [Kuwabara et al, 2001]. As such, we decided to employ the 
tRES to express HH-2. 
Our tRES is an RNA expression plasmid adapted from [Sano & Taira, 2004], where the RNA 
to be expressed is placed under a pol III promoter. The version used here is that of a modified 
human tRNA for Valine (tRNAVal) with the last seven bases removed and replaced with a short 
linker to prevent 3’ end processing. The resulting expressed RNA has a ~ 91 nucleotide 
tRNAVal attached to the 5’ of the RNA. This extra 5’ domain should fold like a tRNA with a 
cloverleaf structure, which facilitates the transport of the entire RNA into the cytoplasm. 
4.4.1.5.2 Design and construction of HH-2-1_tRES. 
We designed a tRES sequence for HH-2, which would express HH-2 with a partial tRNAVal 
sequence 5’ of the HH-2 sequence for the expression benefits as explained above. The final 
expressed RNA was denoted as HH-2-1_tRES. 
The design of HH-2-1_tRES was accomplished as instructed in [Sano & Taira, 2004]. This 
essentially involved concatenating the following three RNA segments (as shown in Table 4.4-3) 
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together, in 5’ to 3’ order: 
1) tRES 5’ sequence, which included the required pol III promoter sequence. 
2) Existing HH-2 sequence with one initial U on the Rz binding arm removed as a 
continuous run of four Us would terminate a pol III transcript. 
3) tRES 3’ termination sequence, which is four repeats of Us. 
 
Table 4.4-3 Sequences for the design of HH-2-1_tRES. 














HH-2-1 UUUCGACUGAUGAGGCCGAAAGGCCGAAAGUUUCAUA 37 
tRES(3’) UUUU 4 
As recommended in [Sano & Taira, 2004], we predicted the secondary structure of 
HH-2-1_tRES to ensure that the critical cloverleaf structure is formed (without which the 
entire RNA is likely to accumulate in the nucleus, rather than get exported to the cytoplasm 
where they are supposed to function). As shown in Figure 4.4-4, our HH-2-1_tRES was 
predicted to form the cloverleaf structure (nucleotides 4 to 88). 
In addition, we wanted to further ensure that our HH-2 binding arms could bind correctly and 
with the right HH Rz structure to the substrate, without being interfered by, nor interfering 
with the cloverleaf structure. By adding the substrate (RTS-2) sequence 3’ to the 
HH-2-1_tRES sequence and performing a secondary structure prediction for the entire 
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construct, as shown in Figure 4.4-5, we were assured that this was the case (HH Rz structure 
was defined from nucleotides 92 to 128). 
 
 





Figure 4.4-5 HH-2-1_tRES was predicted to be able to bind correctly and with the right 
HH Rz structure (nucleotides 92 to 128) to the substrate. 
There was no predicted interference by, nor interference to the cloverleaf structure. 
 
We constructed the double stranded DNA of HH-2-1_tRES with protruding 3’ A de novo 
(using gene synthesis via oligonucleotide ligation, as described in Section 3.1.9) and then 
inserted it via TA-cloning into pGEM-T Easy vectors to created the plasmid pHH-2-1_tRES. 




Figure 4.4-6 Ligation oligos configurations for HH-2-1_tRES. 
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Table 4.4-4 Ligation oligos sequences for HH-2-1_tRES. 
Ligation 
Oligo 
Sequence (5’ to 3’) 
HH-2-1_tRE
S Fwd L1 
ACCGTTGGTTTCCGTAGTGTAGTGGTTATCACGTTCGCCTAACACGCGA 
HH-2-1_tRE







S Rvs L1 
AAAATATGAAACTTTCGGCCTTTCGGCCTCATCA 
HH-2-1_tRE








4.4.1.5.3 Test of HH-2-1_tRES to activate iEGFP in HEK293. 
Using a similar experimental protocol as the previous experiment, we tested the ability of 
pHH-2-1_tRES to activate the inducible system, this time using iEGFP instead of iECFP. We 
created iEGFP similarly to the way we created iECFP, by cloning an EGFP sequence into 
pcDNA4/TO/myc-His A. 
Briefly, on Day -1, HEK293 cells were seeded at a density equivalent to about 1 x 105 cells / 
well in 24 well plate. On Day 0, the inducible gene system (with pTR to iEGFP at ratios of 7:1, 
3:1, 1:1) was transfected. On Day 1, instead of RNA transfection, pHH-2-1_RES was 
transfected at 1 and 2 μg, and tet (1μg/ml) induction were carried out. On Day 2 cells in each 
well were replated into 3 wells (with 1 coverslips) in a 24 wells plate. On Day 3 and Day 4, 
after formaldehyde fixation, cells on coverslips were mounted on slides using Fluorsave. 
Fluorescence microscopy was used to evaluate the slides for iEGFP activation, and pictures 
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were taken on at least one day. 
Despite the testing of many conditions, we were unable to observe significant activation of 
iEGFP in pHH-2-1_tRES transfected wells compared to wells with no Tet induction (some 
representative pictures were as shown in Figure 4.4-7). iEGFP was inducible for cells induced 
with Tet (1 μg/ml). 
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Figure 4.4-7 HH-2-1_tRES was unable to specifically activate iEGFP in HEK293. 
This could be seen as GF was not significantly different from cells not transfected with 
HH-2-1_tRES and with Tet not added. Cells induced with Tet (1 μg/ml) served as positive 
control for functional iEGFP. Pictures shown here were from Day 3, for wells with 1 μg inducible 
system transfected at 7:1 ratio of pTR:pPLG. Wells at other ratios did not have better results. 
4.4.1.5.4 RT-PCR of HH-2-1_tRES in transfected HEK293 cells. 
We decided to check if the lack of activation of iGFP by pHH-2-1_tRES could have been due 
to the HH-2-1_tRES RNA not being expressed in cells. To investigate this possibility, we 
scaled up the transfection of pHH-2-1_tRES in order to harvest sufficient cells for RNA 
isolation and subsequent RT-PCR to determine level of HH-2-1_tRES expression, but 
otherwise maintained the same or similar transfection protocol, such as DNA mass to cells 
transfected. 
Briefly, on Day -1, HEK293 cells were seeded at 7.5 x 105 cells / well for 6 wells plate (a 
density equivalent to about 1.5 x 105 cells / well in 24 well plate). On Day 0, pHH-2-1_RES 
was transfected at 5 μg / well (equivalent to 1 μg / well for 24 well plate).  
On Day 1, Day 2, Day 3, Day 4 transfected cells were harvested for RNA isolation. For cells 
harvested on Day 3 and Day 4, they were replated on Day 1 and Day 2 respectively, in order 
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to maintain similar phase of growth and cell density on day of harvest. Cells on Day 2 had 2 
days of growth after transfection of pHH-2-1_tRES, similar to the Day 3 cells in the previous 
experiment. On Day 2, untransfected cells were also harvested for HEK293 RNA isolation. 
Harvested cells were pelleted and kept at -80 °C 
RNA was isolated from all the harvested cells on the same day. RT-PCR was performed for 
HH-2-1_tRES and β-Actin (βA) as a positive control. Primer information and RT-PCR 
conditions were as detailed in Methodology. For each gene, a “-RT” control was done where 
the same procedure was used except that an equal volume of H2O was added in place of the 
Reverse Transcriptase (RT) enzyme. This control would indicate whether (and the 
approximate amount if so) the amplified products were due to contaminating DNA sequences 
(plasmid or genomic DNA) in the isolated RNA. A “H2O” or water control was performed for 
each gene where an equal volume of H2O was added in place of the RNA sample to ensure 
that no contaminants in the reagents gave rise to amplified products. 
HH-2-1_tRES primers were designed to give a 134 nt product while the β-Actin primers were 
designed to give a 643 nt product. RT-PCR products were analysed on an agarose gel stained 
with EtBr, as shown in Figure 4.4-8. 
 143 
 
Figure 4.4-8 Agarose gel analysis of RT-PCR products for HEK293 cells transfected with 
pHH-2-1_tRES on Day 0. 
 
For HH-2-1_tRES, Day 1, Day 2, Day 3 RNA all showed the expected product bands. 
However, these products were also shown in the respective –RT lanes, which indicated that 
there were likely some DNA amplification from transfected plasmids present in the isolated 
RNA. 
For Day 2, the RT lane product seemed much more intense than that of the –RT lane, 
compared to those of Day 1 and Day 3. The β-Actin band was also more intense on Day 2 
than Day 1 and Day 3, indicating that more RNA was likely to have been harvested on Day 2, 
as expected with normal cell proliferation. This indicated that HH-2-1_tRES RNA was a able 
to accumulate from Day 1 to Day 2, in tandem with normal cell proliferation. Since there was 
an increase in the ratio of RT lane band intensity to that of –RT lane, some of the RT lane 
product in Day 2 was likely amplified from expressed RNA, and that the amount of 
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HH-2-1_tRES RNA per well was higher on Day 2, compared to Day 1 and Day 3. 
Day 4 RNA showed no significant HH-2-1_tRES products, although all β-actin RT lanes had 
products, indicating that RNA were isolated from all samples and that HH-2-1_tRES RNA 
and its plasmid were no longer present in Day 4 cells. 
RNA from untransfected HEK293 cells did not give any HH-2-1_tRES product, indicating 
that the Day 1 to Day 3 products were not from some native genes in HEK293 cells. 
There were no products in H2O lane, indicating that the products obtained in all lanes were not 
due to contamination in the reagents. 
From these results, we concluded that HH-2-1_tRES RNA was likely expressed in 
pHH-2-1_tRES transfected HEK293 cells, and continued to be expressed on Day 2 (i.e. 2nd 
day after transfection – the day of transfection was Day 0). However, it could be possible that 
the level of expression was insufficient to activate the iEGFP system. This could also be due 
to rapid removal of the expressed RNA as Day 3 cells already showed no significant presence 
of HH-2-1_tRES RNA. As such, we decided to try to improve expression levels of 
HH-2-1_tRES by including a T7 RNA Pol III promoter 5’ of the HH-2-1_tRES sequence in 
the pHH-2-1_tRES plasmid. 
4.4.1.5.5 Design and construction of HH-2-2_tRES 
We created the HH-2-2_tRES construct by adding a T7 RNA Pol III promoter 5’ of the 
HH-2-1_tRES sequence in the pHH-2-1_tRES plasmid, thus creating the plasmid, 
pHH-2-2_tRES. 
This essentially involved concatenating the following two RNA segments (as shown in Table 
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4.3-7) together, in 5’ to 3’ order: 
1) T7 RNA Pol III promoter sequence (T7 Pol), from -17 to +2. 
2) The original HH-2-1_tRES sequence. 
T7 Pol was the minimum sequence required for efficient transcription. RNA Transcription 
with T7 Pol started at +1, hence the expressed RNA, HH-2-2_tRES would have an extra GG 
at 5' compared to HH-2-1_tRES. Like in the case of HH-2-1_tRES, transcription termination 
would occur after the four runs of U at the end of the sequence. 
Table 4.4-5 Sequences for the design of HH-2-2_tRES. 

















As in the case for HH-2-1_tRES we predicted the secondary structure (Figure 4.4-9) of 
HH-2-2_tRES to ensure that even with the additional two bases at 5’, the critical cloverleaf 
structure (nucleotides 6 to 90) was formed, and that the HH-2 binding arms could bind 
correctly and with the right HH Rz structure (defined from nucleotides 94 to 130) to the 




Figure 4.4-9 HH-2-2_tRES was predicted to be able to bind correctly and with the right 
HH Rz structure (nucleotides 94 to 130) to the substrate. 
There was no predicted interference by, nor interference to the cloverleaf structure. 
We synthesised the double stranded DNA of HH-2-2_tRES by adding via PCR a T7 Pol 
sequence (19 nt) to the 5’ end of the PCR template, which was the double stranded DNA 
sequence of HH-2-1_tRES (obtained by PCR from pHH-2-1_tRES, using primers 
HH-2-1_tRES Fwd L1 and HH-2-1_tRES Rvs L1). The forward primer contained the T7 Pol 
sequence with a short 3’ sequence matching the 5’ start of the HH-2-1_tRES sense sequence, 
and the reverse primer (HH-2-1_tRES Rvs L1) matched the 5’ end of the HH-2-1_tRES 
antisense sequence. The double stranded HH-2-2_tRES was then gel purified and inserted via 
TA-cloning into pGEM-T Easy vectors to create the plasmid pHH-2-2_tRES. Primer and 
template sequences were as shown in Table 4.4-6. 
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Table 4.4-6 Primer and template sequences for PCR synthesising HH-2-2_tRES. 











HH-2-2_tRES Fwd TAATACGACTCACTATAGGACCGTTGGTTT 
HH-2-1_tRES Rvs L1 AAAATATGAAACTTTCGGCCTTTCGGCCTCATCA 
4.4.1.5.6 Test of HH-2-2_tRES to activate iEGFP in HEK293. 
Using a similar experimental protocol as that for HH-2-1_tRES, we tested the ability of 
pHH-2-2_tRES to activate the iEGFP inducible system. 
Briefly, on Day -1, HEK293 cells were seeded at a density of about 1 x 105 cells / well in 24 
well plate. On Day 0, 1 μg of the iEGFP inducible gene system (with pTR to iEGFP at ratios 
of 7:1) was transfected. On Day 1, pHH-2-2_RES was transfected at 1 and 2 μg. On Day 2, 
fresh media was introduced and tet (1μg/ml) induction was carried out. On Day 2, Day 3 and 
Day 4, cells were examined for iEGFP activation via Fluorescence microscopy, and pictures 
were taken on at least one day. 
As for the case of HH-2-1_tRES, we were unable to observe significant activation of iEGFP 
in both 1 μg and 2 μg pHH-2-2_tRES transfected wells compared to wells with no Tet 
induction (some representative pictures were as shown in Figure 4.4-10). iEGFP was 
inducible for cells induced with Tet (1 μg/ml).
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Figure 4.4-10 HH-2-2_tRES was unable to specifically activate iEGFP in HEK293 as GF 
was not significantly different from cells not transfected with HH-2-2_tRES and with Tet 
not added. 
Cells induced with Tet (1 μg/ml) served as positive control for functional iEGFP. Pictures shown 
here were from Day 2. Observations on other days did yield better results. 
4.4.2 Test of RS in place of inducible gene system. 
For paradigm 2 of e-SRS (i.e. to activate a RS if and only if NTS is present), we attempted to 
transfect both e-SRS sensors and RSs into cells to allow detection of specific RNA within 
cells. However, the RSs degraded when transfected into culture vessels with cells grown and 
were thus not usable. The problem was not resolved by the use of nuclease resistant 
modifications, such as phosphorothioate bonds and addition of 2’-O- methyl groups. 
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4.4.2.1 Test of Mz-1,2,3 to activate RS in HEK293. 
We tested the ability of Mz-1, Mz-2, Mz-3 to activate their respective RS within HEK293 
cells. The concepts of Mz and RS were explained in Section 4.3, particularly Sections 4.3.1 to 
4.3.3, and 4.3.7. Sequences were given in Table 4.3-2 for RS and Table 4.3-8 for Mz. For 
experiments in this Section, the RS used (RTS-1, RTS-2, RTS-3, and RTS-b1a2) were labelled 
at 5’ with 6-FAM, and at 3’ with BHQ1. When viewed with a fluorescence microscope, the 
cleavage of such RS would give rise to green fluorescence (GF) due to the conjugated 6-FAM.  
We tested the ability of Mz and HH to activate their respective RS (5’ 6-FAM, 3’ BHQ1) 
using: 
1) Mz-1, Mz-2 (40 pmol) with 
a. sNTS 37a (40 pmol) 
b. sNNS 37b (40 pmol) 
c. RS 
i. 40 pmol 
ii. 400 pmol 
2) Mz-3, Mz-b1a2 (40 pmol) with 
a. sNTS 37a (40 pmol) 
b. sNNS 37b (40 pmol) 
c. RS 
i. 400 pmol 
3) HH-1, HH-2 (40 pmol) with 
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a. RS 
i. 40 pmol 
ii. 400 pmol 
4) HH-3, HH-b1a2 (40 pmol) with 
a. RS (400 pmol) 
Briefly, on Day -1, HEK293 cells were seeded at a density of about 1.5 x 105 cells / well in 24 
well plate. On Day 0, RNA were transfected. On Day 1, fresh media was introduced. Cells 
were examined for RS activation via Fluorescence microscopy. Visual observations were 
made on both days and important results were recorded. 
On Day 0, in the 1 hour immediately after transfection, all wells transfected with RS started 
showing some percentage of cells with GF, which increased with time until about 10 % of 
cells (for those with 400 pmol RS) were GF (percentage and GF intensity were less for 
samples with 40 pmol RTS). Since this included cells transfected with only RS (no Mz), the 
observation suggested that the GF observed were not due to activated Mz cleavage of RS. 
Control wells not transfected with RS were not GF. 
On Day 1, after the change of media, it appeared that the major GF difference between wells 
seemed to be the amount of RS transfected, i.e., whether or not Mz (with sNTS or sNNS) was 
present did not seem to make a difference to GF detected. In general, for cells transfected 
with: 
1) 40 pmol RS, ~ 20% of cells were GF, with weak intensity. 
2) 400 pmol RS, greater than 90% of cells were GF, with medium intensity. 
These observations strongly suggested that the GF produced were due to cleavage of RS 
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without the need for any activated Mz based sensors. 
It was concluded that the RS transfected (synthesised from standard ribonucleotide bases) 
were most likely degraded, probably by nucleases present in the cell cultures. 
4.4.2.2 Test of Mz-2, HH-2, and HH-2-2_tRES to activate RS 
(nuclease resistant) in HEK293. 
In vitro testing of the various Mz based sensor had at this point revealed that Mz-2 had the 
best ability to specifically activate its RS in the presence of NTS-37a. As such, we focused our 
RS based cell line experiments on Mz-2, HH-2, and HH-2-2_tRES, all designed to activate 
specifically RTS-2. 
In addition, as the findings from the previous section showed that RS made of standard 
ribonucleotide bases were easily degraded after transfection, we decided to confer nuclease 
resistant properties to the RS by using phosphorothioate bonds and 2’-O-methyl RNA bases 
where we believed they would not significantly interfere with Rz cleavage of the RS. As a 
result, we created a new RS with such modifications, named RTS-2_M-P2, based on the 
sequence of RTS-2. Sequence of RTS-2_M-P2 was as shown in Table 4.4-7. RTS-2_M-P2 
was 17 nt, was labelled at 5’ with Cy3, and at 3’ with BHQ2. When viewed with a 
fluorescence microscope, its cleavage would give rise to red fluorescence (RF) due to the 
conjugated Cy3. 
Table 4.4-7 Sequence of RTS-2_M-P2. 
Sequence (5’ to 3’) 
(Cy3)-mU*mA*mU*mG*mA*mA*rA*rC*rU*rCrU*rC*mG*mA*mA*mA*mA-(BHQ2) 
Legend: *, Phosphorothioate Bond (PS); mN, 2’-O-methyl RNA base; rN - RNA base. 
In case the RNA sNTS transfected were in some way inactivated (e.g. by degradation by 
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nuclease, or clumping to proteins), we also transfected some wells with NTS or NNS in the 
form of pECFP-Cav 2.1EFa or pECFP-Cav 2.1EFb, which would express the full length NTS 
or NNS. These plasmids were similar to the pEGFP-Cav2.1EFa and pmCherry-Cav2.1EFb 
used previously (Section 4.4.1.4.1) except that the EGFP and mCherry sequences were 
removed by restriction digest and the ECFP sequence from pECFP inserted in their places. 
We tested the ability of HH-2-2_tRES, Mz-2, and HH-2 to activate their RTS-2_M-P2 (5’ Cy3, 
3’ BHQ-2) using: 
1) HH-2-2_tRES at 
a. 1, 2 μg 
i. RS 40 pmol 
2) Mz-2 (40 pmol) at 
a. pECFP-Cav 2.1EFa / pECFP-Cav 2.1EFb (1 μg), Nothing 
i. RS 4 pmol 
ii. RS 40 pmol 
iii. RS 400 pmol 
b. sNTS / sNNS (40 pmol). 
i. RS 4 pmol 
ii. RS 400 pmol 
3) HH-2 (40 pmol) at 
a. RS 4 pmol 
b. RS 400 pmol 
 153 
4) Nothing at 
a. RS 4 pmol 
b. RS 40 pmol 
c. RS 400 pmol 
Briefly, on Day -1, HEK293 cells were seeded at a density of about 1.0 x 105 cells / well in 24 
well plate. On Day 0, HH-2-1_tRES (at 1 and 2 μg), pECFP-Cav 2.1EFa (1 μg), and 
pECFP-Cav 2.1EFb (1 μg) were transfected for specific wells. On Day 1, RNA (including RS) 
were transfected. On Day 2, fresh media was introduced. On Day 2, Day 3, and Day 4, cells 
were examined for RS activation via Fluorescence microscopy, and pictures were taken on at 
least one day (some representative pictures were as shown in Figure 4.4-11, Figure 4.4-12, 
and Figure 4.4-14).
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HH-2-2_tRES (1 μg), RTS-2_M-P2 (40 pmol). HH-2-2_tRES (2 μg), RTS-2_M-P2 (40 pmol). 
Channels: WIY. Channels: WIY. 
RTS-2_M-P2 (40 pmol).  
Channels: WIY.  
Figure 4.4-11 Test of HH-2-2_tRES to activate RTS-2_M-P2. 
Similar activation of RTS-2_M-P2 (RF) was observed in all wells. The amount of HH-2-2_tRES 
transfected (0, 1 or 2 μg) did not appear to change activation of RS. Pictures shown here were 
from Day 2. 
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Mz-2 (40 pmol), NTS (1 μg), RTS-2_M-P2 (400 
pmol). 
Mz-2 (40 pmol), NNS (1 μg), RTS-2_M-P2 (400 
pmol). 
Channels: WIY. Channels: WIY. 
Mz-2 (40 pmol), RTS-2_M-P2 (400 pmol). RTS-2_M-P2 (400 pmol). 
Channels: WIY. Channels: WIY. 
Figure 4.4-12 Test of Mz-2 with NTS-37a or NTS-37b to activate RTS-2_M-P2. 
Similar activation of RTS-2_M-P2 (RF) was observed in all wells. The presence of Mz-2, NTS, 
and NNS did not appear to affect the activation of RTS-2_M-P2. All concentrations of 
RTS-2_M-P2 showed similar trends. Pictures shown here were from Day 2. 
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Mz-2 (40 pmol), sNTS (40 pmol), RTS-2_M-P2 
(400 pmol). 
Mz-2 (40 pmol), sNNS (40 pmol), RTS-2_M-P2 
(400 pmol). 
Channels: WIY. Channels: WIY. 
Mz-2 (40 pmol), RTS-2_M-P2 (400 pmol). RTS-2_M-P2 (400 pmol). 
Channels: WIY. Channels: WIY. 
Figure 4.4-13 Test of Mz-2 with sNTS-37a or sNTS-37b to activate RTS-2_M-P2. 
Similar activation of RTS-2_M-P2 (RF) was observed in all wells. The presence of Mz-2, sNTS, 
and sNNS did not appear to affect the activation of RTS-2_M-P2. All concentrations of 
RTS-2_M-P2 showed similar trends. Pictures shown here were from Day 2. 
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HH-2 (40 pmol), RTS-2_M-P2 (4 pmol). HH-2 (40 pmol), RTS-2_M-P2 (400 pmol). 
Channels: WIY. Channels: WIY. 
RTS-2_M-P2 (4 pmol). RTS-2_M-P2 (400 pmol). 
Channels: WIY. Channels: WIY. 
Figure 4.4-14 Test of HH-2 to activate RTS-2_M-P2. 
Similar activation of RTS-2_M-P2 (RF) was observed in all wells. The presence of HH-2 did not 
appear to affect the activation of RTS-2_M-P2. All concentrations of RTS-2_M-P2 showed 
similar trends. Pictures shown here were from Day 2. 
These observations strongly suggested that the RF produced were due to cleavage of RS 
(RTS-2_M-P2) without the need for any activated Mz based sensors, HH-2, or HH-2-2_tRES. 
It was concluded that even with significant nuclease resistant protection, the RS RTS-2_M-P2 
was still degraded after transfection, probably by nucleases present in the cell cultures. 
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4.4.2.3 Test of transfection components to activate RTS-2_M-P2 and 
RTS-2 (RTA). 
If we were able to limit the agent(s) responsible for degrading the RS to certain components 
of the transfection process, then it might still be possible to alter the transfection process so 
that such agent(s) were removed from contact with the RS until the RS were mostly 
transfected into cells. Hence, we proceeded to test transfection elements for their ability to 
degrade RTS-2_M-P2 and RTS-2. 
Essentially, both RS (RTS-2_M-P2 and RTS-2) were added to agent(s) involved in 
transfection in a 96 well plate, and viewed with a fluorescence microscope. Activation (i.e. 
degradation) of the RS would be indicated by red fluorescence (RF) or green fluorescence 
(GF) for RTS-2_M-P2 and RTS-2 respectively. Pictures were taken as shown in Figure 4.4-15. 
RTS-2_M-P2 (5’ Cy3, 3’ BHQ-2) and RTS-2 (5’ 6-FAM, 3’ BHQ-1) were tested for activation 
when the following were added: 
1) DMEM 
2) Opti-MEM 
3) Lipoffectamine 2000 
4) Opti-MEM with Lipoffectamine 2000 
All RS were added at 5 pmol (1000 nM). Where Lipoffectamine 2000 was added, it was 
added at a ratio (as for RNA transfection before) of 5 pmol RNA to 0.25 μl LF2000. 
Opti-MEM was added at 3.5 μl per well where needed. All wells were top up to 5 μl with 
DEPC treated water where needed. 
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Figure 4.4-15 DMEM was identified as the agent that degraded both RS, while Opti-MEM 
and Lipoffectamine 2000, or their combinations did not activate RS. 
As the results showed in Figure 4.4-15, the presence of DMEM quickly activated (degraded) 
both RS to release the respective fluorescence, while the other transfection agents had no 
significant effect on the RS. 
Upon discovering that DMEM was apparently able to activate the RS, we repeated the 
experiments in Section 4.4.2.2 with the modification that transfection of RNA was done 
without DMEM in the media. 
This was accomplished by washing cells 3 times with 500 μl of OPTI-MEM, with the final 
wash remaining as new media, just before the transfection of RNA. DMEM (10% FBS, 1% 
P/S) was returned as the media only 6 hours after transfection of RNA, by when most 
transfection of RNA into cells should have occurred. 
However, similar results were obtained as before, that the RF produced were due to cleavage 
of RS (RTS-2_M-P2) without the need for any activated Mz based sensors, HH-2, or 
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HH-2-2_tRES. 
It was concluded that even with significant nuclease resistant protection and the removal of 
DMEM during transfection, the RS, RTS-2_M-P2 was still degraded after transfection, 
probably by nucleases present within the cells. 
At this stage, it was decided that based on the findings, time and resources available, it was 
best to develop e-SRS for in vitro applications. 
4.5 Applications in Nucleic Acid in vitro detection. 
Our experience from the previous section suggested that the e-SRS technology was not yet 
applicable in the environment of living cells. However, positive data in application of e-SRS 
in test tube environment lead us to redirect development towards in vitro diagnostic purposes, 
in the specific detection of Malaria infection (Plasmodium falciparum, Chloroquine resistance 
strains – CVIET and SVMNT haplotypes for the pfcrt gene, and the Chloroquine sensitive 
strain – CVMNK haplotype for pfcrt gene) and Dengue viral infection (Serotypes of DEN-1, 
DEN-2, DEN-3, DEN-4). 
Specifically, we would try to develop in vitro diagnostic tests for specific detection of: 
1) Malaria infection of Plasmodium falciparum 
a. Chloroquine sensitive strain – CVMNK haplotype for pfcrt gene, denoted 
here as Mfs. 
b. Chloroquine resistance strains, with pfcrt gene haplotypes: 
i. SVMNT (predominant in South America, but also found in South 
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East Asia), denoted here as Mfr1. 
ii. CVIET (predominant in Asia) , denoted here as Mfr2. 
2) Dengue viral infection 
a. All four common serotypes (DEN-1, 2, 3, 4), denoted here as D1, D2, D3, 
D4. 
4.5.1 sNTS 
The sNTS sequences used for both Dengue and Malaria were as shown in Table 4.5-1. 
Table 4.5-1 sNTS for Dengue and Malaria. 
sNTS Strain Sequence (5’ to 3’) Lengths 
(nt) 
sNTS-D1 DEN-1 CGTCTCAGTGATCCGGGGG 19 
sNTS-D2 DEN-2 CGCCACAAGGGCCATGAACAG 21 
sNTS-D3 DEN-3 TAACATCATCATGAGACAGAGC 22 
sNTS-D4 DEN-4 CTCTGTTGTCTTAAACAAGAGA 22 
sNTS-Mfr1 S99 TGTAATGAATACAATTTTTGCTAA 24 
sNTS-Mfr2 Dd2 TGTAATTGAAACAATTTTTGCTAA 24 
sNTS-Mfs 3D7 TGTAATGAATAAAATTTTTGCTAA 24 
The column “Strain” indicates the viral or parasitic strains from which DNA sequence have been 
derived. Highlighted bases for Malaria NTS indicate differences compared to sNTS-Mfs (the 
wild type Chloroquine sensitive sequence). 
4.5.2 Computational design of Mz based sensors 
In the previous section, with only one category in which one NTS was paired with one NNS, 
the design process was performed manually, which although rather time consuming, was still 
feasible. With current targeting of seven new NTS, with each NTS being paired with two or 
three NNS, there was not just a need to design significantly more (seven) new specific Mz 
based sensors, but each new sensor had a more complex level of specificity requirement 
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during the design phase. This prompted us to consider automating the Mz based sensor design 
process, for the three main reasons discussed below. 
1) The most immediately obvious reason was to handle the dramatically increased 
design workload and time required. There were a lot more secondary structures to 
generate and assess. In fact, within each category (i.e. Dengue or Malaria), a linear 
increase in the number of NTS would lead to non-linear increase in design work and 
time as each new NTS meant not just a new specific Mz based sensor but also an 
additional NNS for the other sensors in the category. For a category with n number of 
NTS, each potential Mz design had to be evaluated for (n + 1) secondary structures 
(1 of Mz+NTS+STS, (n-1) of Mz+NNS+STS, and 1 of Mz+STS). This had to be 
done for every NTS. Hence, even if only one potential Mz design was assessed and 
accepted for each NTS (typically, many different designs had to be assessed before an 
appropriately specific design could be obtained), for a category with n NTS, the 
amount of secondary structures to be generated and assessed would be n x (n + 1), or 
(n2 + n). In other words, the amount of work and time required in Mz based sensor 
design increased exponentially with the number of NTS targeted in each category. In 
addition, the increase in secondary structures to be assessed would increase the 
likelihood of error if these assessment continued to be done manually i.e. by visual 
examination of secondary structure figures. Before creating a computational tool for 
Mz based sensor design, we made a detailed estimate of the amount of design work 
required for our new NTS, as presented in Section 4.5.2.1. 
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2) Besides the increase in workload faced, the difficulty of design was also increased 
when there were more NTS in each category. This was because each modification of 
Mz design, say in order to address a particular problem in one RNA combination (e.g. 
Mz+NTS+STS), would likely also affect secondary structures of other RNA 
combinations. As such, it could become very difficult to make any corrections of 
inadequate Mz based sensor designs, via manual design. 
3) Last but not least, automated Mz based sensor design would allow us to easily 
evaluate all possible configurations of SAS (Sensor Arm Split) designs in order to 
select the optimised Mz based sensor design for a given NTS, its associated NNS, 
and STS. While experience generated some strategies in the “trial and error” based 
manual design, it is likely that such an approach would not produce the optimised Mz 
design, particularly as the number of NTS in each category increased. 
4.5.2.1 Estimation of the number of Mz based sensor designs to be 
examined for Dengue and Malaria detection. 
In order to better determine whether there was a need to create a computational tool for Mz 
based sensor design for our new development in Dengue and Malaria detection, we made a 
detailed estimate of the amount of design work required for our new NTS. The finding that 
over 640 secondary structures had to be generated and assessed for correctness (active or 
inactive catalytic structure) supported our decision to automate the Mz based sensor design. 
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4.5.2.1.1 RNA regions to adjust in designing a Mz based sensor. 
While we recognise 4 regions (sensor arm, Stem II, catalytic core, and catalytic arm) as 
important in deciding a Mz based sensor design (Section 4.3.6.2), the catalytic core sequence 
is conserved and hence need not be adjusted. This leaves 3 main regions of adjustment in 
designing a specific Mz based sensor, as follows: 
1) Sensor arm 
a. Sequence and length can be adjusted depending on NTS. 
b. SAS can be adjusted, from 1 to one less than the length of the sensor arm. 
2) Stem II 
a. Both MzL and MzR Stem II can be adjusted, without need for perfect 
matches or equal lengths. 
3) Catalytic arm 
a. Sequence and length can be adjusted depending on STS. 
b. Catalytic Arm Split can be adjusted, from 1 to one less than the length of the 
catalytic arm, as long as the Rz recognition site on the STS is also adjusted 
accordingly. 
In the current case, in order to have the greatest chance of success, we kept unchanged as 
many aspects of our functionally successful Mz-2 design as possible. Hence, we limited 
changes to only those aspects that must necessarily change, i.e., the sensor arms only (points 
1(a) and (b) above). 
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4.5.2.1.2 Number of Mz based sensor designs for Dengue and Malaria 
detection. 
The 7 NTS involved here have lengths of ranging from 19 to 24, (only one was less than 21 
nt), meaning that the maximum SAS range for each NTS was 20 or more for six NTS and 19 
for one. Assuming conservatively that the SAS range involved for each Mz based sensor was 
20, point 1(b) above meant that there were 20 different variants of Mz designs that we could 
test for appropriate folding via RNAstructure 4.5. 
As described in Section 4.3.6.1, for each Mz variant, there was a need to test for appropriate 
secondary structures for three types of RNA combinations (Mz+NTS+STS, Mz+NNS+STS, 
and Mz+STS), according to table Table 4.5-2. 
Table 4.5-2 Number of RNA combinations to be assessed for each NTS. 
No. of RNA Combinations Category No. 
of 
NTS 
Mz+NTS+STS Mz+NNS+STS Mz+STS Total 
Sub-Total 
(No. of NTS x Total 
no. of RNA 
Combinations) 
Malaria 3 1 2 1 4 12 (= 3x4) 
Dengue 4 1 3 1 5 20 (= 4x5) 
Total 32 
Based on the above estimates, there were about 20 (variants per Mz) x 32 (number of RNA 
combinations per variant) ≈ 640 secondary structures to generate and assess for correctness 
(active or inactive). 
In order to obtain the best possible designs (within the constraints of following most of Mz-2 
design) we faced a conservative estimate of about 640 RNA secondary structures to generate 
and evaluate for correctness (active or inactive). The actual figure was 676 (4x(23+23+23) + 
5x(18+20+21+21)). 
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4.5.2.2 Computational algorithm for optimising designs of Mz based 
sensor 
In order to automate the design of Mz based e-SRS sensor, we developed in Perl 5.8.8 a 
computational algorithm that using RNAstructure 4.5 for secondary structure prediction, 
generated sequences for the optimal Mz based sensor to specifically recognise a given RNA 
target (NTS) and not any other given RNA sequences (NNS). This software tool (a Perl script 
named “eSRS.pl”) greatly automated the 3 processes of: 1) designing sequences for specific 
e-SRS Mz-based sensor(s) for each NTS, 2) generating their resultant secondary structures, 
and 3) assessing these structures for appropriate specificity (presence of absence of catalytic 
conformation in various situations). 
The entire source code of eSRS.pl was given in the Section Appendices. 
4.5.2.2.1 Inputs required by algorithm 
There are essentially 3 kinds of inputs that are required by the Perl script, eSRS.pl. 
1) Sensor regions to be entered into Perl script eSRS.pl. As mentioned in Section 
4.5.2.1.1, we did not want to change elements of our successful Mz-2 designs that 
were not required to be changed when targeting new NTS. As such, these sequences 
were hard-coded into the Perl scripts, as shown in Table 4.5-3. Should changes to 
these regions (e.g. Stem II sequences) be needed, the user could do a text search for 
the Declaration lines and substitute the existing values between the quotations marks 
for the desired values. 
2) System information such as the Categories of NTS involved, and path information in 
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order for eSRS.pl to access required information, such as where the text file 
containing NTS/NNS information is located, where RNAstructure 4.5 was installed, 
etc. These inputs are shown in 
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Table 4.5-4. As above, these information can be edited. The difference in entering path 
information (except where stated), is that every back slash has to be replaced by two 
back slashes, for e.g. “C:\eSRS\” would become “C:\\eSRS\\”. Other details for 
editing values were given in the table. 
3) NTS sequences for each category, which are not hard-coded as they are likely to 
change with each use of the tool. The sequences for each category have to be 
provided in a tab delimited text file, named and placed in a folder as specified in 
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Table 4.5-4 for System information. In each file, there must be only two columns. The 
first column contains the NTS name, and the second column contains the NTS 
sequence in uppercases. An example for the Dengue category is shown in Table 4.5-5. 
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Table 4.5-3 Sensor regions hard-coded into eSRS.pl. 
Region Variable 
Name 
Default Value Declaration line 














$MzL_stem2 UGA my $MzL_stem2 = "UGA"; 
MzR 
Stem II 








$MzR_RTSrc3 AGUUUCAUA my $MzR_RTSrc3 = 
"AGUUUCAUA"; 
Linker $Loop gaaa my $Loop = "gaaa"; 
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Variable Name Default Value Declaration line 
Categories. @cat Malaria 
Dengue 
my @cat = qw(Malaria Dengue); 
To edit, insert new values 
between “qw(” and “);”. Multiple 
values should be separated by a 









Sequence of path info must 
follow that of categories above 
(i.e. the category listed first must 
also have the path info listed 
first, and so on). 
Use single back slash for path. 



















































$ct_path C:\eSRS\CT\$cat\ my $ct_path = 
"C:\\eSRS\\CT\\$cat\\"; 
Folder for 






my $ct_func_path = 
"C:\\eSRS\\CT\\Functional\\$cat\
\"; 
Note: “$cat” in the last 4 rows should not be edited. It gives the last part of the path information 
that is specific to the category. 
Table 4.5-5 An example of Dengue NTS file for use with eSRS.pl. 





Note: The header row shown here is given for information only and should not be present in the 
NTS file. Columns should be tab delimited, meaning there should be a tab character between 
the NTS name and its sequence on each line. There should be only 1 tab character on each 
line. The NTS file should be saved as a tab delimited text file with a file name and extension as 
given in the “@NTS_path” variable. 
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4.5.2.2.2 Outline of algorithm 
For each Category, 
 Get list of NTS names and sequences into 2D (2 dimensional) array, @NTS. 
o 1st D array contains references to 2nd D arrays, one for each NTS. 
o 2nd D array has 2 elements. 1st element is the NTS name. 2nd element is the 
NTS sequence. 
 Get possible MzL & MzR pairs of Stem II into 2D array, @stem2. 
o 1st D array contains references to 2nd D arrays, one for each possible Stem II. 
In the existing version, only one Stem II (that of Mz-2) was used. 
o 2nd D array has 3 elements. 1st element is the Stem II Name. 2nd and 3rd 
elements are the MzL and MzR Stem II sequence respectively. 
 Stem II Name was given as “<MzL StemII sequence>,<MzR StemII 
sequence>”, for e.g. “UGA,AGCA”. Each MzL and MzR sequence 
was made up to a minimum of 3 characters per stem with extra "-" 
for those with less than 3 characters. 
 For each NTS,  
o Get possible MzL & MzR pairs of sensor arm into 3D array, @NTSrc. 
 1st D array contains references to 2nd D arrays, one for each NTS. 
 2nd D array has 2 or more elements. 1st element is the NTS Name. 
Remaining elements are 3rd D arrays, one for each possible sensor 
arm, generated by setting values of SAS from 1 to (length of 
NTS-1). 
 3rd D array has 3 elements. 1st element is the SAS (possible range is 
01 to 99) for the particular sensor arm. 2nd and 3rd elements are the 
MzL and MzR sensor arm sequences respectively. 
 Get possible MzL & MzR pairs into 4D array, @mz. 
o 1st D array contains references to 2nd D arrays, one for each NTS. 
o 2nd D array has 2 or more elements. 1st element is the NTS Name. Remaining 
elements are references to 3rd D arrays, one for each possible Stem II. 
o 3rd D array has 2 or more elements. 1st element is the StemII Name. 
Remaining elements are references to 4th D arrays, one for each possible 
sensor arm for the current NTS. 
o 4th D array has 3 elements. 1st element is the Mz Name for the current sensor 
arm. 2nd and 3rd elements are the MzL and MzR sequences respectively. 
 Mz Name was given as “Mz_<NTS Name, less "sNTS">_<StemII 
Name>_<SAS (01-99)>", for e.g. Mz_D1_UGA,AGCA_05 and 
Mz_Mfr1_UGA,AGCA_13. 
 MzL and MzR sequences for a particular SAS were obtained by 
joining 4 RNA segments each, as explained in Sections 4.3.6.3.1 and 
4.3.6.3.2 respectively. Briefly: 
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 MzL - 5' catalytic arm; MzL catalytic core; MzL StemII; 3' 
sensor arm. 
 MzR - 5' sensor arm; MzR StemII; MzR catalytic core; 3' 
catalytic arm. 
 For each NTS, 
o Get list of NNS names and sequences into 2D (2 dimensional) array, @NNS. 
 Structure is the same as that of @NTS. 
 Created by copying all elements of @NTS except the element 
containing current NTS. 
o Assess each Mz based sensor design. 
 Get MzL and MzR from @mz. 
 Assemble RNA combination(s) into .seq text files of (RNAstructure 
4.5 format), write to an output folder, and send to RNAstructure 4.5 
to assess activity, in the following order. Should a combination be 




 .seq file Name: <Mz Name>_<T/N/A>_<NTS or NNS Name, less 
"sNTS">.<seq>. E.g.: Mz_D1_UGA,AGCA_05_T_D1.seq 
 <T/N/A> referred to the RNA combination involved. T for 
Mz+NTS+STS, N for Mz+NNS+STS, A (stands for Mz 
alone) for Mz+STS. 
 Each .seq file would be assessed by RNAstructure 4.5, which would 
produce a .ct (Connectivity Table) text file describing its predicted 
secondary structure, and which would be stored in an output folder. 
 .ct file Name: <Mz Name>_<T/N/A>_<NTS or NNS Name, less 
"sNTS">.<ct>. E.g.: Mz_D1_UGA,AGCA_05_T_D1.ct 
 <T/N/A> referred to the RNA combination involved. T for 
Mz+NTS+STS, N for Mz+NNS+STS, A (stands for Mz 
alone) for Mz+STS. 
 Validity of an RNA combination is assessed by examining the .ct 
file. 
 The most stable structure(s) are assessed based on .ct file 
information. 
 Based on the combined length of the structure, the 
minimum requirement for an active structure is calculated 
(as described in Section 4.3.6.4.1) and stored in a 2D array, 
@ss_active. 
o 1st D array contains references to 2nd D arrays, one 
for the pairing condition of each of the 15 bases 
defined as part of the sufficient conditions for an 
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active secondary structure. 
o 2nd D array has 2 elements. 1st element is one of the 
15 bases, the 2nd element is its pairing partner. 
 Each of the most stable structure of each .ct file is scanned 
and compared to @ss_active. For each RNA combination: 
o Mz+NTS+STS 
If any of the most stable structure(s) is inactive, 
design is considered invalid. This is a conservative 
selection criteria favouring more active sensors. 
o Mz+STS 
If any of the most stable structure(s) is active, 
design is considered invalid. This is a conservative 
selection criteria favouring more specific sensors. 
o Mz+NNS+STS 
If any of the most stable structure(s) is active, 
design is considered invalid. This is a conservative 
selection criteria favouring more specific sensors. 
 For each sensor design, details will be written to an output text file 
(see next Section). 
o For valid sensor designs, .seq and .ct files would be moved to a "Functional" 
folder, for ease of reference (amongst the many files generated altogether). 
 
4.5.2.2.3 Outputs produced by algorithm 
There are essentially 3 outputs produced by the Perl script, eSRS.pl. 
1) .seq files. These are eSRS.pl generated text files containing the sequences of a 
particular RNA combinations (Mz+NTS+STS, Mz+STS, or Mz+NNS+STS) for a 
particular Mz based sensor merged into a single RNA sequence with lowercase linker 
sequences “gaaa”. 
a. Not all RNA combinations of a particular sensor design may be present, as 
explained in Section 4.5.2.2.2. 
b. Format follows the RNAstructure 4.5 .seq sequence file format. 
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c. .seq file Name: <Mz Name>_<T/N/A>_<NTS or NNS Name, less 
"sNTS">.<seq>. E.g.: Mz_D1_UGA,AGCA_05_T_D1.seq 
Details were explained in Section 4.5.2.2.1. 
d. Output folder is C:\eSRS\Fold_seq\$cat\, $cat represents the name of the 
category involved, as explained in Section 4.5.2.2.1. 
e. .seq files belonging to valid sensor designs would be moved to 
C:\eSRS\Fold_seq\Functional\$cat\ 
2) .ct files. These are RNAstructure 4.5 generated text files containing the predicted 
secondary structure(s) of a particular RNA combinations (Mz+NTS+STS, Mz+STS, 
or Mz+NNS+STS) for a particular Mz based sensor. 
a. Not all RNA combinations of a particular sensor design may be present, as 
explained in Section 4.5.2.2.2. 
b. Format follows the RNAstructure 4.5 CT (Connectivity Table) file format. 
c. .ct file Name: <Mz Name>_<T/N/A>_<NTS or NNS Name, less 
"sNTS">.<ct>. E.g.: Mz_D1_UGA,AGCA_05_T_D1.ct 
Details were explained in Section 4.5.2.2.1. 
d. Output folder is C:\eSRS\CT\$cat\, $cat represents the name of the category 
involved, as explained in Section 4.5.2.2.1. 
e. .ct files belonging to valid sensor designs would be moved to 
C:\eSRS\CT\Functional\$cat\ 
3) e-SRS Sensor sequence files. These are eSRS.pl generated tab delimited text files 
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containing the sequences and other information of all designed Mz based sensor for 
each category (one file per category). They can be easily viewed with Microsoft 
Excel. 
a. The format and information contained are illustrated in Table 4.5-6. 
i. Each row represents the values for one Mz based sensor design, of 
the Category given in the “Category” column. 
ii. MzL or MzR Name were given as “Mz<L or R>_<NTS Name, less 
"sNTS">_<StemII Name>_<SAS (01-99)>", for e.g. 
MzL_D1_UGA,AGCA_05 and MzR_D1_UGA,AGCA_05. 
iii. “MzL” and “MzR” Columns give the MzL and MzR RNA 
sequences (5’ to 3’) respectively. 
iv. After the “MzR” column follows a number of pairs of “NTS” and 
“Energy” Columns, one pair for each RNA combination in the 
Category. This would mean (n+1) pairs where n is the number of 
NTS in the Category. For e.g., Dengue (four NTS) with five RNA 
combinations would have five such pairs. 
1. Each pair indicates for a particular RNA combination, in the 
“NTS” column, the NTS Name for the NTS (or NNS) 
present, and in the “Energy” column, the free energy (in 
kcal/mol) predicted by RNAstructure 4.5 for its most stable 
structure. 
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2. The first pair indicates the values for Mz+NTS+STS. 
3. The second pair indicates the values for Mz+STS. The NTS 
Name would be given as “A” for Mz alone (i.e., without 
NTS or NNS). 
4. The remaining pairs would be values for Mz+NNS+STS, 
one for each NNS. 
v. The RNA combinations would be assessed in an order as explained 
in Section 4.5.2.2.2. 
1. The first RNA combination that failed to meet design 
requirements would have an “!” indicated for its “Energy” 
column. 
2. Following combinations would not be assessed and would 
have values of “-” for both “NTS” (except in the case of 
Mz+STS, which would still have “A”) and “Energy” 
Columns. 
3. An Mz based sensor design would be considered valid if it 
has numerical values for all “Energy” columns designs. It 
should have no “!” or “-” values. 
b. Output folder is C:\eSRS\Sensor_Seq\, $cat represents the name of the 
category involved, as explained in Section 4.5.2.2.1. 
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MzR NTS Energy NTS Energy 
         
Note: Header names are approximate only and actually output may differ slightly. Two pairs of 
“NTS” and “Energy” Columns are shown here. Actual number of such pairs would be (n+1) 
where n is the number of NTS in the Category. 
4.5.2.2.4 Strategies and guidelines for selecting from valid sensors. 
Our algorithm outputs sensor designs that are predicted to be valid for their given NTS and 
NNS. The valid sensor designs for Dengue and Malaria are shown in Table A 5 and Table A 6 
respectively. As these results demonstrate, each NTS may have more than one valid design, 
indeed, for the Dengue category, there were between 4 to 13 valid designs for each NTS. 
With limited resources, we employed the following selection strategies and guidelines to 
select one sensor per NTS for in-vitro testing. If upon in-vitro testing, any sensor was found 
unsatisfactory, by being 1) of low activity in detecting NTS, or 2) of exhibiting non-specific 
activity in the presence of NNS, or both, corresponding strategies (i.e. to increase specific 
activity or decrease non specific activity) from the following were used to select a new sensor. 
To predict the relative activities of different RNA combinations, which we associate with their 
stability, we created an index called the Stability Buffer (SB). This indicated how much 
“buffer” the most stable structure had for it to stay in its conformation, and thus how stable 
that particular structure was likely to be. To appreciate this concept, one should bear in mind 
the dynamic nature of most RNA secondary structures. As explained in Section 4.3.6.1, each 
RNA combination could have more than one predicted secondary structure, each with a 
particular free energy that indicates its stability. Thus although all sensor designs considered at 
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this stage fit the validity criteria in having most stable Mz+NTS+STS structures that are active 
and most stable Mz+NNS+STS and Mz+STS structures that inactive, there could be 
undesirable active or inactive structures (as befit each combination) of lower stability. Such 
less stable structures might still have a chance of forming, which leads to either lower specific 
activity (for Mz+NTS+STS) or higher non-specific activity (for Mz+NTS+STS and Mz+STS), 
and thus should be kept to a minimum. 
SB then measures the magnitude of the free energy difference between the most stable 
structure and the most stable undesired structure. It can be measured for all three RNA 
combinations: 
1) For Mz+NTS+STS, it is the difference between the most stable structure (active) and 
the most stable inactive (MSI) structure. 
2) For Mz+NNS+STS and Mz+STS, it is the difference between the most stable 
structure (inactive) and the most stable active (MSA) structure. 
MSA)or  (MSIEnergy  - structure) stable(most Energy   SB   
Note: if MSI or MSA structures are not predicted, their free energies were assumed to be zero. 
The larger the SB, the more likely the most stable (and desired) structure will be formed.  
SB% is SB calculated as a percentage of the free energy value of the most stable structure. 
structure) stable(most Energy 
SB 100%  SB%   
The larger the SB%, the greater the proportion of structures formed that is in the most stable 
(and desired) conformation. SB% allows the relative stability of different sensor designs to be 
compared to each other. 
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To increase rate of specific reaction, we select for sensor designs with greater SB% and SB of 
Mz+NTS+STS structure. This is so that more active Mz+NTS+STS structures would be 
formed, giving a greater reaction rate for STS cleavage, given that other factors are not 
limiting. 
To increase specificity (i.e. to reduce non-specific activity against a particular NNS), we select 
for sensor designs with: 
1) Absence of active conformation in the Mz+NNS+STS or Mz+STS structures 
predicted. As explained above, such active structures could contribute to non-specific 
activity (i.e. activity in the presence of NNS) and thus should be kept to a minimum. 
If such structures are present, then: 
a. The SB% should be as high as possible, so as to keep the proportion of 
inactive structures as high as possible. 
b. Such structures being ranked in stability as many ranks behind the most 
stable structure as possible. 
c. Having as little such structures as possible. 
2) The most stable inactive Mz+NNS+STS for NNS concerned. If an Mz+NNS+STS 
structure is highly stable in an inactive conformation, the structure would be “locked” 
(i.e. unlikely to change out of such structure) in an inactive conformation and thus not 
contribute to non-specific activity. 
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4.5.3 Sequences of Mz based sensors 
Mz based sensors were designed for Dengue and Malaria targets using above software. 
For each NTS of the Dengue and Malaria category, valid sensor designs for Dengue and 
Malaria were obtained as shown in Table A 5 and Table A 6 respectively. Following the 
strategies and guidelines above, specific Mz based sensor were manually selected from the 
pool of valid designs and sent for synthesis. The final list of MzL and MzR sequences used 
and their respective NTS are as shown in Table 4.3-8. All RNA oligonucleotides (including 
STS, MzL, MzR, NTS, NNS) were synthesised commercially with HPLC purification.
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Table 4.5-7 Final selection of MzL and MzR sequences. 




















































































STS used were all RTS-2. The unit of SB is kcal/mol 
4.5.4 Detection of Dengue Serotypes D1, D2, D3, D4 sNTS. 
We were able to distinguish between sNTS of D1, D2, D3, and D4 (sNTS-D1, sNTS-D2, 
sNTS-D3, and sNTS-D4) using their specific Mz, Mz-D1, Mz-D2, Mz-D3, and Mz-D4 
respectively. As shown in  
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Figure 4.5-1, RTA assays were specific for each Mz. These results are representative of at 
least 3 repeats. 
Optimised reactions conditions for all Dengue Mz based sensors were 200 nM Mz, 200 nM 


























Mz-D1, Mz-D2, Mz-D3, Mz-D4 vs NNS or H2O.
 
Figure 4.5-1 RTA results for sNTS using Mz based sensors for Dengue. 
The RTA result for each Mz-based sensor was colour coded: Red for Mz-D1; Blue for Mz-D2; 
Green for Mz-D3; Orange for Mz-D4. Each sensor was tested against all conditions, i.e. vs NTS; 
vs NNS; vs H2O (i.e. alone). Separations of the fluorescence curves for sensors vs NTS and 
those vs NNS or H2O were clear. The RTA responses of all sensors vs NNS or H2O were 
essentially at background levels. Hollow points indicate averaged replacement values for 
values that reached saturation (for Mz-D1 vs sNTS-D1). 
4.5.5 Detection of Malaria Strains Mfs, Mfr1, Mfr2 sNTS. 
We were able to distinguish between sNTS of Mfs, Mfr1, and Mfr2 (sNTS-Mfs, sNTS-Mfr1, 
and sNTS-Mfr2) using their specific Mz, Mz-Mfs, Mz-Mfr1, and Mz-Mfr2 respectively. As 
shown in  
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Figure 4.5-2, RTA assays were specific for each Mz. These results were representative of at 
least 3 repeats. 
In the cases of Mz-Mfs and Mz-Mfr1, we initially had difficulty in differentiating between 
sNTS-Mfr1 and sNTS-Mfs. We attempted to improve specificity by optimising Mg2+ 
concentration (from 2mM to 10 mM in steps of 1mM, and then from 1 to 2 mM in steps of 0.2 
mM) and incubation temperature (37, 39.5, 42 °C). While changing incubation temperature 
did not seem to improve specificity, reducing Mg2+ improved specificity for both. However, 
only Mz-Mfs became totally specific at 2 mM Mg2+. Mz-Mfr1 seemed most specific at 3 mM 
Mg2+ but still showed too much activation against sNTS-Mfs. 
Subsequently, we discovered that when sNTS-Mfr2 was added into the RTA mix for Mz-Mfr1, 
it reduced the signal for reactions against sNTS-Mfs (i.e., the NNS), while not significantly 
reducing that against sNTS-Mfr1 (i.e., the NTS). sNTS-Mfr2 seemed to act as a “competitor 
nucleotide” (CN) against both NTS and NNS for their binding for Mz, but with a greater 
reduction of the NNS (sNTS-Mfs) affinity for Mz-Mfr1, than that of the NTS affinity for 
Mz-Mfr1. The critical issue was thus to add just the right amount of CN that would derive the 
maximum affinity reduction for the NNS with the least impact on NTS affinity to the Mz. 
Hence, to improve the specificity of Mz-Mfr1 to acceptable levels, we optimised the 
concentration of the competitor nucleotide sNTS-Mfr2 added to the RTA (testing 0, 20, 100, 
200, 400, 1000, 2000, 4000, 10000, 20000 nM). We discovered that 2000 nM of sNTS-Mfr2 
added to RTA for Mz-Mfr1 made it specific enough to distinguish the NTS (sNTS-Mfr1) from 
NNS (sNTS-Mfr2). 
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Optimised reactions conditions were as follows: 
For sNTS-Mfs: 
200 nM Mz, 200 nM sNTS, 1000 nM RTS-2, 50 mM Tris (pH 8.0), 2 mM MgCl2, and 
incubation at 37 C. 
For sNTS-Mfr1: 
200 nM Mz, 200 nM sNTS, 1000 nM RTS-2, 50 mM Tris (pH 8.0), 3 mM MgCl2, 2000 nM 
sNTS-Mfr2 (as CN to improve specificity), and incubation at 37 C. 
For sNTS-Mfr2: 
200 nM Mz, 200 nM sNTS, 1000 nM RTS-2, 50 mM Tris (pH 8.0), 3 mM MgCl2, and 



























Mz-Mfs, Mz-Mfr1, Mz-Mfr2 vs sNNS or H2O.
 
Figure 4.5-2 RTA results for sNTS using Mz based sensors for Malaria. 
The RTA result for each Mz-based sensor was colour coded: Red for Mz-Mfs; Blue for Mz-Mfr1; 
Green for Mz-Mfr2. Each sensor was tested against all conditions, i.e. vs sNTS ; vs sNNS; vs 
H2O (i.e. alone). The points for sNTS, sNNS, and H2O were marked with diamonds, crosses, 
and dashes (-) respectively. Separations of the fluorescence curves for sensors vs sNTS and 
those vs sNNS or H2O were clear. The RTA responses of all sensors vs sNNS or H2O were 
essentially at background levels, and were labelled on the graph together as “Mz-Mfs, Mz-Mfr1, 
Mz-Mfr2 vs sNNS or H2O.”. 
4.5.6 Detection of Malaria Strains Mfs, Mfr1, Mfr2 NASBA NTS. 
4.5.6.1 Use of NASBA to detection DNA NTS. 
One way to distinguish between genomic DNA of Mfs, Mfr1, and Mfr2 was to amplify 
desired genomic segments into RNA via a process called NASBA. NASBA is a 41 °C 
isothermal reaction that uses a forward (with T7 promoter attached) and reverse primer to 
produce from the NASBA template, a DNA amplicon (with T7 promoter attached) that can 
then transcribe many RNA copies of the amplicon (less the T7 promoter region). 
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The starting NASBA template can be an RNA, in which case the included Avian 
Myeloblastosis Virus Reverse Transcriptase (AMV-RT) creates a DNA copy using the forward 
primer. The RNA from this DNA-RNA duplex is then digested by the included RNase H. The 
AMV-RT then reverse transcribe this DNA strand into a double stranded version (using the 
reverse primer), which serves as an in-vitro transcription (IVT) template. If the starting 
template is genomic or other double stranded DNA, an initial denaturation is required, after 
which AMV-RT would also create a suitable IVT template using the forward primer. From the 
IVT template, many copies of the RNA amplicon would be transcribed by the included T7 
RNA polymerase. More IVT templates would be produced from the RNA amplicons, thereby 
generating an amplification cycle with an amplification factor of 106 to 109 in 90 minutes. 
After NASBA is performed, the RNA in the NASBA product can then be subjected to e-SRS 
detection in a NASBA RTA reaction. 
4.5.6.2 Cloning of NTS segment from genome into plasmids. 
To test this approach, we first cloned a segment of the 3 Plasmodium falciparum strains’ 
genomes containing the NTS into plasmids. We managed to PCR out approximately 200 nt 
amplicons using primers Mal Fwd 02 and Mal Rvs 01 for Mfs and Mfr1, and Mal Fwd 01 and 
Mal Rvs 01 for Mfr2. Mal Fwd 02 added an additional T7 promoter sequence used in NASBA 
to the amplicon. These amplicons were gel purified and cloned into pGEM-T Easy vectors. 
The plasmids were then sequenced with both forward and reverse vector primers to ensure 
amplification were what we expected and thus contained original sequences of NTS. 
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Oligonucleotide information were as shown in Table A 7. Using these plasmids, we performed 
NASBA template synthesis via PCR (Elongase Enzyme Mix) with primers Mal Fwd 02 and 
Mal Rvs 01. PCR products of the right sizes (223 nt) were gel purified and served as NASBA 
templates. 
4.5.6.3 Initial tests of NASBA RTA. 
We performed 90 minutes of NASBA using 6x105, 6x107, and 6x109 copies of NASBA 
template per μl of NASBA reaction. 1 μl of these NASBA products were used in 50 μl of 
NASBA RTA reaction. As NASBA was supposed to provide amplification of 106 to 109 in 90 
minutes, only about 6.022 x 103 to 6.022 x 106 of NASBA template per μl NASBA reaction 
was required to produce the standard 200 nM of NTS that was routinely detectable in sNTS 
RTA. However, NASBA RTA produced no specific signals for all three NTS (Mfs, Mfr1, 
Mfr2). 
We tried to improve NASBA efficiency via reducing the size of the NASBA amplicons by 
selecting another forward primer, Mal Fwd 03. Using Mal Fwd 03 and Mal Rvs 01, shorter 
DNA and RNA amplicons were generated (142 and 120 nt respectively, as compared to 223 
and 201 nt previously). Oligonucleotide information were as shown in Table 4.5-8. 
Using the new primers, we repeated the entire process from NASBA template synthesis to 
NASBA RTA, but still did not obtain any specific NASBA RTA signals. 
Table 4.5-8 Oligonucleotides for NASBA RTA of Mfs, Mfr1, Mfr2. 
Oligonucleo
tides 




Role Sequence (5’ to 3’) Length (nt)












NASBA template and 




Mal Fwd 03 










NASBA RNA amplicon 
using primers: 
Mal Fwd 03 







NASBA DNA and RNA Amplicons shown were those for Mfs. Those for Mfr1 and Mfr2 were of 
the same length, with a few different bases at the NTS region. The grey highlight indicated the 
NTS detection region. 
In order to further ascertain that the lack of RTA signal was not due to insufficient NTS 
concentration, we tried to further increase the concentration of NASBA NTS (nNTS) in RTA 
by increasing the amount of NASBA product used in RTA. From the previous 1 μl NASBA 
product in 50 μl of RTA reaction, we tested 1, 5, 10, and 15 μl NASBA products, using the 
previous maximum of 6x109 copies of NASBA template per μl of NASBA reaction. If the 
NASBA process performed as claimed by the kit manufacturer, these parameters would 
provided estimated concentrations of NTS far in excess of what worked well for sNTS RTA 
(200 nM). The estimated nNTS concentrations were as shown in Table 4.5-9. To obtain the 
NTS concentration for RTA, the following formula was used: 
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)10 x (6.022number  Avogadro x (L) RTA volume
factorion Amplificat x Lper   templatestarting x (L)product NASBA  23
 
Table 4.5-9 Estimated nNTS concentrations achieved in RTA. 
RTA NTS Concentration (mM) with amplification factor of Volume of NASBA product (ul) 
106 109 
 
1 0.2 199.3 
5 1.0 996.3 
10 2.0 1992.7 
15 3.0 2989.0 
NASBA was done with starting template of 6 x 109 Copies / μl. RTA reaction volume was 50 μl. 
However, the RTA results showed that no specific signals were obtained, although the RTA 
signals appeared to increase somewhat for greater volumes of NASBA products used, 
including NASBA water (i.e. NASBA reaction with no starting template), which showed that 
NASBA reagents might somehow contribute to signals in RTA. 
4.5.6.4 Use of Antisense oligonucleotides to activate detection of long 
NTS from NASBA. 
As this stage, we believed that insufficient NTS concentration was unlikely to be the cause of 
the lack of RTA activation, and suspected that the problem was likely due to secondary 
structures obstructing the Mz binding site (i.e. the NTS), which could be a common issue 
when attempting to detect long NTS. We decided to try to improve access to the NTS by 
adding antisense oligonucleotides (AS) that could bind to sequences close to and flanking the 
NTS. Upon binding of the AS, the secondary structure that previously obscured the NTS 
would be at least partially denatured, thus improving access to the NTS by the e-SRS. In 
addition, as RNase H was provided by in NASBA, RNase H digestion of the RNA strand at 
the DNA/RNA duplex regions flanking the NTS (where the AS bind) would release the NTS 
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as a sNTS, thus allowing RTA to proceed as if sNTS were supplied (instead of long NTS). 
However, if the RNase H digest occurred during NASBA, it could very well reduce the 
amplification factor during NASBA, as additional IVT template would not be generated from 
the digested RNA. 
4.5.6.4.1 NASBA with AS added during or after NASBA. 
As such, we decided to conduct a series of NASBA reactions with AS present during the 
NASBA reaction, and another series of NASBA reactions where the AS were added after the 
NASBA reaction. 
5’ and 3’ AS, Mal Rvs 194-215, Mal Rvs 242-271 were designed and used for this experiment 
(AS information was as shown in Table 3.4-5). 
For AS present during NASBA, 7 μl reactions with 4.2 x1010 gel purified DNA template using 
primers F3R1 were performed. Final AS concentrations were 100 μM, 10 μM, 100 nM, and 1 
nM. NASBA was conducted at 41°C for about 1.5 hours. 
For AS added after NASBA, 10 μl reactions with 6.0x1010 GP DNA (previously performed) 
using primers F3R1 were performed. NASBA was conducted at 41°C for about 1.5 hours. 
Subsequently, 5.6 μl of NASBA product was added to 1.4 μl of AS and incubated at 41°C for 
2 hours for denaturation with AS. Final AS concentrations were 10 μM, 100 nM, and 1 nM. 
4.5.6.4.2 NASBA RTA with AS added during or after NASBA. 
 
9 NASBA RTA was conducted as before with the exception of using 5 μl of NASBA product, 
some of which had AS added (either during or after NASBA, as describe above). The 
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reactions were as follows: 
For AS added during NASBA: 4 Mz+NTS+STS reactions with 100 μM, 10 μM, 100 nM, and 
1 nM of AS. 
For AS added after NASBA: 3 Mz+NTS+STS reactions with 10 μM, 100 nM, and 1 nM of 
AS. 
In addition, there was 1 Mz+NTS+STS reaction with no AS added, and 1 Mz+STS reaction 
with 10 μM AS. 
In parallel, 4 sNTS Mfs RTA was also conducted to observe the possible effects of NASBA on 
the previously optimised sNTS Mfs RTA. The sNTS RTA were conducted as before, with the 
exception of adding various amount of AS. The reactions were as follows: 
2 Mz+NTS+STS reactions with 100 μM, and 10 μM of AS. 
1 Mz+NTS+STS reactions with no AS. 
1 Mz+STS reaction with no AS. 
As shown in Figure 4.5-3 and Figure 4.5-4, for 10 μM and 100 μM AS NASBA RTA 
reactions, specific RTA signals were obtained, indicating that such concentration of AS could 
indeed help activate RTA, regardless of whether they were added during or after NASBA 
reactions (for 10 μM AS). 
However, the remaining concentrations of AS (100, 1, 0 nM) did not help to activate NASBA 
RTA. About 8 minutes into the RTA, these reactions still did not show any specific signals, 
whereas those reactions that did show specific signals activated as soon as observation started. 
To further verify the ability of AS to help activate NASBA RTA, the RTA measurement was 
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temporarily suspended, the plate extracted, and an additional 100 μM AS was quickly added 
(by addition of 5 μl 1000 μM AS to existing reaction) to the following reactions that had not 
activated: 
At 839.0 s, to the 2 NASBA RTA 1 nM AS reactions. 
At 1210 s, to sNTS RTA water reaction (Mz+STS) with no AS. 
At 2199 s, to NASBA RTA with no AS, and NASBA water (Mz+STS) with 10 μM AS.  
Upon addition of AS, the RTA plate was returned to the fluorometer and measurements 
resumed. 
For the NASBA RTA Mz+NTS+STS with 1 nM and 0 nM AS reactions, there were no signs 
of any specific signals until the additional 100 μM AS were added (about 14 and 36 minutes 
respectively into the RTA). After addition of AS, specific signals were detected immediately 
upon replacement of the RTA plate into the fluorometer and resumption of fluorescence 
measurement. 
The fact that similar addition of AS into sNTS RTA (Figure 4.5-5) and NASBA RTA water 
reactions about 20 and 36 minutes respectively into the RTA, had no activation effect on RTA 
indicated that the AS themselves did not activate the cleavage of RS. In addition, as shown in 
Figure 4.5-5, the presence of 100 μM and 10 μM of AS in sNTS RTA of Mfs did not 
significantly affect the RTA results as compared to sNTS RTA with no AS. 
The observed immediate effect of AS on inducing RTA signal implied that the denaturation 
action of AS were almost immediate and suggested that AS functioned via simple AS pairing 
with nNTS (resulting in denaturation of secondary structures around the NTS) rather than via 
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RNase H action. 
Figure 4.5-3 RTA results for NASBA RTA (with AS added during NASBA) 
using Mz based sensors for Mfs. 
Arrows indicated the addition of 100 μM AS. Labels and arrows were the same colours as the 
lines they applied to. Hollow points indicate averaged replacement values for values that 
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Figure 4.5-4 RTA results for NASBA RTA (with AS added after NASBA) using Mz 
based sensors for Mfs. 
Arrows indicated the addition of 100 μM AS. Labels, arrows and lines were given the same 
colour for the results of the same Mz based sensor. X-Axis was in seconds. Y-Axis was in 
relative fluorescence units. 
Figure 4.5-5 RTA results for sNTS RTA (with some AS added in RTA) using Mz based 
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Arrows indicated the addition of 100 μM AS. Labels and arrows were the same colours as the 
lines they applied to. X-Axis was in seconds. Y-Axis was in relative fluorescence units. 
The results of this experiment indicated that denaturation via addition of AS appeared to be a 
good method for overcoming issues of secondary structure obscuring the NTS when dealing 
with long NTS RTA. 
4.5.6.5 Optimised conditions for NASBA RTA (AS added at RTA). 
Since AS denaturation appeared effective even when added after NASBA, we decided to 
perform AS denaturation by adding AS to the NASBA products, with incubation at 70 C for 
2 minutes, followed by immediate incubation on ice before use. This process was effective. 
After testing of various concentrations and sequences to use as AS, we eventually used a 5 μl 
denaturation mix with 3 μl NASBA product, 0.75 μl each of 100 μM 5’ and 3’ AS (final 
concentration of 15 μM), and 0.5 μl of DEPC treated water. 3 different AS sequences were 
used as shown in Table 4.5-10. 
Table 4.5-10 Oligonucleotides in NASBA RTA. 
Oligonucl
eotides 
Role Sequence (5’ to 3’) Length (nt)
Mal Rvs 
194-215 
5’ AS for Mfr2. CATACACTTAAATAAATAATAC 22 
Mal Rvs 
206-214 






















Role Sequence (5’ to 3’) Length (nt)
NASBA F3R1 
DNA 






























NASBA DNA Amplicon shown was that for Mfs. Those for Mfr1 and Mfr2 were of the same 
length, with a few different bases at the NTS region. The grey highlight indicated the NTS 
detection region, which are bases 40 to 63 of the NASBA RNA amplicon. Underlined 
sequences were those that differed amongst the 3 NTS. The yellow and green highlights 
indicated the regions where the 5’ and 3’ AS bind respectively. 
Eventually, we were able to distinguish between NASBA amplified NTS (in the form of DNA 
amplified from regions of genomic DNA) of Mfs, Mfr1, and Mfr2 (N-Mfs, N-Mfr1, and 
N-Mfr2) by their using specific Mz based e-SRS sensors, for Mz-Mfs and Mz-Mfr2. As 
shown in  
Figure 4.5-6, RTA assays were specific for each Mz. These results were representative of at 
least 3 repeats. 
To distinguish between NASBA amplified NTS of Mfs and Mfr1 (N-Mfs and N-Mfr1) using 
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Mz-Mfr1, we were only able to perform one repeat, due to exhaustion of reagents. If more 
reagents were available, we would extent the incubation during to 6 hours and for another 3 
repeats. 
Optimised reactions conditions were as follows: 
For NASBA NTS-Mfs: 
200 nM Mz, 3 μl NASBA NTS, 1000 nM RTS-2, 50 mM Tris (pH 8.0), 2 mM MgCl2, and 
incubation at 37 C. 
For NASBA NTS-Mfr1: 
200 nM Mz, 3 μl NASBA NTS, 1000 nM RTS-2, 50 mM Tris (pH 8.0), 3 mM MgCl2, 2000 
nM sNTS-Mfr2 (to improve specificity), and incubation at 37 C for at least 6 hours. 
For NASBA NTS-Mfr2: 
200 nM Mz, 3 μl NASBA NTS, 1000 nM RTS-2, 50 mM Tris (pH 8.0), 3 mM MgCl2, and 
incubation at 37 C. 
Each of the NASBA NTS should be denatured at 70 C for 2 mins with 10 μM of AS (Mal 


























Mz-Mfs, Mz-Mfr2 vs NNS or H2O.
 
Figure 4.5-6 RTA results for NASBA amplified NTS using Mz based sensors for Mfs and 
Mfr2. 


























Figure 4.5-7 RTA results for NASBA amplified NTS using Mz based sensors for Mfr1. 
Separation of the signal between Mfr1 and Mfs is expected to increase with increased 
incubation time, as the fluorescence curve for Mfs remained flat (at 7000 s) while that for Mfr1 
was rising steadily. 
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CHAPTER 5 DISCUSSIONS 
5.1 Overview of project. 
As summarised in Figure 5.1-1, e-SRS development can be broadly viewed as 3 major phases, 
1) the initial design and testing of an intelligent gene expression platform known as e-SIGE, 2) 
the design and testing of the present e-SRS, and 3) application of e-SRS in the detection of 
Nucleic Acids in test tubes using RSs. 
The following sections will discuss what we learnt from some of the important problems 
encountered, and their solutions. The relevance of e-SRS as a molecular gene detection 
method, particularly as it pertains to Malaria diagnosis would be discussed. Finally, future 







e-SIGE - Initial 







Designed e-SIGE system [4.1] with sequences for a basic design, Integrated RNA 
silencing Construct (IRC). Aim 1a and 1b designed to test key elements of IRC 
mechanisms [4.2]. 
 
Synthesised Aim 1a and 1b contructs [4.2.2]. 
Problem: Assembly PCR yielded many sequence errors. 
Action: “Gene synthesis via oligonucleotide ligation”. 
 
Tested IRC via Ribozyme Cis-cleavage Assays (RCA) [4.2.3]. 
RCA results analysed via Denaturing PAGE were mostly unexpected. 
 
Conclusions: 1) Initial e-SIGE sensor was unworkable. 2) New assay needed for 
analysing RCA that gave clear and immediate signals, and did not involve gel 




based sensors to 
replace e-SIGE. 
Designed e-SRS system [4.3] using modification of allosteric ribozyme, the 
Maxizyme (Mz). Created RS [4.3.2] to assay Ribozyme Trans-cleavage Assays 
(RTA). 
 
Successfully tested e-SRS RTA in vitro with RS [4.3.8]. 
 
Tested e-SRS in cell lines to: 
1. Activate inducible gene system [4.4.1]. 
Problem: Mz-based sensors did not activate e-SRS. 
Action: Focused on using the simpler HH-2 ribozyme instead. 
Problem: Transfected HH-2 RNA did not activate e-SRS. 
Action: Expressed HH-2 with tRNA promoter, T7 RNA Pol promoter. 
2. Activate RS [4.4.2]. 
Problem: RS degraded when transfected. 
Action: Added nuclease protection to RS. 
Problem: RS degraded by DMEM despite nuclease protection. 
Action: Removed DMEM during transfection. 
 
Conclusions: 1) RS likely degraded in cells. 2) Therefore, it was best to develop 
e-SRS for in vitro applications. 
 
e-SRS for in 
vitro nucleic 
acid detection 
using RS [4.5]. 
Designed Mz-based e-SRS sensors for 3 Malaria & 4 Dengue targets [4.5.2]. 
Problem: Too many Mz-based sensor designs to manually generate & assess. 
Action: Computational algorithm to greatly automate the design and 
assessment of Mz-based sensors. 
 
Tested e-SRS RTA [4.5.4, 4.5.5]. 
Problem: Mz-Mfr1 unable to distinguish 1 nt difference. 
Action: Added “competitor nucleotide” to improve specificity. 
 
Tested Malaria e-SRS via NASBA RTA [4.5.6]. 
Problem: NASBA products did not activate RTA. 
Action: Added antisense DNA to remove interfering secondary structures. 
 
Conclusions: 1) Malaria & Dengue RTA works. 2) Malaria NASBA RTA 
specific for 2 strains. 
 
Figure 5.1-1 Overview of e-SRS development (relevant Sections in square brackets). 
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5.2 Gene synthesis via oligonucleotide ligation . 
In Section 4.2.2, we attempted to synthesise double stranded DNA templates of our test 
constructs via assemebly PCR. Surprisingly, this long established technique, which had been 
used to synthesise genes as long as 3 kb in a single step [Stemmer et al, 1995] failed to 
produce a single sequenced clone with correct DNA sequence for our short constructs. Many 
of these clones had stretches of missing segments. For the 89 nt DNA template of HP-LR-CS, 
we were able to extend a 70 nt middle segment by end primers, using 2 rounds of PCR. 
However, an attempt to repeat this method for the 184 nt DNA template of T1a (even with 
PAGE purification of synthesized oligonucleotide) produced similar sequence errors as in 
assembly PCR. 
The problem was unlikely to be due to routine DNA polymerase insertion error as our 
amplicons were relatively short, and we also eventually used high fidelity DNA polymerases 
(Elongase Enzyme Mix from Invitrogen and PfuTurbo DNA polymerase from Stratagene). 
Rather, we suspected that it was the large degree of secondary structures present in our test 
constructs that caused DNA polymerases to skip certain areas of tight secondary structures 
and thus resulted in the missing segments. 
In contrast, the DNA ligation method, Gene Synthesis via Oligonucleotide Ligation that we used 
to synthesise the remaining constructs easily and quickly produced clones with correct 
sequences. The execution of Gene Synthesis via Oligonucleotide Ligation (as described in 
Sections 3.1.9 and 4.2.2.3) was possibly even simpler than that of assembly PCR, which 
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required two rounds of PCR. Gene Synthesis via Oligonucleotide Ligation required only one 
step to anneal (in about 1 hour) all required oligonucleotides, and then an overnight 16 °C 
ligation of an aliquot of annealed oligonucleotides. The generation of ligation 
oligonucleotides was also fairly simple, with lengths between about 40 to 70 nts and overlaps 
of 15 nt. We did not take extra precautions to avoid secondary structures at overlap regions. 
A potential feature of Gene Synthesis via Oligonucleotide Ligation that makes it particularly 
suitable for templates with regions of sequence similarity (as is the case for highly structured 
templates) is that the annealing process is performed from an intial (denaturating) temperature 
of 95 °C to an end point of 25 °C at a gradual pace that drops 0.02 °C per second (which can 
be done in many thermal cycler). This gradual annealing should allow better annealing 
accuracy than the typical fast annealing process in each amplification cycle of a typical PCR. 
The initial stage of assembly PCR involves assembly of an incomplete template, i.e. a 
semi-double stranded DNA template that has single stranded regions. These single stranded 
areas are more likely to form secondary structures and thus any PCR based methods utilising 
incomplete templates are particularly unsuitable for highly structured constructs. 
In addition, as PCR tend to favour shorter amplicons (such as those with skipped regions), 
incorrect sequences with skipped regions tend to be selectively amplified. There is no such 
selective generation of incorrect sequences for Gene Synthesis via Oligonucleotide Ligation. 
In this work, Gene Synthesis via Oligonucleotide Ligation successfully synthesised up to 200 
nt long DNA templates with high degree of secondary structures using commercially 
synthesised unpurified oligonucleotides. This technique also yielded a large percentage of 
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constructs with correct sequences. We thus believe that Gene Synthesis via Oligonucleotide 
Ligation can serve as a simple and cost effective way for gene synthesis, particularly those 
sequences with significant secondary structures. 
5.3 Computational algorithm to optimise & assess 
Maxizyme designs. 
Traditionally, the instruction for Maxizyme (Mz) design (given a specific NTS and STS) in 
the literature [Tanabe et al, 2000; Kuwabara et al, 1998 (Figure 1b)] provides only a 
fundamental principle that for a valid design, in the presence of NTS, an active secondary 
structure should be most stable (i.e. lowest free energy), and that in the absence of NTS or 
presence of NNS, an inactive secondary structure should be most stable. This fundamental 
principle was elaborated upon in Section 4.3.6.1. As to how such a valid design could be 
obtained, after deciding on the NTS, NNS, and STS, the existing literature did not seem to 
elaborate on, and it seemed mainly a process of trial and error, where Mz sequences were 
adjusted until some valid design(s) emerged in the secondary structure prediction programme. 
We initially also designed our Mz-based sensors via some trial and error based adjustment of 
invalid designs until we obtained valid designs (Section 4.3.6.4.2). In the process, we came up 
with some general strategies & guidelines for achieving desired secondary structures. 
However, these guidelines were merely that, and as expected, they quite often do not 
immediately lead to a valid design the first time. There were still a significant amount of trial 
and error adjustments of Mz-based sensor designs. As such, when the number of categories 
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and NTS increased, the amount of design work increased greatly (as explained in Section 
4.5.2), and we decided to create a computational algorithm to automate much of the design 
work. 
The first step involved making a definition of active and inactive secondary structure that 
could be computationally assessed (Section 4.3.6.4.1). To do that, we had to first analyse the 
anatomy of the Mz to delineate the functions of various regions, particularly those responsible 
for catalytic activity (Section 4.3.6.2). We placed priority on specificity over sensitivity as the 
strength of e-SRS lies in its ability to distinguish between closely related nucleic acid 
sequences. This meant that emphasis was placed on avoiding false positives of specific Mz 
designs, i.e. where RNA combinations without NTS (intended and predicted to be inactive) 
were actually active. In other words, any structure that had any chance at all of being active 
should be declared as active in our algorithm. As such, we established the definition of an 
active structure as the bare minimum required for a Mz to cleave STS. All other structures 
were considered inactive. 
With a computationally assessable definition of an active structure, all that was needed was to 
create (and then assess) all possible Mz designs (given the NTS and STS). As described in 
Section 4.5.2.1.1, this could be done by varying three factors: 1) Sensor arm, particularly the 
SAS, 2) Catalytic arm, particularly the Catalytic Arm Split, and 3) Stem II sequences. 
However, in order to have the greatest chance of success, we kept unchanged as many aspects 
of our functionally successful Mz-2 design as possible. Therefore, our algorithm only tested 
each possible SAS to gather valid designs. 
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Our computational algorithm did not only reduce the manual design work. As it performs an 
exhaustive scan of all the possible designs by using all possible SAS, it also produces all the 
valid Mz designs possible within the given boundaries. If more than one valid design was 
available, one could select all or the preferred ones for in vitro testing. This should 
significantly improve the chances of finding the optimal Mz compared to manual trial and 
error based Mz design. Since there were often more than one valid design per NTS, we also 
came up with some strategies and guidelines for selecting amongst the valid designs (Section 
4.5.2.2.4). 
Since this was our first computational algorithm for designing Mz-based e-SRS sensor, there 
are certainly many areas for improvement. An improved version of the algorithm could 
include: 
1) The ability to insert desired STS. Currently, the STS is fixed. 
2) The ability to allow scanning of all possible Catalytic Arm Split by varying the STS 
sequence around all potential cleavage sites on STS. 
3) The ability to insert the desired Stem II sequences. 
4) The ability to exhaustively scan all possible Stem II sequences limited by the length 
of each strand of the stem. 
5) The ability to sort and rank valid designs according to various strategies for their 
selection. 
6) A Graphical User Interface (GUI) such that data entry and general usage is easy, even 
for users without computing background. 
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In conclusion, our computational algorithm is a prototype tool that paves the way for 
automatic and systematic Mz design. It allows anyone wishing to design Mz, not necessarily 
for e-SRS sensors, to save time and labour, and gain the ability to select the optimal designs 
amongst valid ones. 
5.4 Detection of single nucleotide difference. 
We had no difficulties in distinguishing the 4 Dengue sNTS, which were greatly different in 
sequences and were of length between 19 and 22 nt. However, sNTS-Mfs and sNTS-Mfr1 
were hardly distinguishable by their respective Mz-based sensors, when we started with 
standard conditions – both Mz-Mfs and Mz-Mfr1 were strongly activated by both sNTS. The 
3 Malaria sNTS were 24 nt long and between Mfs and Mfr1, there was only a Single 
Nucleotide Difference (SND). 
To improve the specificity of the two Mz-based sensors for their own NTS, we tried to 
optimise RTA temperature and Mg2+ concentration. Apparantly, only the latter was somewhat 
effective. This is likely due to the two roles of Mg2+ in RTA, which are 1) to participate in 
catalytic ribozyme cleavage reaction when recruited by the catalytic core of the Mz, and 2) to 
help anneal the negatively charged RNA strands. As such, with the reduction of RTA Mg2+ 
concentration, the annealing condition becomes more stringent (specific), and the requirement 
of proper secondary structure (brought about by correct binding of NTS and STS) for the 
recruitment of Mg2+ (so as to activate the Mz) possibly increases. 
Mz RTA protocol in general uses 10 mM Mg2+. However, our titration downwards of Mg2+ 
 209 
concentration showed that while RTA activity may decrease, RTA specificity may improve 
with less than 10 mM Mg2+. In fact, at 2 mM Mg2+, Mz-Mfs became specific, while 
Mz-Mfr1was the most specific at 3 mM Mg2+ (although still not totally specific). This also 
indicates that for all new Mz designed, RTA could potentially be optimised by varying the 
Mg2+ concentration, although 10 mM might be a good starting point when selecting amongst 
several valid starting designs. 
As it was, while testing the ability of each Mz-based sensor to activate in the presence of both 
NTS and NNS, we discovered that the presence of NNS invariably reduced the activation 
produced by the NTS. This provided the inspiration to use a “competitor nucleotide” (CN), 
which could be a NNS that had been found not to activate the Mz-based sensor (such as 
sNTS-Mfr2 for the case of Mz-Mfr1) in order to improve specificity. After optimisation, we 
discovered that adding 2000 nM of sNTS-Mfr2 as CN made Mz-Mfr1 completely specific. 
CN seemed to improve specificity by reducing the activity of Mz-based sensor against both 
NTS and NNS, but doing so more for NNS than for NTS. Too much CN (e.g. 10000 nM and 
above) can reduce activity for both to non-existant levels. Hence, the key was to find a level 
of CN that allowed the NTS to activate the Mz-based sensor but reduced activation by NNS to 
non-significant levels. 
Judging by such behaviour of CN, we speculate that CN could bind to Mz-based sensors (at 
the sensor arm) but due to the significant mismatches with the sensor arm, holds the Mz-based 
sensor in an inactive conformation. In other words, CN “competes” (hence the name 
“competitor nucleotide”) with both NTS and NNS for binding with the Mz-based sensors, and 
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holds the sensor in an inactive conformation. As such, CN sequence should be close enough to 
the NTS sequence to bind the Mz-based sensor, yet different enough that it does not result in 
sensor activation. In our case, the CN sNTS-Mfr2 had 3 nucleotides different from that of 
sNTS-Mfr1 (see Table 4.5-1) while the NNS sNTS-Mfs had only 1 nucleotide different from 
sNTS-Mfr1. Since the NTS (sNTS-Mfr1) had complete complementary match to its Mz-based 
sensor’s sensor arm, while the NNS (sNTS-Mfs) had a single complementary mismatch with 
the same sensor arm, it seems logical that the CN would compete more strongly with the NNS 
than with the NTS. As a result, the CN reduced the ability to activate the Mz-based sensor 
more strongly for the NNS than for the NTS. 
We therefore believe that the design and use of an appropriate CN could be a useful strategy 
to help improve Mz specificity that is still lacking after optimisation of Mg2+ concentration, 
especially when there are no other valid designs that could be tested (Mz-Mfr1 had only 1 
valid design, as shown in Table A 6). 
Molecular Beacons (MB) have been established to show good SND distinguishing ability for 
probe region of 15 nt [Bonnet et al, 1999]. Compared to this, Mz-based e-SRS seems at least 
comparable in the detection of sNTS, as we could distinguish between 1 SND in a much 
longer probe region (24 nt). While more SND should be tested for proper comparisons of 
specificity between Mz-based e-SRS and MB, this initial result is promising. In fact, SND 
specificity will likely improve if we were to shorten the detection region (to say 15 nt, like 
that of the MB), as the disruptive effect of the single base mismatch would be even greater on 
the secondary structure of the Mz-based sensor, thereby reducing the chances of 1) sensor arm 
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binding to NNS, and 2) an appropriate secondary structure of the Mz catalytic core being 
formed even if the NNS did bind with the sensor arm. 
In testing NASBA RTA, we again had trouble distinguishing SND for Mz-Mfs and Mz-Mfr1, 
despite using the optimised conditions derived from the sNTS RTA. One possibility is the 
carry over of Mg2+ from the NASBA reaction. However, the NASBA reaction is not stated by 
the manufacturers to contain Mg2+ and our use at 3μl of NASBA product for 50 μl of RTA 
would likely significantly dilute any Mg2+ carried over from NASBA. NASBA reaction does 
contain K+, which would add 0.6 mM K+ eventually to RTA. If this small amount of K+ had 
any effect, it would likely be limited to slightly reducing the specificity of RNA annealing, 
and not serve to increase the ease of Mz catalytic core activation, which requires the 
recruitment of Mg2+. 
We suspect that the major issue was the increased length of NTS provided by NASBA (120 nt) 
compared to that of sNTS (24 nt). The additional length may result in secondary structures 
that partially obscure the NTS region where the SND exist and therefore reduce the specificity 
of Mz-based sensor annealing to the NTS. The additional secondary structures may also 
interfere with the predicted secondary structure of the Mz-based sensor. The use of AS 
(antisense oligonucleotides) could be improved on to help in this case, for instance, by having 
more units of AS that span most of the long NTS such that essentially only the NTS region is 
single stranded and available for e-SRS sensor detection. This would greatly reduce the 
amount of single stranded region and thus secondary structures that the long NTS could form 
and therefore reduce their interference with the Mz-based sensor. 
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5.5 Use of AS to facilitate the detection of long NTS. 
Our earliest attempts at NASBA RTAs produced no significant fluorescence due to the 
secondary structures of the detected RNA. We initially suspected that a likely factor was that 
of insufficient NASBA NTS (nNTS) for detection (Section 4.5.6.3). However, despite 
increasing the amount of NASBA template as well as NASBA products used in RTA, the 
problem was not resolved. As such, we suspected that the problem was due to secondary 
structures of the relatively long NTS obscuring the 24 nt detection region, thus denying the 
Mz-based sensor access to it. 
In order to open up the RNA surrounding the detection region, we added AS (antisense 
oligonucleotides) that would bind to regions flanking and close by to the NTS detection 
region. As our results showed, AS indeed resolved the non-activation issue in NASBA RTA, 
and we optimised a set of AS sequences and concentration for the three Malaria NTS. 
To our delight, the denaturation action of AS were almost immediate upon their addition to the 
RTA mix, which suggested that AS functioned via simple AS pairing with nNTS that 
denatured secondary structures around the NTS rather than via RNase H action that released 
sNTS from their original nNTS. Indeed, this was corroborated when similar long NTS 
generated via in vitro transcription (with no RNase H added) could be detected by NASBA 
RTA when AS were added, but not without addition of AS (data not shown). 
We further analysed the functions of AS by predicting secondary structures (using 
RNAstructure 4.5) of Mz-based sensors activated by nNTS, both in the presence and absence 
of AS. To predict nNTS structure in the presence of AS (denoted as nNTS+AS) , we combined 
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the various RNA (e.g. AS, sNTS, Mz, STS) sequences into a single sequence, with “gaaa” 
separating each segment, just like how we predicted the binding of Mz-based sensors with 
NTS and STS (Section 4.3.6.3). The sequences were joined as given in Table 5.5-1. Our 
secondary structure predictions showed that AS bind to their designated regions and prevented 
the NTS detection regions from forming secondary structures with external regions. 
Table 5.5-1 Strand sequences used in Mz based sensor design. 
RNA combinations Strand sequences (5’ to 3’) 
nNTS+AS. 5’ AS, nNTS, 3’ AS. 
nNTS with Mz and STS. STS, MzL, nNTS, MzR. 
nNTS+AS with Mz and STS. STS, MzL, 5’ AS, nNTS, 3’ AS, MzR. 
Note that for strand sequences, each comma indicated the addition of a linker “gaaa”. 
One way to determine whether AS were able to improve the chances of Mz-based sensor 
activation was to see if the free energy change of formation for the activated complex (i.e., 
nNTS correctly binding to the Mz-based sensor and STS) was larger with AS added. The 
larger (i.e. more negative) the free energy change of formation, the more stable (and thus 
likely to occur) the activated complex is compared to the structures before binding. We 
therefore compared the free energy change of binding in two cases: 1) nNTS alone 
binding with the Mz and STS to form activated complex, 2) nNTS+AS (i.e. nNTS already 
in the presence of AS) binding with the Mz and STS to form activated complex. As Table 
5.5-2 showed, the formation of the actived complex from nNTS resulted in significantly 
greater stabilisation (larger free energy change, note last two columns in Table) when AS 
was present as compared to when no AS was present. This clearly showed that the 
presence of AS promoted the formation of the activated complex, compared to having 
only the nNTS alone.
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Table 5.5-2 Comparison of the free energy values of nNTS e-SRS activation with and without AS. 
AS Free Energy Change of formation/process (kcal/mol) Stability increase for 
activation in presence of AS 
NTS 









kcal/mol As a % of the 
value without AS 
Mfs Mal Rvs 206-214 Mal Rvs 242-271 -15.8 -41.3 -25.5 -45.1 -84 -38.9 -13.4 52.5% 
Mfr1 Mal Rvs 206-214 Mal Rvs 242-271 -15.7 -43.4 -27.7 -46.9 -86.1 -39.2 -11.5 41.5% 
Mfr2 Mal Rvs 194-215 Mal Rvs 242-271 -14.2 -43.2 -29 -64.3 -104.3 -40 -11 37.9% 
Note that a negative value for “Stability increase for activation in presence of AS in kcal/mol” indicates an increase in stability. Free energy change of e-SRS 
activation was calculated as the free energy of the activated complex subtracted from that of the sNTS (either with or without AS).
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It should be noted that the increases in free energy change (in the presence of AS) were not 
due to the free energy change of AS binding the nNTS as such bindings were already present 
at the initial stage (nNTS+AS). One factor that may account for this increase in free energy 
change (when AS is present), is that when AS prevent the detection region from binding to 
other segments of the nNTS, the detection region would either remain single stranded, or only 
form bonds within itself, which by probability are usually less stable than those that could 
have been formed with outside regions (since there are more sequences outside the detection 
region for long NTS, and binding with outside regions would likely produce less 
conformational strain). As such, when forming the activated complex with Mz-based sensor 
and STS, less energy would be needed to break bonds that the detection region had already 
formed. 
Based on the above understanding, AS may be used to facilitate in general all DNA or RNA 
hybridisation where the probe and the target have difficulty annealing due to secondary 
structures of the target nucleic acid. This may include facilitating RNA knock down in cells, 
whether by siRNA, microRNA, or ribozyme, as well probe hybridisation whether in vivo or in 
vitro. The general principle would be to synthesise AS flanking the detection region. If 
secondary structure prediction shows the detection region to pair with far off regions, AS 
could also be targeted to those far off regions. Multiple (i.e. more than 2) sites could in 
principle be targeted by AS. If choices between several AS had to be made, a comparison of 
the relative benefits of the AS could be made by comparing which AS enables a greater 
change in free energy for the intended probe-target hybridisation, as was done above. Using 
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such a methodology, a computational algortithm could be written to suggest the best AS (of 
defined number and length) to use for any given probe-target hybridisation. 
5.6 Use of e-SRS in cell lines. 
e-SRS was not successfully developed in cell lines. The RS system was shown to be 
unfeasible due to degradation of the RS (Section 4.4.2.3), despite the use of significant 
nuclease resistant protection. This could be due to the presence of a single unprotected normal 
phosphodiester RNA bond in the RS, which was required if the Mz-based sensor was to be 
able to cleave it. 
The other e-SRS cellular paradigm was to activate an inducible gene expression system in and 
only in the presence of NTS. This was also not successfully developed. The problem did not 
appear to be simply due to the activation of Mz-based sensor, as even the use of the simpler 
HH-2 (a Hammerhead ribozyme) in an attempt to knock down the TetR mRNA did not allow 
even the slightest activation of the PLG (Section 4.4.1.5). This was despite various ways of 
expressing HH-2 in cell lines, where it was affirmed by RT-PCR that HH-2 was indeed 
expressed (Section 4.4.1.5.4). 
A simple explanation could be that the TetR mRNA was too highly expressed to knock down. 
However, after our subsequent experience of how the optimised conditions of sNTS RTA 
could fail to work when NASBA NTS, which were long NTS, were used, and how the 
addition of appropriate AS (antisense oligonucleotides) could almost instantly activate 
NASBA RTA, we believe that a similar problem of secondary structure was responsible in the 
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non-activation of PLG. In other words, secondary structures of the TetR mRNA and/or long 
NTS obscuring the STS cleavage region or NTS detection region could be the main factor 
preventing the activation of PLG. 
As such, a possible solution would be to design and add AS around the STS cleavage region 
(or elsewhere on the TetR mRNA, as described in Section 5.5) to help activate PLG using 
HH-2. Once this is successful, transfected Mz-based sensor and sNTS could be tested to 
activate PLG. Eventually, long NTS as expressed in cells could be tested with Mz-based 
sensors to activate PLG, and if activation difficulties arise, AS could be designed for the long 
NTS as well. Note that such AS should be RNA oligonucleotides in order to avoid undesired 
RNase H degradation of the NTS. In addition, the length of AS RNA should be kept 
significantly shorter than the typical 19 to 21 nt siRNA length. This is in order to avoid having 
the duplexed RNA region from being subject to siRNA effects. 
5.7 Comparison of e-SRS to other molecular gene detection 
methods. 
As covered in the Introduction, conventional methods of detecting Nucleic Acid sequences 
(NA) based on hybridisation of complementary oligonucleotides probes to target NA have two 
intrinsic weaknesses: 1) They are often limited in their ability to detect small differences in 
sequence, especially single nucleotide differences (SND), and 2) They usually have poor 
Signal to Noise Ratio (SNR) as typically they have each only 1 signal per hybridisation of 
probe and target, and that unhybridised probes contribute to a significant background. 
 218 
In contrast, the existing e-SRS sensor, the Maxizyme (Mz) has been shown to be highly 
specific in recognition, being able to distinguish SND both in the literature (SND in 16 nt) 
[Kong et al, 2003; Kong et al, 2005] as well as in our own work (SND in 24 nt). The overall 
secondary structure of the Mz must be correct before catalytic structure can be achieved for 
signal generation. The overall secondary structure of the Mz is in turn highly dependent on the 
correct pairing of the NTS and sensor arm of the Mz. As such, any mismatch in the pairing 
has a greater chance to disrupt the complex structural requirement of an active complex, thus 
leading to abolishment of catalytic activity and hence signal generation. In comparison, 
conventional probes rely merely on hybridisation of 2 short strands of NA, wherein successful 
hybridisation, whether perfect or with mismatch(es) would lead to signal generation. 
In addition, as the Mz-based sensors are designed specifically to distinguish between NTS and 
NNS via RNA secondary structure prediction software, sensors can be computationally 
screened to be amongst the better ones (out of many possibilities) to distinguish NTS from 
NNS. 
While having high specificity in detection, the e-SRS sensor is not so specialised as to be 
limited to detecting only SND, as in the case for some systems, such as QUAL (see Section 
5.7.2). Such systems would likely face problems in differentiating between 3 or more NA 
species with multiple mismatches. This is not a problem for e-SRS as correct secondary 
structure along the entire Mz sensor arm (not just a specific point along the sensor arm), 
contributes towards inducing the appropriate conformational change into an active Mz. 
Currently, e-SRS utilises fluorescence based RSs that are quenched when non-activated, 
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resulting in low background signal. In addition, e-SRS has signal amplification power as each 
activated Mz can cleave many RS as long as the NTS is present, resulting in multiple 
fluorescent reporter per copy of NTS detected. Both factors contribute to improve SNR for 
e-SRS. 
e-SRS also separates NTS detection and signal generation (RS cleavage) into 2 distinct 
modules and hence is more amenable to turnover optimisation, where required. 
e-SRS therefore has many advantages compared to conventional hybridisation probes. It is 
hence of greater interest to compare e-SRS with more advanced gene detection methods, such 
as the Molecule Beacon and some of its derivatives and other methods that incorporate signal 
amplification. 
5.7.1 Comparison with Molecular Beacons and derivatives. 
The relatively recent introduction of Molecular Beacons (MB) has significantly improved 
specificity and SNR over conventional hybridisation probes [Tyagi & Kramer, 1996]. A MB 
comprises of an oligonucleotide conjugated on opposite ends with a fluorescence reporter and 
a quencher that are constitutively close by, and which separate upon binding of target NA and 
thus generate significant fluorescent signal only when hybridised. However a limitation of 
MB is that hybridisation to target NA is required to generate fluorescence, hence at most 1 
fluorescent reporter is generated by each copy of target NA. In addition, specificity is still 
determined primarily by hybridisation of NA, hence there is still room for improvement in 
resolution of closely related sequences. 
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There have been attempts to improve specificity and/or sensitivity of the MB, such as the 
Hairpin Inversion Probes that reduces interaction of stem sequences with targeted Nucleic 
Acid (NA) [Browne, 2005]; Binary DNA Probes that separates hybridisation sequences into 2 
portions to improve specificity [Kolpashchikov, 2006]; Tentacle probes that provide additional 
sensing surface to improve sensitivity and specificity [Satterfield et al, 2007]; Nuclease S1 to 
improve sensitivity by digesting DNA templates of non-perfect matches [Ye et al, 2007]; 
Single Wall Carbon Nanotube (SWNT) quenches unhybridised MB to reduce background and 
increases specificity [Yang et al, 2008]. These methods however, have not become 
mainstream methods, and none of them have amplification of signal. 
Activation of the MB is based primarily on hybridisation to create conformational strain that 
can unwind the MB stem region. Hence, successful binding with mismatch(es) of a wrong 
sequence will still activate MB, since binding, whether fully complementary or with 
mismatches will unwind the MB stem, thus releasing quenching of the reporter. 
Unlike the MB, for the e-SRS Mz-based sensors to activate, binding of the target NA is 
required to provide the necessary energetic stabilisation so that correct conformation change 
can occur for the Mz catalytic core to capture an Mg2+ and become catalytically active. As 
such, activation of the Mz-based sensor upon recognition of target NA does not depend only 
on hybridisation of the sensor arm with target NA, but also on the induction of appropriate 
secondary structure changes (set into motion by the hybridisation) that allows an appropriate 
catalytic core conformation to be adopted. If there was a mismatch(es) in the hybridised target 
NA, the distortion in secondary structure could impact negatively on the adoption of the active 
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conformation and thus successful binding of a wrong sequence will not necessarily activate 
e-SRS. 
For applications of MBs with signal amplification, there are two approaches. One of these is 
an enzyme based method called Nicking Enzyme Signal Amplification (NESA) [Li et al, 
2008]. In the basic version, NESA uses a DNA nicking enzyme (N.BstNB I) to cleave an 
activated MB that has hybridised to its target, which must contains a nicking enzyme 
recognition sequence (GACTC). After cleaving, the two fragments that remain of the MB 
dissociate (with the fragment containing the fluorescent reporter permanently unquenched) 
and allow more MBs to bind and be cleaved, thus creating amplification of signal. An 
extended version of NESA requires the additional elements of DNA padlock probe, DNA 
ligase, DNA polymerase, and primer that together allow Rolling Circle Amplification of the 
target NA, which are then detected like in basic NESA. Rolling Circle Amplification creates 
many more copies of the target NA with the nicking enzyme recognition sequence added if it 
was not orginally present in the target NA. This allows greater amplification as well as 
removed the restriction of only targeting NA with the nicking enzyme recognition sequence. 
Compared to e-SRS, NESA, especially the extended version requires the provision of 
additional protein enzymes and reaction buffers, which tends to make a system more 
complicated and fragile. Basic NESA requires the DNA nicking enzyme recognition site to be 
present on both the MB and the sequence of detection, resulting in a very restricted choice of 
NTS. Rolling Circle Amplification allows additional amplification, but is really a “generic” 
amplification technique that could be used by conventional hybridisation probes as well 
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e-SRS. The critical difference it made to NESA is that it allowed NA without the nicking 
enzyme recognition sequence to be targeted. Ultimately, NESA whether with or without RCA 
still depends on MB for specificity, and like other MB based sensor systems, NESA is 
unlikely to be as specific as the e-SRS Mz-based sensors. 
The other approach to signal amplification with MB is via the use of catalytic DNA molecules 
called deoxyribozymes (Dz) that are fused with a MB domain. One group created constructs 
they called catalytic molecular beacons, whereby they modified a hammerhead-type Dz (able 
to cleave RNA) with an added MB domain such that one of the MB stem is also the binding 
arm of the Dz [Stojanovic et al, 2001]. When the MB domain is not activated, the other stem 
anneals with the binding arm and prevents full binding of a separate DNA substrate sequence. 
This substrate sequence, like our RS, has a constitutively quenched reporter. Upon activation 
of the MB domain, the binding arm of the Dz is no longer blocked and allows binding and 
cleavage of the substrate sequence, resulting in fluorescence. Since apparently the Dz domain 
remains in a catalytically active conformation even without addition of target NA, activation 
of such catalytic molecular beacons, like the MB, would be based primarily on simple 
hybridisation (albeit with competition with a blocking MB stem), and thus is unlikely to 
match Mz for specificity. 
Another group created the Catalytic Beacons [Xiao et al, 2004]. Starting with a Dz that is able 
to intercalate Hemin (an iron-containing porphyrin) to exhibit peroxidase like activity, they 
extended the sequence of the Dz with a sequence that can bind the target NA. In the absence 
of target NA, the additional sequences would form secondary structures with the Dz, thus 
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disrupting its active structure and rendering it inactive. Upon binding of the targeted NA, 
secondary structure disruption to the Dz domain is removed and the activated Dz can then 
generate chemiluminescence in the presence of Hemin, H2O2 and luminol. Like the e-SRS 
Mz-based sensor, the activation of Catalytic Beacon requires conformation change initiated by 
the binding of target NA. However, for the Mz-based sensor, the target NA helps to structure 
the binding arm domain while for the catalytic beacon, the target NA serves to remove a 
complementary segment that disrupted the active conformation. Since the degree of disruption 
and the ability of target NA to remove this disruption defers for different target NA sequence, 
it is not clear that such conformational changes can be easily generalised to any target NA 
sequence. In addition, when the target NA was provided at 200 nM (the concentration of 
sNTS used in e-SRS sNTS RTA), the activity of the catalytic beacon seemed only slightly 
above that of when no target NA was provided. This implied that the degree to which the 
target NA could control the activation of the catalytic beacon was not as high as that for the 
e-SRS Mz-based sensor. 
5.7.2 Comparison with methods with signal amplification. 
QUenched Auto-Ligation (QUAL) probes consist of a pair of probes (typically 7 and 17 nt 
each) designed to anneal on adjacent location on target NA, and which have between them a 
reporter and a quencher. Upon being positioned adjacent to each other, auto-ligation occurs 
between the two probes via a 3’ phosphorothioate group on the 5’ probe, joining them into one 
long probe, with the concurrent displacement of the reporter or quencher. This results in the 
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release of fluorescence signal [Xu et al, 2001; Sando et al, 2002]. While QUAL may 
potentially generate multiple reporters per copy of target NA, this process requires ligated 
probes to dissociate from the target NA strand. This would be less efficient than in the case of 
e-SRS Mz as the ligated probe would be around 20 nt, while each cleaved fragment of RS 
would be about 7-10 nt only. 
Further modification was made to QUAL via addition of a short “universal linker” to 
destabilise the ligated product (which would otherwise be too stable to dissociate significantly 
for multiple auto-ligation on each copy of target NA) so as to allow some amplification of 
signal [Abe & Kool, 2004]. However, dissociation rates may not be as high as that of 2 
separate 7-10 nt strands (as in e-SRS), as the dissociation of regions near the “universal 
linker” (without total dissociation of ligated probe) may be sufficient to greatly reduce its 
destabilising effect, particularly if the combined probe is long. 
Pertaining to the optimisation of substrate turnover, QUAL has an intrinsic design limitation 
as the reporter sequence is the reverse complement of the sequence of detection (i.e. NTS), 
and hence is dictated by and dependent on the specific NTS of interest. In e-SRS, the RS 
binding region of the Mz-based sensor is a distinct entity and entirely independent of the 
sequence of the NTS binding region (responsible for target NA specificity). As such, substrate 
turnover and NTS binding can be fairly independently optimised, and substrate turnover is 
much less dependent on the specific NTS of interest. For instance, while the current e-SRS RS 
is 17 nt long (before cleavage), it can be shortened significantly (to improve dissociation after 
cleavage) without significantly affecting specificity. 
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The auto-ligation step limits the specificity of QUAL as this reaction (which results in the 
activation of QUAL) will occur so long as the two QUAL probes are place adjacent in the 
right 5’ to 3’ orientation. This means that the segment of NTS where the sequence can be 
reliably determined is restricted to the bases close to the junction of the two probes. The 
system would likely face problem in differentiating between 3 or more NA species with 
multiple mismatches, where there is no Single Nucleotide Difference (SND) that is unique for 
a particular NTS. Hence QUAL appears more suited for SND detection (and which must be 
unique amongst species present) rather than all-purpose NA detection, like for e-SRS. In 
addition, while QUAL typically distinguishes SND in ~17 nt sequences, we have shown 
e-SRS capable of distinguishing SND in up to 24 nt sequences. 
5.8 Potential advantages of e-SRS compared to PCR based 
diagnosis of Malaria. 
The current gold standard for Malaria diagnosis is the microscopic examination of 
Giemsa-stained thick and thin blood films [Murray et al, 2008]. Immunochromatographic 
antigen detection assays have also been developed as Malaria Rapid Diagnostic Tests 
(MRDTs), which are fast and simple to use [Murray et al, 2008]. However, as discussed in the 
introduction, both such methods have significant disadvantages. 
The key advantage of PCR based methods is their superior sensitivity achieved via the power 
of exponential amplification of PCR. Unfortunately, the sensitivity of e-SRS NASBA RTA 
was not determined in this work. Before it was realised that initial NASBA RTAs were 
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unsuccessful due to the secondary structures of the detected RNA, it was suspected that a 
likely factor was that of insufficient NTS for detection. As such, increasingly high amounts of 
NASBA template as well as NASBA products were used in NASBA RTA.This lead to the 
eventual high concentration of estimated NTS provided in NASBA RTA, even though we 
eventually realised that the problem was due to NTS secondary structure rather than NTS 
concentration. Unfortunately, by the end of the project, there were insufficient resources to 
establish the sensitivity limits of NASBA RTA. 
The sensitivity of e-SRS should be further established in future work by titrating downwards 
the amount of NASBA template used. While the sensitivity of e-SRS NASBA RTA has not yet 
been established, the process may hold several potential advantages when compared to PCR 
based methods for diagnosis of diseases. 
5.8.1 Specificity. 
The amplification power of PCR based methods can be a double edged sword, as any 
non-specific priming can easily and quickly lead to amplification of non-specific amplicons, 
resulting in false positives and hence reduced specificity. 
PCR based assays exist that provide specificity at the level of Malaria as well as individual 
human infecting Plasmodium species. There are Malaria consensus quantitative PCR (qPCR) 
primers that can amplify all 4 human infecting Plasmodium species, and each of these could 
be distinguished via melting curve analysis [Mangold et al, 2005]. For P. falciparum strains, 
qPCR assays were developed that distinguishes between Chloroquine sensitive (CQS) 
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CVMNK haplotype and resistant (CQR) SVMNT and CVIET haplotypes [Farcas et al, 2006]. 
Consensus proprietary primers were used to amplify the region around the P.f pfcrt gene 
codon 76, which differs between the three strains. Sequence specific FRET probes for each 
strain were used. Subsequently, melting curve analysis was used to distinguish between the 3 
strains. 
If PCR products are assayed directly via non-sequence specific probes, such as ethidum 
bromide in agarose gel electrophoresis, the reduced specificity of amplification applies 
directly to the assay specificity if the non-specific amplicons have similar sizes as the specific 
amplicons. However, if sequence specific probes are used, the reduced specificity of 
amplification can be modulated by the specificity of the probing process. 
This is the case for e-SRS NASBA RTA. While NASBA also amplifies, e-SRS NASBA RTA 
has an additional layer of specificity as detection requires specific activation of the e-SRS 
Mz-based sensor. Even if NASBA amplifies a lot of non-specific products, an optimised 
e-SRS would still not activate unless the intended target was present. This was clearly shown 
(Section 4.5.6.5) when the optimised e-SRS Mz-Mfs and Mz-Mfr2 only activated when their 
intended targets were provided, and not when similar sequences were provided. As discussed 
in Sections 5.4 and 5.7, e-SRS sensor specificity is better than conventional hybridisation 
based nucleic acid probes and at least comparable to the Molecular Beacon. 
In distinguishing between species, the use of consensus amplification primers have the 
advantage of reducing amplification bias due to primer-target affinity differences [McNamara 
et al, 2004]. As shown in Table 4.5-10, e-SRS NASBA RTA used consensus NASBA primers 
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for all 3 strains detected. This would be an advantage in quantification accuracy between 
different strains when compared to PCR based assays that use different primers to distinguish 
between species with closely related sequences. 
5.8.2 Ease of use and flexibility in application. 
The e-SRS sensor as applied in NASBA RTA provide great ease of use. Unlike a PCR-based 
assay, no expensive and sophisticated equipment such as the thermal cycler is required. All 
that is needed are a constant temperature (41 °C and 37 °C) water bath and a fluorometer. 
There is also no need for any significant expertise in the analysis of results, unlike that for 
quantitative PCR melting curve analysis. In addition, fast real time results could be obtained, 
with no need to run gels or apply probes in a second step. 
The PCR as applied in molecular diagnostic is in essence only an amplification method. Only 
in the case of real-time PCR (without probes) can it be considered to be a detection as well as 
amplification method (however, the equipment and skills required are sophisticated). e-SRS 
(employed with the RS) however, is intrinsically both an amplification and a detection 
method. 
It would be desirable to further improve simplicity in future development. This could be done 
by developing the use of minimally processed samples instead of extracted genetic material. 
For instance, it would be highly desirable if mosquito tissues or blood, or patients’ blood 
could be used as input. As far as e-SRS is concerned, the major concern is probably ensuring 
that RNase activities are inhibited.  
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In addition, as discussed in Section 5.3, our current software tool for e-SRS Mz-based sensor 
design could be further developed into a user friendly version that allows a typical wet-lab 
biologist to easily use e-SRS for detection of their nucleic acids of interest. 
Due to the modular nature of the e-SRS, meaning the existence of the sensor and the RS as 
two physically separate entities, there is great flexibility in coupling e-SRS with other 
amplification (e.g. NASBA) or detection methods. As the situation requires, the existing 
fluorescence based detection of the e-SRS RTA can be converted into various powerful 
detection formats, as shown in the following sections. 
5.9 Application of e-SRS in other formats of detection. 
5.9.1 Coloured dye based detection 
To reduce the need for complex equipment, a coloured dye based assay could be developed as 
a field suitable assay kit. There are two variations of such a colour based assay that could be 
developed as a small hand held kit with some transparent chambers: 
1) RS attached to surface in chamber. 
In this “RS attached” version, the RS is immobilised on a surface in chamber 1 with 
the free end conjugated to a coloured dye. RTA mixture (less the RS) including the 
sample Nucleic Acid (NA) is then introduced to chamber 1. 
RTA then occurs in chamber 1, and the cleavage of RS enables its free end with the 
coloured dye to be released into solution. Upon completion of RTA, the solution is 
allowed to flow (or is washed) into chamber 2, which was previously colourless or 
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coloured in contrast to the dye attached to the RS. 
Comparison of colours between the 2 chambers can indicate the degree of e-SRS 
activation. 
2) RS not attached (i.e. in solution). 
In this “RS not attached” version, the RS is free in a buffer with one end biotinylated 
and the other end conjugated to a coloured dye. RTA mixture including the RS and 
the sample NA is prepared and introduced into chamber 1, an inert chamber. 
RTA then occurs in chamber 1. Upon completion of RTA, the solution is allowed to 
flow (or is washed) into chamber 2, with a layer of immobilised streptavidin. The dye 
conjugated end of the cleaved RS will not attach to the streptavidin coated chamber 2, 
while those of the uncleaved RS will attach via the conjugated biotin (at the other end 
of the RS) and remain in chamber 2. 
The solution is allowed to flow (or washed) into chamber 3, which was previously 
colourless or coloured in contrast to the dye attached to the RS. 
Comparison of colours between chambers 2 and 3 will indicate the degree of e-SRS 
activation. 
Both methods have their advantages. The “RS attached” method is more convenient, utilises 
less material, and is thus suitable for mass production of kits that are unlikely to change in 
reagents (in particular the RS sequence). The “RS not attached” method is more flexible, since 
the RS required can be ordered and synthesised separately, according to the needs of 
individual applications. The kit itself (less the RS) can therefore be manufactured in large bulk, 
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and be offered for different applications. 
5.9.2 Silicon Nanowire based electrical detection 
For greater sensitivity and digital readout, the e-SRS sensor could be coupled to the Silicon 
Nanowires (SiNW) electrical detection method to combine the selectivity and amplification of 
the e-SRS sensor with the sensitivity and the simple, rapid and electrical read out of the 
SiNW. 
SiNW as an electrical biomolecular detection method has in recent been shown to hold great 
potential [Gao et al, 2007]. Sensitivity had been reported to reach 1 fM of RNA (signal 
strength increases with DNA concentration) [Zhang et al, 2009] while selectivity for single 
base mismatch had been reported [Zhang et al, 2008a; Zhang et al, 2009]. The electrical 
detection output is easily digitised and the whole setup can be minaturised into tiny hand held 
SiNW chips that provide results without the use of labels (e.g. fluorescent probes or coloured 
dyes) [Gao et al, 2007]. 
SiNW based biomolecular detection is based on the synthesis of a SiNW chip, which typically 
contains an array of many SiNW, each with molecular probes preattached. A small volume of 
the sample nucleic acid (NA) is then introduced in an appropriate buffer solution onto the 
SiNW chip. Each SiNW will change significantly in electrical resistance when target 
molecules bind to the attached probes, as these target molecules bring significant amount of 
charges into close proximity of the SiNW [Zhang et al, 2008b]. In the case of NA, 
complementary Peptide Nucleic Acid (PNA) probes could be conjugated onto SiNW. When 
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target NA bind to their probe on the SiNW, the negative charges on the target NA sugar 
phosphate backbones would cause an increase in the resistance of the SiNW. PNA probes are 
commonly used as the lack of charges on their backbone enable very low contribution to the 
background electrical resistance, and allow high hybridisation efficiency [Zhang et al, 2008a]. 
The changes in resistance of the SiNW can be easily and accurately determined, leading to 
easy realtime quantification of target-probe binding. 
There are two variations by which the e-SRS sensor could be coupled to the SiNW chip to 
obtain an e-SRS SiNW chip for detection of NA: 
1) Direct RS conjugation to SiNW. 
In this “direct RS conjugation” method, instead of having PNA probes conjugated to 
SiNW, the RSs are conjugated in their place. 
The RTA mixture with an appropriate e-SRS sensor (less the RS) including the 
sample Nucleic Acid (NA) is prepared with appropriate buffer. A small volume of the 
whole mixture is added to the SiNW chip, where RTA then occurs. e-SRS sensors 
activated by the target NA (if present) would then cleave the RS conjugated on the 
SiNW. 
Since the RS were RNA and thus contained negative charges on their sugar phosphate 
backbones, their cleavage would reduce the negative charges concentration on their 
attached SiNW, and therefore result in a reduction of electrical resistance of the SiNW. 
The reduction of resistance of the SiNW would therefore indicate the amount of 
activation of e-SRS sensors, which in turn indicate the amount of target NA binding 
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by the e-SRS sensoss. 
2) Indirect RS conjugation via binding to short PNA linkers on SiNW. 
In this “indirect RS conjugation” method, instead of directly conjugating the RS to 
SiNW, RS are annealed to short complimentary PNA linkers that are conjugated on 
the SiNW. These short PNA linkers (with short defined sequence, such as “GGGGG”) 
are conjugated in place of the PNA probes on existing SiNW chips. The 
complementary linker sequence (e.g. “CCCCC”) is added to the appropriate end of 
the RS sequence, such that the RS can anneal to the PNA linkers (with the remainder 
of the RS pointing away from the SiNW). 
The RS can then be added in two ways: 
a. The RS is applied first to the SiNW chip, and allowed to bind onto the PNA 
linkers. The SiNW resistance is monitored to ensure sufficient RS has bound 
to the SiNW via the PNA linkers. When the resistance value stabalise, excess 
RS are washed off. The e-SRS SiNW chip is then ready for use as in the 
“direct RS conjugation” method. 
b. The same RS as above (with linkers attached) is used, but the RTA mixture is 
prepared in whole (i.e. with all components, including RS, e-SRS sensor, and 
sample NA), and a small volume is added to the SiNW chip (with PNA 
linker conjugated). The RS, whether cleaved or uncleaved will then bind to 
the PNA linkers on the SiNW. The results would be measured and analysed 
just like in the “direct RS conjugation” method. 
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While the SiNW based detection is in itself a very promising biomolecular detection method, 
there are significant advantages that combining e-SRS with SiNW can bring to existing SiNW 
based NA detection. 
1) Improved sensitivity via amplification by e-SRS. 
The coupling of e-SRS sensors with SiNW detection would allow for amplification of 
signal due to the ability of each activated e-SRS sensor to cleave many RS. This 
would therefore further increase the sensitivity of the assay. 
2) Improved selectivity conferred by the e-SRS sensor. 
The existing SiNW NA detection is still based on simple hybridisation of target NA with 
their probes conjugated on SiNW, just like the conventional hybridisation probes 
described in Section 1.1. As such the e-SRS sensors could offer similar improvements on 
selectivity for SiNW as they could for the conventional hybridisation probes. 
As discussed in [Zhang et al, 2008b], non-fully complementary target nucleic acid (NA) 
seemed to be able to hybridise almost as effectively as fully complementary target NA. In 
diagnosing between highly similar NA, this would lead to some signal being generated 
even when the NA bound to probe is not the target NA, since the non-targeted NA bound 
would also bring similar amount of negative charge close to the SiNW, leading to 
resistance changes. As explained in Section 5.7.1, successful binding of a non-targeted 
(i.e. non-fully complementary) NA would not necessarily activate e-SRS, meaning that 
such binding would not activate the e-SRS sensor to cleave the RS (on the SiNW), and 
therefore not lead to resistance changes of the SiNW (which are indicative of NA binding). 
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In [Zhang et al, 2008a], for a 22 nt DNA at 1 nM, target NA hybridisation resulted in a 
signal about 6.375 times that for a Single Nucleotide Difference (SND) hybridisation. In 
the case of e-SRS RTA, as described in Section 4.5.5 and as shown in Figure 4.5-2 for 
the sNTS-Mfs (a 24 nt RNA) at 200 nM (with 2000 nM competitor nucleotide), at 
about 95 minutes, the e-SRS sensor registered relative fluorescence units of 55500, 
15375, and 10890 respectively for the target NA, SND NA, and water control. After 
normalising with respect to the water control, target NA hybridisation resulted in 
signal about ~9.946 times that of SND hybridisation. As such, the e-SRS sensor could 
potentially add to the specificity of the SiNW chip. 
3) Simpler fabrication of SiNW chips. 
A major challenge in SiNW based detection is the consistent and precise large scale 
fabrication of the SiNW chip, which includes the attachment of various probes on the 
SiNW [Gao et al, 2007]. The conjugation of probe of different sequences and lengths 
on each new SiNW chip could add to variation of fabrication conditions and thus 
increase the difficulty in ensuring consistency in SiNW chip fabrication. 
When coupled to e-SRS using the “direct RS conjugation”, the same RS could be 
conjugated on all chips, with the application specific e-SRS sensor added to the 
sample rather than pre-attached on the SiNW chip. Alternatively, if the “indirect RS 
conjugation” is used, fabrication is even easier as only a standard short PNA linker 
need be conjugated to the SiNW. This configuration could be mass produced for 
different applications which could have their own specific RS easily synthesised as 
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short RNAs. Hence, fabrication of e-SRS SiNW chips would be simpler than 
traditional SiNW chips and result in greater ease of production and consistency of 
signal. 
4) Improvement in detection format. 
Typical SiNW based detection for NA measures the increase in SiNW resistance 
when NA bind to PNA probes [Gao et al, 2007]. The SiNW resistance is actually 
determined by monitoring the current following through the SiNW, when a known 
voltage is applied. The higher the resistance becomes, the smaller the current 
monitored, which has a minimum of zero ampere (for a positive current). Due to the 
inverse relationship between current and resistance, the larger the resistance increase, 
the smaller the current decrease. As such, this detection format becomes less sensitive 
as more target NA bind to their probe. In e-SRS SiNW based detections where the RS 
were attached before the addition of sample NA, the resistance of SiNW actually 
reduces as more RS are cleaved from the SiNW. This means that the monitored 
current actually increases, and increases more rapidly with more RS being cleaved. 
Therefore incorporating the e-SRS sensor in SiNW detection may actually improve 
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Sequences in PCR of PLG for adding short tags with 
restriction sites. 











































































Shaded regions indicated restriction sites. In amplicon sequences, upper cases indicated 
primer sequences or their reverse complements, and underlined regions indicated segments 
on template that annealed to primers.
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Possible sequences of e-SIGE IRC segments. 
Table A 2 Possible sequences of e-SIGE IRC segments. 




































































































































































C variant 1 gggatccatt 
C variant 2 gcgcacccga 
C variant 3 cgcggttaca 
C-1_R CTTGTACGGA 
E variant 1 
(37a) 
ATTCACTATA 
E variant 2 
(37a) 
GCCCCCT 
E variant 3 
(37b) 
ATGCCTTACC 

















F variant 1 ccaatacttacgcgtcg 
gtacggggtgactacta 
acagtcgcgcggaagcc 










Note: For RC and CS, lower cases indicated ribozyme cleavage active site sequence (on both 
substrates and ribozyme). 
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Aim 1a construct segments. 
Table A 3 Aim 1a construct segments. 

























































































































Sequences of ligation oligos for Aim 1a and 1b constructs. 
Table A 4 Sequences of ligation oligos for Aim 1a and 1b constructs. 
Ligation Oligo Sequence (5’ to 3’) 
T/C1a Fwd L1 TAATACGACTCACTATAGGAAACAGagaaGTCAACCAGAGAAACA
CACGTTGTGGTATATTACCTGGTAtac 
T1a Fwd L2 atgtccttatagtgaatAAACCACAACTTGTACGGAGTCA 
T1a Fwd L3-A-3’ CCAAATAGGATTCAAGAGATGACagtcCTGTTTAATGGATCCCGT
TCGGCAGCTTCAAGAGAGCTGCCGAACA 
T1a Rvs L1 GTTCGGCAGCTCTCTTGAAGCTGCCGAACGGGATCCATTAAACAG
gactGTCATCTC 
T1a Rvs L2 TTGAATCCTATTTGGTGACTCCGTACAAGTTGTGGTTTattcact
ataaggacatgtaTACCAGGTAATA 
T/C1a Rvs L3-A-3’ TACCACAACGTGTGTTTCTCTGGTTGACttctCTGTTTCCTATAG
TGAGTCGTATTAA 
C1a/Cla(-) Fwd L2 atgtccttatagtgaatAAACCACAAGGGATCCATTAAAC 
C1a Fwd L3-A-3’ AGgactGTCATTCAAGAGATGACagtcCTGTTTAATGGATCCCGT
TCGGCAGCTTCAAGAGAGCTGCCGAACA 
C1a Rvs L1 GTTCGGCAGCTCTCTTGAAGCTGCCGAACGGGATCCATTAAACAG
gactGTCATCTC 
C1a Rvs L2 TTGAATGACagtcCTGTTTAATGGATCCCTTGTGGTTTattcact
ataaggacatgtaTACCAGGTAATA 
C1a(-) Fwd L3-A-3’ AGcgaaGTCATTCAAGAGATGACttcgCTGTTTAATGGATCCCGT
TCGGCAGCTTCAAGAGAGCTGCCGAACA 
C1a(-) Rvs L1 GTTCGGCAGCTCTCTTGAAGCTGCCGAACGGGATCCATTAAACAG
cgaaGTCATCTC 
C1a(-) Rvs L2 TTGAATGACttcgCTGTTTAATGGATCCCTTGTGGTTTattcact
ataaggacatgtaTACCAGGTAATA 
T1b/T1b(-) Fwd L1 TAATACGACTCACTATAGGAAACAGagaaGTCAACCAGAGAAACA
CACGTTGTGGTATATTACCTGGTAtacatgtc 
T1b Fwd L2 cttatagtgaatAAACCACAATTCAAGAGATTGTGGTTTccaata
c 
T1b/T1b(-) Fwd L3-A-3’ ttacgcgtcgATTCACTATAGGGTCCACCTCCTCGCGGTaaacca
tGGGCATCCGTTCGCGGATGGCTAAGGGACCCA 
T1b/T1b(-) Rvs L1 GGGTCCCTTAGCCATCCGCGAACGGATGCCCatggtttACCGCGA
GGAGGTGGACCCTATAG 
T1b Rvs L2 TGAATcgacgcgtaagtattggAAACCACAATCTCTTGAATTGTG
GTTTattcactataaggacatgtaTACCAGG 
T1b/T1b(-) Rvs L3-A-3’ TAATATACCACAACGTGTGTTTCTCTGGTTGACttctCTGTTTCC
TATAGTGAGTCGTATTAA 
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Ligation Oligo Sequence (5’ to 3’) 
T1b(-) Fwd L2 cttatagtgaatAAAGGAAAATTCAAGAGATTTTCCTTTccaata
c 
T1b(-) Rvs L2 TGAATcgacgcgtaagtattggAAAGGAAAATCTCTTGAATTTTC
CTTTattcactataaggacatgtaTACCAGG 
DT-LR-CS Fwd L1 TAATACGACTCACTATAGGTTCAAGAGATTGTGGTTTATGGGTCC
ACCTCCTCGCG 
DT-LR-CS Fwd L2-A-3’ GTaaaccatGGGCATCCGTTCGCGGATGGCTAAGGGACCCA 
DT-LR-CS Rvs L1 GGGTCCCTTAGCCATCCGCGAACGGATGCCCatggtttACCGCGA
GGAGGTGGACC 
DT-LR-CS Rvs L2-A-3’ CATAAACCACAATCTCTTGAACCTATAGTGAGTCGTATTAA 
sNTS 37a Fwd-A-3’ TAATACGACTCACTATAGGATTCACTATAAGGACATGTAA 
sNTS 37a Rvs-A-3’ TACATGTCCTTATAGTGAATCCTATAGTGAGTCGTATTAA 
sNTS 37b Fwd-A-3’ TAATACGACTCACTATAGGATGCCTTACCCGGACATGTAA 
sNTS 37b Rvs-A-3’ TACATGTCCGGGTAAGGCATCCTATAGTGAGTCGTATTAA 
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Valid e-SRS sensor designs for Dengue 
Table A 5 Valid e-SRS sensor designs for Dengue. 































































CCCCCGGAGCACGAAAGUUUCAUA D1 -53 A -18
.1 






































































































































































































































































































































































































































































































Valid e-SRS sensor designs for Malaria. 
Table A 6 Valid e-SRS sensor designs for Malaria. 




















































































































Oligonucleotides in cloning of Mfs, Mfr1, Mfr2 NTS. 
Table A 7 Oligonucleotides in cloning of Mfs, Mfr1, Mfr2 NTS. 
Oligonucleo
tides 
Role Sequence (5’ to 3’) Length (nt)
NASBA F3R1 
DNA 











Mal Fwd 01 











in PCR and 
NASBA. 
Cloned sequence as 
well as IVT 
template produced 
in NASBA using 
primers: 
Mal Fwd 02 















Mal Fwd 02 















Mal Fwd 01 Cloning forward 
primer. 
ACGTTTAGGTGGAGGTTCT 19 




















NASBA DNA and RNA Amplicons shown were those for Mfs. Those for Mfr1 and Mfr2 were of 




Using the computational algorithm for e-SRS Mz-based 
sensor design. 
Ensure that Perl 5.8.8 or later is installed in the computer running the algorithm. This can be 
done by downloading and installing ActivePerl by following the instuctions at 
http://www.activestate.com/activeperl/. 
After proper installation of an appropriate version of Perl, copy the computer programme 
(written in Perl) for the algorithm, named “eSRS.pl” in the accompanying CD to any desired 
location on the computer with Perl installed. Alternatively, eSRS.pl can be obtained by 
copying the source code of eSRS.pl (provided below) onto a “Plain Text” file (with no 
additional formatting whatsoever) and saved as a “Plain Text” file named “eSRS.pl”. Copying 
the eSRS.pl file from the CD is preferred for minimising the chances of errors in obtaining 
eSRS.pl. 
Follow the instructions in Section 4.5.2.2.1 to edit the appropriate parameters in eSRS.pl and 
provide the required inputs. eSRS.pl is a text file that can be opened and edited with any text 
editor, such as Notepad or Wordpad. Word processors such as Microsoft Word, Abiword, or 
OpenOffice.org Writer can also be used, but take note to save the edited file as “Plain Text”. 
Ensure that the file extension is “.pl” after saving (change it to “.pl” if it became “.txt”). 
After correctly saving the edited version of eSRS.pl, and ensuring that all the required 
preparations have been made (as described in Section 4.5.2.2.1), such as providing the 
appropriate NTS files in the appropriate folder, the algorithm in eSRS.pl can be executed. This 
can be done by double clicking the eSRS.pl file (if ActivePerl was properly installed), or the 
following command can be entered at the Command Promt, followed by the “Enter” key: 
perl c:\eSRS.pl 
Replace “c:\eSRS.pl” with the actual path information of the eSRS.pl file, which varies 
according to where the eSRS.pl file was saved. 
When eSRS.pl is executing, a pop up window may appear and display various useful 
information about the execution process. Once eSRS.pl has finished executing, as indicated by 
the disappearance of the pop up window, or by the command prompt returning to await your 
next input, outputs of the algorithm can be found in the relevant folders as described in 
Seciton 4.5.2.2.3. Any remaining command prompt windows for eSRS.pl can be closed. 
Contents of the accompanying CD. 
The accompanying CD contains the following files: 
1) eSRS.pl 
This is a copy of the computer programme that implements the algorithm for e-SRS 
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Mz-based sensor design. 
2) NTS_Den.xls 
This is the NTS file used for the Dengue category, and can serve as a sample NTS file 
to test eSRS.pl. 
3) NTS_Mal.xls 
This is the NTS file used for the Malaria category, and can serve as a sample NTS file 
to test eSRS.pl. 
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Source code of eSRS.pl. 
#!/usr/local/bin/perl 
# No input from <STDI> or files. 
 
my @cat = qw(Malaria Dengue); 
my @NTS_path = qw(C:\eSRS\NTS\NTS_Mal.xls C:\eSRS\NTS\NTS_Den.xls); 
my $eSRS_path = "C:\\eSRS\\"; 
my $eSRS_seq_path = "C:\\eSRS\\Sensor_Seq\\"; 
my $RNAst_path = "C:\\Program Files\\RNAstructure 4.5\\"; 
 
my $RTS2 = "UAUGAAACUCUCGAAAA"; #STS RTS-2 UAUGAAACUCUCGAAAA 
my $MzL_RTSrc5 = "UUUUCGA";     #MzL 5' catalytic arm UUUUCGA 
my $MzL_Loop = "CUGAUGAG";      #  catalytic core CUGAUGAG 
my $MzL_stem2 = "UGA";          # Stem II UGA 
my $MzL_NTSrc3;                 #  3' sensor arm 
my $MzR_NTSrc5;                 #MzR 5' sensor arm 
my $MzR_stem2 = "AGCA";         #  Stem II AGCA 
my $MzR_Loop = "CGAA";          # catalytic core CGAA 
my $MzR_RTSrc3 = "AGUUUCAUA";   #  3' catalytic arm AGUUUCAUA 
my $Loop = "gaaa";              #Linker Unfolded loop gaaa 
 
foreach $i (0..$#cat) { 
   print "\n************************Designing Mz for 
$cat[$i]...************************\n"; 
   mz_design($cat[$i], $NTS_path[$i]); 




# sub mz_design($cat, $NTS_path) to 
 # $_[0]: category of NTS, e.g. Malaria, Dengue. 
 # $_[1]: full path info of text file containing NTS names & seqs. 
 # Function: Create & test all possible Mz combination with given STS 
& Mz Stem2 seq. 
 # Output: for all qualified Mz designs: 
   # .seq files for Mz, NTS/NNS/Nothing, STS combined seq. 
   # .ct files for above. 
   # Summary files showing MzL & MzR seqs, & energy values for secondary 
structures generated. 
 263 
sub mz_design { 
 my $cat = $_[0]; 
 my $NTS_path = $_[1]; 
 my $fold_seq_path = "C:\\eSRS\\Fold_seq\\$cat\\"; 
 my $fold_seq_func_path = 
"C:\\eSRS\\Fold_seq\\Functional\\$cat\\"; 
 my $ct_path = "C:\\eSRS\\CT\\$cat\\"; 
 my $ct_func_path = "C:\\eSRS\\CT\\Functional\\$cat\\"; 
 system("mkdir \"$fold_seq_path\""); 
 system("mkdir \"$fold_seq_func_path\""); 
 system("mkdir \"$ct_path\""); 
 system("mkdir \"$ct_func_path\""); 
 system("mkdir \"$eSRS_seq_path\""); 
  
 open NTS, "$NTS_path" or die "Can't read $NTS_path: $!\n"; 
 my @NTS; 
 my $iter = 0; 
 # Get list of NTS names and sequences into array, @NTS. 
 while (<NTS>) { 
    chomp $_; 
 # Extract patterns from NTS_n\tNTS_s 
    if ($_ =~ /^(.*)\t(.*)$/) { 
       my $NTS_n = $1; # print $NTS_n; 
       my $NTS_s = $2; # print ":\t$NTS_s\n"; 
 # Ensure $NTS_s is in RNA form (Convert all T to U). 
       $NTS_s = rc(rc($NTS_s, R), R); 
       $NTS[$iter] = [$NTS_n,$NTS_s]; 
       $iter++; 
    } 
 } 
 close NTS; 
 
 # Possible MzL & MzR pairs of Stem II. 
 #  @stem = [\@P1, \@P2, ...] 
 # @P1 = [StemII Name, StemII L, StemII R] 
 # Naming: <StemII L,StemII R (made up to 3 char per stem with "-")> 
 #  e.g.: UGA,AGCA 
 my @stem2; 
 $stem2[0] = [$MzL_stem2.",".$MzR_stem2, $MzL_stem2, $MzR_stem2]; 
  
 # Possible MzL & MzR pairs of sensor arm. 
 # @NTSrc = [\@NTS_1, \@NTS_2, ...] 
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 #  @NTS_1 = [NTS Name, \@P1, \@P2, ...] 
 #   @P1 = [SAS, NTS' L, NTS' R] 
 # SAS: 01-99. 
 my @NTSrc; 
 foreach $i_NTS (0..$#NTS) { 
    # Get NTS name. 
    $NTSrc[$i_NTS][0] = $NTS[$i_NTS][0]; 
    my $NTS = $NTS[$i_NTS][1]; 
    my $NTS_length = length($NTS); 
    my $NTSrc = rc($NTS, "R"); 
    foreach $i_pos (1..($NTS_length-1)) { 
       $NTSrc[$i_NTS][$i_pos] = [pad($i_pos, 0, 2, F), 
seq_split($NTSrc, $i_pos, A)]; 
    } 
 } 
  
 # Possible MzL & MzR pairs 
 # @mz = [\@NTS_1, \@NTS_2, ...] 
 #  @NTS_1 = [NTS Name, \@StemII_P1, \@StemII_P2, ...] 
 #   @StemII_P1 = [StemII Name, \@NTS_P1, \@NTS_P2, ...] 
 #    @NTS_P1 = [Mz Name, MzL, MzR] 
 #  Naming: 
 #  "Mz_<NTS Name, less "sNTS">_<StemII Name>_<SAS (01-99)>" 
 #  e.g.: #Mz_Mfr1_UGA,AGCA_01 
 # MzL: 
 # 5' part of STS' (UUUUCGA);MzL loop (CUGAUGAG);StemII L (UGA);3' 
part of NTS' 
 # MzR: 
 # 5' part of NTS';StemII R(GCA);MzR loop (CGAA);3' part of 
STS'(AGUUUCAUA) 
 my @Mz; 
 my $i_NTS = 0; 
 
 # For each NTS: 
 
 foreach $ele_NTS (@NTS) { 
    my $NTS_name_l = $ele_NTS->[0]; # $NTS_name_l - Long form of 
NTS name. 
    $Mz[$i_NTS][0] = $NTS_name_l; 
    $NTS_name_l =~ /^sNTS-(.*)$/; 
    $NTS_name_s = $1;      # $NTS_name_s - Short form 
of NTS name (without "sNTS"). 
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    my $i_stem = 1; 
 
  # For each StemII: 
 
    foreach $ele_stem (@stem2) { 
       my $stem2_name = $ele_stem->[0]; 
       $stem2L = $ele_stem->[1]; 
       $stem2R = $ele_stem->[2]; 
       $Mz[$i_NTS][$i_stem][0] = $stem2_name; 
 
   # For each SAS of current NTS (read from @NTSrc): 
 
       foreach $ele_NTSrc_NTS (@NTSrc) { 
          if ($ele_NTSrc_NTS->[0] eq $NTS_name_l) { 
             my $i_NTSrc_pos = 1; 
             foreach $ele_NTSrc_pos 
(@{$ele_NTSrc_NTS}[1..$#{$ele_NTSrc_NTS}]) { 
                my $NTSrc_pos = $ele_NTSrc_pos->[0]; 
                my $NTSrc5 = $ele_NTSrc_pos->[1]; 
                my $NTSrc3 = $ele_NTSrc_pos->[2]; 
       
      # Create Mz Name, MzL, MzR. 
                $Mz[$i_NTS][$i_stem][$i_NTSrc_pos][0] = 
"Mz_".$NTS_name_s."_".$stem2_name."_"."$NTSrc_pos"; 
                $Mz[$i_NTS][$i_stem][$i_NTSrc_pos][1] = 
$MzL_RTSrc5.$MzL_Loop.$stem2L.$NTSrc3; 
                $Mz[$i_NTS][$i_stem][$i_NTSrc_pos][2] = 
$NTSrc5.$stem2R.$MzR_Loop.$MzR_RTSrc3; 
                $i_NTSrc_pos ++; 
             } 
          } 
       } 
       $i_stem ++; 
    } 
    $i_NTS ++; 
 } 
    
 print "\@Mz is:\n"; 
 print_a(\@Mz, 0); 
  
 # Get functional Mz. 
 my @Mz_func; 
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 push @Mz_func, [qw (Category MzL_Name MzL MzR_Name MzR NTS 
Energy)]; 
 foreach $NTS (@NTS) { 
    push @{$Mz_func[-1]}, ("NTS", "Energy"); 
 } 
 
 foreach $i_NTS (0..$#NTS) { 
  # Create list of NNS. 
    my @NNS; 
    if ($i_NTS == 0) { 
       @NNS = @NTS[1..$#NTS]; 
    } elsif ($i_NTS != $#NTS) { 
       @NNS = @NTS[0..($i_NTS-1),($i_NTS+1)..$#NTS]; 
    } elsif ($i_NTS == $#NTS) { 
       @NNS = @NTS[0..($i_NTS-1)]; 
    } 
    my $NTS_n_l = $NTS[$i_NTS]->[0]; 
    my $NTS = $NTS[$i_NTS]->[1]; 
    $NTS_n_l =~ /^sNTS-(.*)$/; 
    my $NTS_n_s = $1; 
    foreach $ele_mz_0 (@Mz) {      # $ele_mz_0 = 
\@NTS_1 
   # Only proceed to use Mz designs for current NTS. 
       if ($ele_mz_0->[0] eq $NTS_n_l) { print "\n\nLT01";  
          my @ele_mz_2 = @{$ele_mz_0->[1]}; # @ele_mz_2 = 
@StemII_P1 
          shift @ele_mz_2;       # Remove 
$StemII_P1[0], i.e. StemII Name. 
          foreach $ele_mz_2 (@ele_mz_2) {  # $ele_mz_2 = 
\@NTS_P1...\@NTS_Pn. 
             my $Mz_n = $ele_mz_2->[0];   # $ele_mz_2->[0] = 
Mz Name 
               $Mz_n =~ /^(Mz)(.*)$/; 
               my $MzL_n = $1."L".$2; 
               my $MzR_n = $1."R".$2; 
               my $MzL = $ele_mz_2->[1];   # $ele_mz_2->[1] = MzL 
               my $MzR = $ele_mz_2->[2];   # $ele_mz_2->[2] = MzR 
               my $energy_T = "-"; my $energy_A = "-"; my @energy_N; 
               my $active_T = 1; my $active_A = 0; my $active_N = 0; 
 
     # Test fold_seq_T. 
               my $fold_seq_T = assemble(T, $MzL, $MzR, $NTS); 
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     print "\nMzL: $MzL_n:$MzL,\tMzR: 
$MzR_n:$MzR,\tfold_seq_T:$fold_seq_T\n"; 
     #Naming: <Mz Name>_<T/N/A>_<NTS name , less 
"sNTS">.<seq/ct>. E.g.: Mz_Mfr1_UGA,AGCA_01_T_Mfr1.seq 
               my $fold_seq_T_n = $Mz_n."_T_".$NTS_n_s.'.seq'; 
               my $fold_ct_T_n = $Mz_n."_T_".$NTS_n_s.'.ct'; 
               write_seq($fold_seq_path.$fold_seq_T_n, $fold_seq_T); 
               RNAstructure($fold_seq_path.$fold_seq_T_n, 
$ct_path.$fold_ct_T_n, "-w 3"); 
               my @line_s = @{(stable($ct_path.$fold_ct_T_n))[0]}; 
               my $len = (stable($ct_path.$fold_ct_T_n))[2]; 
               my @ss_active = ss_active($len);      # 
Determine active ss template based on total length. 
     # If any of the most stable ss is inactive, Mz design 
is considered invalid. 
               foreach $line_s (@line_s) { 
                  if (active($ct_path.$fold_ct_T_n, $line_s, 
\@ss_active) == 0) { 
                     $active_T = 0; 
                     $energy_T = "!"; 
                     foreach $i_energy_N (@energy_N[0..$#NNS]) { 
                        @{$i_energy_N} = ("-", "-"); 
                     } 
                     last; 
                  } 
               } 
               if ($active_T == 1) { 
                  $energy_T = (stable($ct_path.$fold_ct_T_n))[1]; 
 
      # Test fold_seq_A. 
                  my $fold_seq_A = assemble(A, $MzL, $MzR, $NTS); 
      #Naming: <Mz Name>_<T/N/A>_<NTS name , less 
"sNTS">.<seq/ct>. E.g.: Mz_Mfr1_UGA,AGCA_01_A_Mfr1.seq 
                  my $fold_seq_A_n = $Mz_n."_A_".$NTS_n_s.'.seq'; 
                  my $fold_ct_A_n = $Mz_n."_A_".$NTS_n_s.'.ct'; 
                  write_seq($fold_seq_path.$fold_seq_A_n, 
$fold_seq_A); 
                  RNAstructure($fold_seq_path.$fold_seq_A_n, 
$ct_path.$fold_ct_A_n, "-w 3"); 
                  my @line_s = @{(stable($ct_path.$fold_ct_A_n))[0]}; 
                  my $len = (stable($ct_path.$fold_ct_A_n))[2]; 
                  print "$ct_path.$fold_ct_A_n \$len is $len.\n"; 
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                  my @ss_active = ss_active($len); 
      # If any of the most stable ss is active, Mz design 
is considered invalid. 
                  foreach $line_s (@line_s) { 
                     if (active($ct_path.$fold_ct_A_n, $line_s, 
\@ss_active) == 1) { 
                        $active_A = 1; 
                        $energy_A = "!"; 
                        foreach $i_energy_N (@energy_N[0..$#NNS]) { 
                           @{$i_energy_N} = ("-", "-"); 
                        } 
                        last; 
                     } 
                  } 
                  if ($active_A == 0) { 
                     $energy_A = (stable($ct_path.$fold_ct_A_n))[1]; 
        
       # Test fold_seq_N. 
       my $NNS_check = 0; 
                     foreach $i_NNS (0..$#NNS) { 
        if ($NNS_check == 1) { 
                         foreach $i_energy_N 
(@energy_N[$i_NNS..$#NNS]) { 
                            @{$i_energy_N} = ("-", "-"); 
                         } 
         last; 
        } 
                        my $NNS_n_l = $NNS[$i_NNS]->[0]; 
                        my $NNS = $NNS[$i_NNS]->[1]; 
                        $NNS_n_l =~ /^sNTS-(.*)$/; 
                        my $NNS_n_s = $1; 
        print "\$NNS_n_l = $NNS_n_l, \$NNS_n_s = 
$NNS_n_s\n"; 
                        my $fold_seq_N = assemble(N, $MzL, $MzR, $NNS); 
        #Naming: <Mz Name>_<T/N/A>_<NTS name , 
less "sNTS">.<seq/ct>. E.g.: Mz_Mfr1_UGA,AGCA_01_N_Mfr2.seq 
                        my $fold_seq_N_n = $Mz_n."_N_".$NNS_n_s.'.seq'; 
                        my $fold_ct_N_n = $Mz_n."_N_".$NNS_n_s.'.ct'; 
                        write_seq($fold_seq_path.$fold_seq_N_n, 
$fold_seq_N); 
                        RNAstructure($fold_seq_path.$fold_seq_N_n, 
$ct_path.$fold_ct_N_n, "-w 3"); 
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                        my @line_s = 
@{(stable($ct_path.$fold_ct_N_n))[0]}; 
                        my $len = (stable($ct_path.$fold_ct_N_n))[2]; 
                        my @ss_active = ss_active($len); 
        # If any of the most stable ss is active, 
Mz design is considered invalid. 
                        foreach $line_s (@line_s) { 
                           $energy_N[$i_NNS][0] = $NNS_n_s; 
                           if (active($ct_path.$fold_ct_N_n, $line_s, 
\@ss_active) == 1) { 
                              $active_N = 1; $NNS_check = 1; 
                              $energy_N[$i_NNS][1] = "!"; 
                              last; 
                           } 
                           $energy_N[$i_NNS][1] = 
(stable($ct_path.$fold_ct_N_n))[1]; 
                        } 
                     } 
                  } 
               } 
     # If Mz is suitable, move all seq, ct files into 
"Functional" folder. 
               if (($active_T == 1) and ($active_A == 0) and ($active_N 
== 0)) { 
                  opendir DH, $fold_seq_path or die "Couldn't open the 
Directory $fold_seq_path\n$!"; 
                  while ($_ = readdir(DH)) { 
       # Extract patterns from: 
       #<Mz Name>_<T/N/A>_<NTS name , less 
"sNTS">.<seq/ct> 
       #e.g.: Mz_Mfr1_UGA,AGCA_01_T_Mfr1.seq 
                     if ($_ =~ /^$Mz_n.*$/) { 
                        my $file_n = $_; 
        print "\nMoving .seq files\n"; 
        print "move /Y 
\"$fold_seq_path$file_n\" \"$fold_seq_func_path$file_n\""; 
                        system("move /Y \"$fold_seq_path$file_n\" 
\"$fold_seq_func_path$file_n\""); 
                     } 
                  } 
                  opendir DH, $ct_path or die "Couldn't open the 
Directory $ct_path\n$!"; 
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                  while ($_ = readdir(DH)) { 
       # Extract patterns from: 
       #<Mz Name>_<T/N/A>_<NTS name , less 
"sNTS">.<seq/ct> 
       #e.g.: Mz_Mfr1_UGA,AGCA_01_T_Mfr1.ct 
                     if ($_ =~ /^$Mz_n.*$/) { 
                        my $file_n = $_; 
        print "\nMoving .ct files\n"; 
        print "move /Y \"$ct_path$file_n\" 
\"$ct_func_path$file_n\""; 
                        system("move /Y \"$ct_path$file_n\" 
\"$ct_func_path$file_n\""); 
                     } 
                  } 
               } 
     # Write @Mz_func; 
     # (Category, MzL Name, MzL, MzR Name, MzR, Energies: 
fold_seq_t, fold_seq_a, fold_seq_n1, fold_seq_n2, fold_seq_n3) 
               push @Mz_func, [$cat, $MzL_n, $MzL, $MzR_n, $MzR, 
$NTS_n_s, $energy_T, "A", $energy_A]; 
               foreach $i (@energy_N) { 
                  push @{$Mz_func[-1]}, @{$i}; 
               } 
          } 
       } 
    } 
 } 
 # print @Mz_func. 
 my $Sensor_seq = "Sensor_Seq_$cat\.txt"; 




# sub _2d_print(\@chk, "\t", ">$chk_file") to 
 # $_[0]: 2d array; $_[1]: delimiter Enclose with care! 
   # '' only process \\ and \' All else are taken literally!! 
   # E.g. '\t' is a string, equivalent with '\\t' and "\\t". 
   # "\t" is a Tab char, and a Tab is still a Tab when using \Q. 
 # $_[2]: Output file to print to, 
   # include > to overwrite, or >> to append. 
   # print to stdout if file not given; 
 # $_[3]: n - no delimiter for last column, 
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   # by default the there will be delimiter for all coluNNS; 
   # if printing to stdout, use "" for $_[2]. 
 # no output. Print 2d array separated by delimiter. 
sub _2d_print { 
   my @array_in = @{$_[0]}; 
   my $dlm = $_[1]; 
   my $file_out = $_[2]; 
   my $last_col = 1; 
   $last_col = 0 if ($_[3] eq 'n'); 
   if ($file_out) { 
      open FILE, "$file_out"; 
      if ($last_col == 1) { 
         foreach $i_01 (@array_in) { 
            print FILE $i_01 if !(@{$i_01});   # print entry that is not 
an array reference. 
            foreach $i_02 (@{$i_01}) { 
               print FILE "$i_02$dlm"; 
            } 
            print FILE "\n"; 
         } 
      } elsif ($last_col == 0) { 
         foreach $i_01 (@array_in) { 
            print FILE $i_01 if !(@{$i_01});   # print entry that is not 
an array reference. 
            foreach $i_02 (@{$i_01}) { 
               if ($i_02 eq $i_01->[-1]) { 
                  print FILE "$i_02"; 
               } else { 
                  print FILE "$i_02$dlm"; 
               } 
            } 
            print FILE "\n"; 
         } 
      } 
      close FILE; 
   } else { 
      if ($last_col == 1) { 
         foreach $i_01 (@array_in) { 
            print $i_01 if !(@{$i_01});   # print entry that is not an 
array reference. 
            foreach $i_02 (@{$i_01}) { 
               print "$i_02$dlm"; 
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            } 
            print "\n"; 
         } 
      } elsif ($last_col == 0) { 
         foreach $i_01 (@array_in) { 
            print $i_01 if !(@{$i_01});   # print entry that is not an 
array reference. 
            foreach $i_02 (@{$i_01}) { 
               if ($i_02 eq $i_01->[-1]) { 
                  print "$i_02"; 
               } else { 
                  print "$i_02$dlm"; 
               } 
            } 
            print "\n"; 
         } 
      } 
   } 
} 
 
# sub assemble(T/N/A, "$MzL", "$MzR", "$NTS") to 
 # $_[0]: T, N, A to indicate type of NTS. A: "Alone", i.e. no NTS, 
 # $_[1]: MzL seq. 
 # $_[2]: MzR seq. 
 # $_[3]: NTS seq. 
   # Includes both NTS & NNS seqs. 
 # Output: Assembled fold_seq. 
sub assemble { 
   my $type = $_[0]; 
   my $MzL = $_[1]; 
   my $MzR = $_[2]; 
   my $NTS = $_[3]; 
print "Starting assemble() for \$type = $type...\t"; 
   my $fold_seq; 
   if ($type eq A) { 
#fold_seq_a 
#RTS, Loop, MzL, Loop, MzR. 
      $fold_seq = $RTS2.$Loop.$MzL.$Loop.$MzR; 
   } elsif (($type eq T)|($type eq N)) { 
#fold_seq_t/n 
#RTS, Loop, MzL, Loop, NNS, Loop, MzR. 
      $fold_seq = $RTS2.$Loop.$MzL.$Loop.$NTS.$Loop.$MzR; 
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   } 
print "Finishing assemble()\n"; 
   return $fold_seq; 
} 
 
# sub RNAstructure($fold_seq_path.$fold_seq_N_n, 
$ct_path.$fold_ct_N_n, "-w 3") to 
 # $_[0]: $fold_seq .seq file with full path info. 
 # $_[1]: $fold_seq .ct file with full path info. 
 # $_[2]: Parameters for RNAstructure 4.5. 
 # Function: Create CT for given fold_seq. 
   # Note that RNAstructure command will only work when given in working 
Directory that has RNAstructure installed. A simple way to achieve this 
is to use chdir EXPR to change working directory to EXPR. If EXPR is 
omitted, changes to home directory. Returns T upon success, F otherwise. 
 # Output: .ct text file. 
sub RNAstructure { 
print "Starting RNAstructure()...\n"; 
   my $fold_seq = $_[0]; 
   my $fold_seq_ct = $_[1]; 
   my $para = $_[2]; 
   my $sys = "RNAstructure /fold -s $fold_seq -c $fold_seq_ct $para"; 
 
   chdir $RNAst_path; 
   print "system(\"$sys\");", "\n"; 
   system("$sys"); 
print "Finished RNAstructure()\n"; 
 
#-d - to use DNA folding parameters. 
#-n xxxx to indicate the maximum number of structures (20 is assumed). 
#-w xxxx to indicate the window size (5 is assumed, 3 is suggested ). 
#-p xxxx to indicate the maximum percent difference (20% is assumed). 
Specify percent as integer. 
} 
 
# sub write_seq($fold_seq_name, $fold_seq) to 
 # $_[0]: $fold_seq Name with full path info. 
 # $_[1]: fold_seq. 
 # Function: write fold_seq as text file in RNAstructure 4.5 format 
for .seq file. 
 # Output: .seq text file. 
sub write_seq { 
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   my $fold_seq_n = $_[0]; 
   my $fold_seq = $_[1]; 
print "Starting write_seq() for $fold_seq_n...\t"; 
# delete old files of the same name, if exist. 
   system("del \"$fold_seq_n\""); 
   open SEQ, ">$fold_seq_n" or die "$fold_seq_n: $!\n"; 
# Write to .seq file: 
# ";\n" # ";" to indicate start of file. 
   print SEQ ";\n"; 
# "fold_seq_name\n" # Title. 
   print SEQ "$fold_seq_n\n"; 
# Sequence "\n" 
   print SEQ "$fold_seq\n"; 
# "1" # Sequence must end with "1". 
   print SEQ "1"; 
   close SEQ; 
print "Finished write_seq()\n"; 
} 
 
# sub stable($ct_path.$fold_ct_T_n) to 
 # $_[0]: $fold_seq .ct file with full path info. 
 # Function: Check for number of most stable structures, return starting 
line of each, the energy, and fold_seq length ($len). 
 # Output: (Array ref of starting lines; Lowest energy, $len). 
sub stable { 
   my $ct = $_[0]; 
 print "Starting stable() for $ct...\t"; 
   my @line_s; my @energy; my $line_c = 0; my $len; 
   open CT, "$ct" or die "Can't read $ct: $!\n"; 
 
   while (<CT>) { 
      $line_c ++; 
      chomp; 
  # Extract patterns from CT for: 
  #   111  ENERGY = -43.4  
C:\eSRS\Fold_seq\Mz_Mfr1_UGA,AGCA_01_T_Mfr1.seq 
      if ($_ =~ /^\s*(\d*)\s*ENERGY = (\S*)\s*.*$/) { 
         $len = $1;   #print "\$1 is $1\n"; 
         push @energy, $2; #print "01: \$len: $len\tEnergy: $2\n"; 
         push @line_s, $line_c; 
         if (scalar @energy > 1) { 
    # Check if the last entry has more positive energy than 
 275 
previous entries, if so, reject it and end searh. 
            if ($energy[-1] > $energy[-2]) { 
               pop @line_s; pop @energy; 
     print "Finishing stable()\n"; 
               close CT; 
               return (\@line_s, $energy[0], $len); 
            } 
         } 
      } 
   } 
 print "Finishing stable()\n"; 
   close CT; 
   return (\@line_s, $energy[0], $len); # This line will only be reached 




# sub ss_active($len) to 
 # $_[0]: length of fold_seq. 
 # Function: Determine active ss of fold_seq of such length. 
 # Output: @ss_active. 
sub ss_active { 
   $len = $_[0]; 
   my @ss_active; 
   $ss_active[0] = [8,$len-7]; 
   $ss_active[1] = [9,$len-8]; 
   $ss_active[2] = [10,0]; 
   $ss_active[3] = [11,28]; 
   $ss_active[4] = [29,0]; 
   $ss_active[5] = [30,0]; 
   $ss_active[6] = [31,0]; 
   $ss_active[7] = [32,0]; 
   $ss_active[8] = [33,0]; 
   $ss_active[9] = [34,0]; 
   $ss_active[10] = [35,0]; 
   $ss_active[11] = [36,$len-12]; 
   $ss_active[12] = [$len-11,0]; 
   $ss_active[13] = [$len-10,0]; 
   $ss_active[14] = [$len-9,0]; 




# sub active($ct_path.$fold_ct_T_n, $line_s, \@ss_active) to 
 # $_[0]: $fold_seq .ct file with full path info. 
 # $_[1]: Starting line to check. 
 # $_[2]: @ss_active. 
 # Function: Check starting from $line_s against @ss_active for exact 
match for active structure. 
 # Output: 1 for active structure, 0 for inactive structure. 
sub active { 
   my $ct = $_[0]; 
   my $line_s = $_[1]; my $line_c = 0; my $pos_s = 0; my $pos = 0; my 
$iter_ss = 0; 
   my $n; my $pp; my $active = 0; 
   my @ss_check = @{$_[2]}; 
print "Starting active() for $ct...\n"; 
   open CT, "$ct" or die "Can't read $ct: $!\n"; 
#  111  ENERGY = -43.4  
C:\eSRS\Fold_seq\Mz_Mfr1_UGA,AGCA_01_T_Mfr1.seq 
#    1 U       0    2  111    1 
# CT file: 2nd line onwards, each line has info about a given base, 
from left to right: 
# Base number, n;# Base.;# n-1.;# n+1.;# Number of the base to which 
n is paired. No pairing is indicated by 0 (zero).;# Natural numbering.  
RNAstructure ignores the actual value given in natural numbering, so 
it is easiest to repeat n here. 
   while (<CT>) { 
      chomp; 
      if (++$line_c == $line_s) { 
         $pos_s = 1;    #print "\$pos_s = $pos_s\n'"; 
         next; 
      } 
      if ($pos_s == 1) { 
         $pos ++; 
# Extract patterns from CT for: 
#     1 U       0    2  111    1 
         $_ =~ /^\s*(\d+)\s*\w\s*\d+\s*\d+\s*(\d*)\s*\d*$/; 
         $n = $1; $pp = $2; 
         my @ss_check_c = @{$ss_check[$iter_ss]}; 
         if ($n != $pos) { 
            print "Error: \$pos = $pos, \$n = $n\n"; 
            last; 
         } elsif ($pos == $ss_check[$iter_ss]->[0]) { 
             if ($pp == $ss_check[$iter_ss]->[1]) { 
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                print "At pos $pos, pairing partner is #$pp, same as 
expected ($ss_check[$iter_ss]->[1])\.\n"; 
                $iter_ss ++; 
      # If we've checked the last of the 15 bases (as 
active), end function and return structure as active. 
                if ($iter_ss == scalar(@ss_check)) { 
                   $active = 1; 
       print "Finishing active(), \$active = 
$active.\n"; 
                   close CT; 
                   return $active; 
                } 
                next; 
             } else { 
                $active = 0; 
                print "Not active: At pos $pos, pairing partner is #$pp 
instead of $ss_check[$iter_ss]->[1].\n"; 
      print "Finishing active(), \$active = $active.\n"; 
                close CT; 
                return $active; 
             } 
         } 
      } 
   } 
# if file ends before reaching 1st element of @ss_check: 
   if ($iter_ss != scalar(@ss_check)) { 
      print "CT file is finished, but we've yet to check element $iter_ss 
of \@ss_check!\n"; 
  print "Finishing active(), \$active = $active.\n"; 
   } 
} 
 
# sub com($seq, "D") to 
 # $_[0]: DNA/RNA seq to complement; $_[1] D, R; 
 # Function: Complement DNA/RNA seq. 
 # if D given, output will have T instead of U. 
 # if R given, output will have U instead of T. 
 # Output: Complemented DNA/RNA seq. 
sub com { 
   my $seq = $_[0]; 
   my $seq_com = $seq; 
   if ($_[1] eq "D") { 
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      $seq_com =~ tr/ATUGC/TAACG/; 
   } elsif ($_[1] eq "R") { 
      $seq_com =~ tr/AUTGC/UAACG/; 
   } 
   return $seq_com; 
} 
 
# sub pad($text, 0, 2, F) to 
 # $_[0]: text to pad; $_[1]: Char used to pad; $_[2]: Number of char 
after padding; 
 # $_[3]: "F" to pad in front, "B" to pad at back; 
 # Function: Pads text with char till given length. 
 # Output: Padded text. 
sub pad { 
   my ($text, $char, $length, $FB) = @_; 
   my $extra = $length-length($text); my $text_pad = $text; 
   if ($extra > 0) { 
      if ($FB eq "F") { 
         $text_pad = ($char x ($extra)).$text; 
      } elsif ($FB eq "B") { 
         $text_pad = $text.($char x ($extra)); 
      } 
   } 
   return $text_pad; 
} 
 
# sub print_a($array, 0) to 
 # $_[0]: Reference of array to print; $_[1]: 0 - Level of indent for 
1st level of array; 
 # print all elements of array. 
 # All lower dimension (i.e., referenced) array to start on new line, 
with 1 more indent. 
 # Outputs reverse complemented DNA/RNA seq. 
sub print_a { 
   my $array = $_[0]; 
   my @array = @{$array}; 
   my $indent = $_[1]; 
   my $indent_c = 0; 
   foreach $ele (@array) { 
      if (ref($ele)) { 
         $indent ++; 
         print_a ($ele, $indent); 
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         $indent--; 
         $indent_c = 0; 
      } else { 
         if ($indent_c > 0) { 
            print "$ele\t"; 
         } else { 
            print "\n","\t"x($indent), "L$indent: ", "$ele\t"; 
            $indent_c ++; 
         } 
      } 
   } 
} 
#my @array_1 = [1,2,3]; my @array_2 = (1,2,3,["4a", "4b", ["4c"]],5); 
#print_a(\@array_2, 0); 
 
# sub rc($Seq, D) to 
 # $_[0]: DNA/RNA seq to reverse complement; $_[1] D, R; 
 # Function: Reverse complement DNA/RNA seq. 
 # Output: Reverse complemented DNA/RNA seq. 
sub rc { 
   my $seq = $_[0]; 
   my $type = $_[1]; 
   return rev(com($seq, $type)); 
} 
#print "$RTS2\n"; 
#print rc(rc($RTS2, R), R), "\n"; 
 
# sub rev($text) to 
 # $_[0]: text seq to reverse; 
 # Function: Reverse text seq. 
 # Output: Reversed text seq. 
sub rev { 
   my $seq = $_[0]; 
   my @seq_f; my @seq_r; my $seq_r; 
# Extract individual letters from text seq, and put each in an array. 
   while ($seq) { 
      if ($seq =~ /^(\w)(.*)$/) { 
         push @seq_f, $1; $seq = $2; 
      } 
   } 
   @seq_r = reverse(@seq_f); 
   foreach $i (@seq_r) { 
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      $seq_r = $seq_r . $i; 
   } 
   return $seq_r; 
} 
 
# sub seq_split($NTSrc, $i_pos, "5") to 
 # $_[0]: text to split into two; $_[1]: Text position after which to 
split; 
 # $_[2]: 5 to return 1st half of split text, 3 to return 2nd half of 
split text, "A" to return both fragments as a list; 
 # Function: Splits text into two fragments. 
 # Output: One or both fragments. 
sub seq_split { 
   my ($seq, $i_pos, $frag) = @_; 
   my @frag; 
# Extract split $seq, and put each in @frag. 
   if ($seq =~ /^(\w{$i_pos})(.*)$/) { 
      @frag = ($1, $2); 
   } 
   if ($frag eq "5") { 
      return $frag[0]; 
   } elsif ($frag eq "3") { 
      return $frag[1]; 
   } elsif ($frag eq "A") { 
      return @frag; 
   } 
} 
